"DRUG_NAME"	"TC"	"Correlation"	"PValue"	"Compound..code.or.generic.name."	"Compound..brand.name."	"Target.s."	"Mechanism.of.action"	"Class"	"Highest.Phase"	"Organization"	"mTC"
"1"	13	"V414"	0.491135128	0	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	103
"2"	13	"V396"	-0.428705127	0	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	97
"3"	13	"V91"	-0.402241626	0	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	134
"4"	13	"V161"	-0.398767572	0	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	17
"5"	6	"V393"	0.384756622	4.31e-12	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	96
"6"	6	"V126"	-0.382897505	5.6e-12	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	9
"7"	6	"V396"	-0.382075372	6.28e-12	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	97
"8"	13	"V177"	-0.377525437	0	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	28
"9"	6	"V346"	-0.366144091	5.29e-11	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	80
"10"	6	"V381"	0.364981043	6.14e-11	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	91
"11"	8	"V12"	0.350208917	1.6e-15	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	8
"12"	23	"V126"	-0.347146148	3.03e-15	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	9
"13"	23	"V177"	-0.345594522	4.16e-15	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	28
"14"	13	"V32"	0.345382391	5.65e-15	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	72
"15"	6	"V177"	-0.344849054	7.37e-10	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	28
"16"	23	"V396"	-0.33909803	1.5e-14	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	97
"17"	7	"V177"	-0.338110216	4.08e-14	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	28
"18"	23	"V381"	0.335646794	2.91e-14	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	91
"19"	6	"V414"	0.326553147	6.05e-09	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	103
"20"	6	"V341"	-0.326113811	6.35e-09	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	78
"21"	15	"V9"	0.323278067	1.4e-11	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	131
"22"	15	"V9"	0.323278067	1.4e-11	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	132
"23"	23	"V207"	-0.319556488	5.4e-13	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	39
"24"	7	"V396"	-0.319376306	1.13e-12	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	97
"25"	23	"V393"	0.316405986	9.33e-13	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	96
"26"	15	"V414"	0.314094067	5.49e-11	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	103
"27"	15	"V381"	0.313644886	5.86e-11	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	91
"28"	6	"V90"	0.311088007	3.23e-08	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	133
"29"	15	"V161"	-0.304393932	2.21e-10	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	17
"30"	15	"V396"	-0.304162529	2.28e-10	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	97
"31"	15	"V280"	0.301002762	3.55e-10	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	61
"32"	7	"V414"	0.299944537	2.7e-11	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	103
"33"	13	"V241"	0.295383783	3.63e-11	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	48
"34"	13	"V405"	-0.292941411	5.32e-11	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	99
"35"	13	"V381"	0.288724194	1.02e-10	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	91
"36"	7	"V393"	0.2869363	1.99e-10	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	96
"37"	13	"V393"	0.286854285	1.36e-10	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	96
"38"	20	"V396"	-0.286771234	1.21e-10	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	97
"39"	13	"V462"	-0.285565567	1.65e-10	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	118
"40"	13	"V142"	0.283236129	2.35e-10	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	11
"41"	6	"V418"	0.281787332	6.05e-07	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	105
"42"	8	"V350"	-0.281307745	2.65e-10	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	82
"43"	6	"V161"	-0.280529633	6.81e-07	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	17
"44"	6	"V329"	-0.279274027	7.67e-07	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	75
"45"	15	"V393"	0.278628787	7.02e-09	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	96
"46"	23	"V414"	0.277980339	4.35e-10	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	103
"47"	16	"V177"	-0.277458538	4.7e-10	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	28
"48"	13	"V448"	-0.276414255	6.45e-10	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	113
"49"	7	"V381"	0.274099642	1.29e-09	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	91
"50"	6	"V102"	0.273845774	1.27e-06	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	3
"51"	16	"V414"	0.270072671	1.38e-09	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	103
"52"	13	"V9"	0.267052139	2.47e-09	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	131
"53"	13	"V9"	0.267052139	2.47e-09	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	132
"54"	3	"V12"	0.266888518	2.17e-09	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	8
"55"	6	"V95"	-0.266369937	2.5e-06	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	136
"56"	13	"V211"	-0.266197808	2.78e-09	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	42
"57"	13	"V418"	0.265717395	2.98e-09	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	105
"58"	13	"V265"	-0.263943694	3.81e-09	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	53
"59"	6	"V170"	0.263530794	3.21e-06	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	22
"60"	23	"V460"	-0.261527805	4.61e-09	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	116
"61"	5	"V12"	0.260449158	5.55e-09	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	8
"62"	6	"V207"	-0.260368326	4.24e-06	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	39
"63"	1	"V177"	0.259800514	6.07e-09	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	28
"64"	20	"V177"	-0.258094458	7.66e-09	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	28
"65"	15	"V177"	-0.256395299	1.06e-07	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	28
"66"	6	"V462"	-0.25559468	6.4e-06	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	118
"67"	7	"V91"	-0.255304448	1.69e-08	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	134
"68"	13	"V207"	-0.25496329	1.3e-08	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	39
"69"	16	"V207"	-0.254817138	1.15e-08	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	39
"70"	12	"V414"	0.253386963	1.45e-08	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	103
"71"	11	"V11"	0.252647739	1.55e-08	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	4
"72"	6	"V32"	0.252019261	8.67e-06	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	72
"73"	23	"V341"	-0.251426111	1.82e-08	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	78
"74"	20	"V414"	0.251020017	1.99e-08	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	103
"75"	15	"V21"	-0.250698555	2.05e-07	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	41
"76"	23	"V346"	-0.249845891	2.24e-08	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	80
"77"	6	"V2"	0.249471613	1.07e-05	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	37
"78"	7	"V207"	-0.247441228	4.69e-08	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	39
"79"	15	"V207"	-0.247074571	3.1e-07	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	39
"80"	20	"V462"	-0.245879565	3.9e-08	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	118
"81"	23	"V329"	-0.245684038	3.87e-08	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	75
"82"	21	"V207"	-0.245658861	3.88e-08	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	39
"83"	6	"V383"	0.245192168	1.53e-05	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	93
"84"	15	"V418"	0.244612772	4.08e-07	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	105
"85"	13	"V150"	0.244156197	5.35e-08	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	12
"86"	16	"V381"	0.243930316	4.86e-08	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	91
"87"	13	"V164"	0.243637967	5.72e-08	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	19
"88"	7	"V266"	-0.243400299	7.81e-08	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	54
"89"	22	"V12"	-0.242416858	5.9e-08	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	8
"90"	16	"V346"	-0.242278426	6.01e-08	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	80
"91"	22	"V396"	-0.241825056	6.36e-08	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	97
"92"	1	"V460"	0.24125437	7.06e-08	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	116
"93"	16	"V161"	-0.240967767	7.1e-08	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	17
"94"	6	"V358"	-0.240235918	2.28e-05	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	85
"95"	14	"V396"	0.239609378	8.44e-08	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	97
"96"	15	"V405"	-0.23953459	7.14e-07	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	99
"97"	6	"V320"	-0.238704314	2.58e-05	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	73
"98"	7	"V142"	0.238606323	1.42e-07	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	11
"99"	12	"V346"	-0.238512451	9.99e-08	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	80
"100"	23	"V90"	0.237695336	1.07e-07	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	133
"101"	23	"V462"	-0.23742492	1.11e-07	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	118
"102"	7	"V161"	-0.237281888	1.67e-07	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	17
"103"	20	"V207"	-0.235277948	1.5e-07	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	39
"104"	23	"V383"	0.234779307	1.54e-07	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	93
"105"	23	"V102"	0.234459207	1.61e-07	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	3
"106"	12	"V341"	-0.234342733	1.68e-07	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	78
"107"	15	"V176"	0.234219603	1.27e-06	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	27
"108"	23	"V161"	-0.23401485	1.7e-07	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	17
"109"	13	"V72"	-0.232509422	2.29e-07	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	125
"110"	15	"V154"	-0.232486077	1.52e-06	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	13
"111"	15	"V344"	-0.232085056	1.59e-06	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	79
"112"	8	"V150"	0.23062007	2.57e-07	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	12
"113"	14	"V455"	0.229585913	2.92e-07	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	114
"114"	12	"V396"	-0.229582467	3e-07	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	97
"115"	13	"V266"	-0.229506534	3.29e-07	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	54
"116"	13	"V459"	0.229266224	3.39e-07	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	115
"117"	13	"V95"	-0.229199212	3.42e-07	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	136
"118"	13	"V412"	0.229178121	3.43e-07	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	101
"119"	7	"V341"	-0.228504366	4.76e-07	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	78
"120"	17	"V414"	0.228098275	3.59e-07	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	103
"121"	6	"V281"	0.227598612	6.13e-05	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	62
"122"	15	"V448"	-0.22625088	2.91e-06	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	113
"123"	23	"V275"	-0.225713196	4.65e-07	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	59
"124"	7	"V10"	0.224980368	7.18e-07	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	1
"125"	15	"V266"	-0.224644684	3.43e-06	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	54
"126"	23	"V320"	-0.223930798	5.74e-07	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	73
"127"	7	"V448"	-0.223917569	8.12e-07	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	113
"128"	16	"V90"	0.223445968	6.08e-07	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	133
"129"	15	"V32"	0.223440918	3.88e-06	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	72
"130"	6	"V72"	-0.223205668	8.54e-05	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	125
"131"	18	"V320"	0.222852318	8.05e-07	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	73
"132"	4	"V332"	-0.222574929	6.92e-07	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	77
"133"	17	"V448"	-0.220757979	8.55e-07	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	113
"134"	12	"V393"	0.220708423	8.6e-07	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	96
"135"	21	"V258"	0.220563536	8.52e-07	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	50
"136"	13	"V102"	0.22013538	9.92e-07	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	3
"137"	13	"V170"	0.219516267	1.07e-06	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	22
"138"	15	"V341"	-0.219240424	5.92e-06	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	78
"139"	13	"V85"	-0.218971959	1.13e-06	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	130
"140"	14	"V332"	-0.218476326	1.09e-06	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	77
"141"	13	"V346"	-0.218175498	1.24e-06	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	80
"142"	16	"V341"	-0.216924088	1.3e-06	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	78
"143"	15	"V2"	0.215728031	8.38e-06	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	37
"144"	15	"V462"	-0.215465853	8.6e-06	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	118
"145"	15	"V281"	0.215310096	8.73e-06	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	62
"146"	17	"V9"	0.214753262	1.7e-06	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	131
"147"	17	"V9"	0.214753262	1.7e-06	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	132
"148"	7	"V460"	-0.214475188	2.35e-06	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	116
"149"	15	"V17"	0.214190904	9.74e-06	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	21
"150"	6	"V260"	0.213990914	0.000167579	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	52
"151"	6	"V91"	-0.213918878	0.000168446	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	134
"152"	15	"V63"	-0.212872259	1.11e-05	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	123
"153"	23	"V170"	0.21282556	2.06e-06	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	22
"154"	16	"V396"	-0.212696461	2.09e-06	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	97
"155"	23	"V32"	0.212325386	2.18e-06	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	72
"156"	23	"V418"	0.210238857	2.75e-06	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	105
"157"	15	"V142"	0.210208657	1.43e-05	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	11
"158"	7	"V55"	-0.209482242	4.05e-06	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	122
"159"	8	"V306"	0.209463461	3e-06	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	69
"160"	23	"V299"	-0.209207126	3.09e-06	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	66
"161"	3	"V306"	0.209137937	3.11e-06	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	69
"162"	7	"V186"	0.209116163	4.21e-06	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	33
"163"	20	"V393"	0.209031231	3.22e-06	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	96
"164"	16	"V393"	0.208663268	3.28e-06	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	96
"165"	20	"V161"	-0.208657275	3.36e-06	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	17
"166"	15	"V90"	0.208545609	1.68e-05	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	133
"167"	6	"V142"	0.206685115	0.000280406	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	11
"168"	12	"V207"	-0.206430789	4.28e-06	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	39
"169"	23	"V72"	-0.206378295	4.21e-06	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	125
"170"	13	"V55"	-0.206270751	4.66e-06	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	122
"171"	21	"V10"	0.206034969	4.37e-06	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	1
"172"	20	"V186"	0.205931059	4.52e-06	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	33
"173"	22	"V418"	0.205728857	4.51e-06	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	105
"174"	15	"V72"	-0.204769863	2.39e-05	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	125
"175"	15	"V460"	-0.203887242	2.59e-05	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	116
"176"	13	"V2"	0.203422355	6.32e-06	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	37
"177"	13	"V341"	-0.203379342	6.35e-06	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	78
"178"	13	"V329"	-0.203067033	6.57e-06	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	75
"179"	13	"V90"	0.202981631	6.63e-06	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	133
"180"	6	"V10"	0.202959343	0.000362197	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	1
"181"	8	"V382"	0.202761717	6.22e-06	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	92
"182"	7	"V344"	-0.20256031	8.43e-06	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	79
"183"	14	"V311"	-0.20219882	6.6e-06	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	71
"184"	1	"V418"	-0.201397888	7.34e-06	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	105
"185"	13	"V383"	0.200860295	8.29e-06	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	93
"186"	13	"V460"	-0.200823205	8.32e-06	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	116
"187"	15	"V10"	0.200425828	3.57e-05	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	1
"188"	16	"V258"	0.200027403	8.31e-06	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	50
"189"	23	"V91"	-0.200015034	8.32e-06	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	134
"190"	15	"V170"	0.199735613	3.8e-05	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	22
"191"	16	"V460"	-0.199507161	8.78e-06	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	116
"192"	6	"V275"	-0.199259955	0.000464964	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	59
"193"	18	"V150"	-0.198926684	1.1e-05	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	12
"194"	8	"V462"	-0.196375491	1.22e-05	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	118
"195"	12	"V381"	0.196304447	1.25e-05	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	91
"196"	5	"V418"	-0.196174142	1.27e-05	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	105
"197"	7	"V358"	-0.195746805	1.69e-05	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	85
"198"	13	"V291"	-0.195677994	1.42e-05	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	64
"199"	23	"V142"	0.19565232	1.31e-05	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	11
"200"	17	"V344"	-0.195595585	1.35e-05	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	79
"201"	4	"V405"	-0.195579906	1.35e-05	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	99
"202"	16	"V142"	0.195472711	1.34e-05	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	11
"203"	7	"V32"	0.195380807	1.76e-05	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	72
"204"	4	"V455"	0.195375596	1.38e-05	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	114
"205"	14	"V320"	0.195280337	1.36e-05	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	73
"206"	16	"V155"	0.195033921	1.4e-05	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	14
"207"	13	"V171"	-0.194368705	1.62e-05	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	23
"208"	1	"V306"	0.194169347	1.56e-05	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	69
"209"	21	"V95"	-0.193397204	1.65e-05	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	136
"210"	20	"V418"	0.193042243	1.75e-05	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	105
"211"	13	"V21"	-0.192864092	1.89e-05	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	41
"212"	7	"V9"	0.192730311	2.29e-05	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	131
"213"	7	"V9"	0.192730311	2.29e-05	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	132
"214"	19	"V72"	-0.192492977	4.33e-05	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	125
"215"	16	"V462"	-0.1924182	1.83e-05	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	118
"216"	15	"V91"	-0.192310746	7.37e-05	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	134
"217"	6	"V208"	-0.19228502	0.000735928	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	40
"218"	15	"V346"	-0.192179422	7.45e-05	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	80
"219"	11	"V177"	-0.192117575	1.88e-05	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	28
"220"	15	"V171"	-0.191595628	7.84e-05	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	23
"221"	12	"V156"	0.190969047	2.16e-05	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	15
"222"	15	"V358"	-0.190000474	9.01e-05	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	85
"223"	18	"V100"	0.19000039	2.72e-05	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	2
"224"	17	"V32"	0.189929455	2.4e-05	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	72
"225"	7	"V21"	-0.189315227	3.2e-05	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	41
"226"	4	"V311"	-0.188925509	2.65e-05	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	71
"227"	12	"V72"	-0.188875638	2.66e-05	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	125
"228"	24	"V12"	0.188873343	3.04e-05	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	8
"229"	16	"V10"	0.188071308	2.83e-05	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	1
"230"	22	"V393"	0.187999103	2.85e-05	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	96
"231"	17	"V161"	-0.186917315	3.23e-05	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	17
"232"	15	"V200"	-0.186852923	0.000118122	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	38
"233"	13	"V299"	-0.186680136	3.5e-05	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	66
"234"	14	"V393"	-0.186604518	3.27e-05	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	96
"235"	15	"V186"	0.186079308	0.000126161	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	33
"236"	15	"V299"	-0.185953857	0.000127512	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	66
"237"	23	"V2"	0.18552614	3.64e-05	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	37
"238"	19	"V155"	0.185357632	8.3e-05	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	14
"239"	16	"V448"	-0.185049241	3.81e-05	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	113
"240"	22	"V414"	0.184614253	3.98e-05	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	103
"241"	23	"V281"	0.184327262	4.09e-05	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	62
"242"	13	"V17"	0.184229452	4.44e-05	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	21
"243"	13	"V306"	-0.183961194	4.56e-05	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	69
"244"	4	"V85"	-0.183662746	4.44e-05	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	130
"245"	13	"V416"	0.183216887	4.9e-05	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	104
"246"	16	"V91"	-0.182253595	5e-05	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	134
"247"	12	"V2"	0.182068002	5.18e-05	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	37
"248"	7	"V170"	0.181849054	6.54e-05	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	22
"249"	11	"V95"	-0.181792698	5.23e-05	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	136
"250"	6	"V460"	-0.181675614	0.001437137	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	116
"251"	1	"V358"	0.18109375	5.69e-05	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	85
"252"	7	"V17"	0.181083734	7.03e-05	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	21
"253"	13	"V156"	0.18091228	6.1e-05	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	15
"254"	13	"V258"	0.180303765	6.46e-05	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	50
"255"	23	"V118"	0.180264064	6.05e-05	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	6
"256"	22	"V259"	-0.179718663	6.38e-05	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	51
"257"	17	"V95"	-0.179689016	6.51e-05	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	136
"258"	23	"V156"	0.179688199	6.4e-05	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	15
"259"	7	"V90"	0.179574797	8.09e-05	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	133
"260"	6	"V265"	-0.179272038	0.00166435	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	53
"261"	22	"V306"	-0.179253576	6.66e-05	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	69
"262"	22	"V72"	-0.179220244	6.69e-05	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	125
"263"	12	"V459"	0.179194733	6.82e-05	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	115
"264"	16	"V72"	-0.179096954	6.76e-05	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	125
"265"	17	"V142"	0.178648502	7.18e-05	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	11
"266"	4	"V9"	0.178625828	7.2e-05	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	131
"267"	4	"V9"	0.178625828	7.2e-05	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	132
"268"	11	"V393"	0.178498086	7.16e-05	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	96
"269"	6	"V416"	0.178485923	0.001745525	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	104
"270"	7	"V280"	0.178461524	8.97e-05	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	61
"271"	21	"V186"	0.1781297	7.41e-05	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	33
"272"	7	"V150"	0.177970438	9.38e-05	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	12
"273"	20	"V463"	-0.17785323	7.74e-05	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	119
"274"	23	"V10"	0.177773381	7.67e-05	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	1
"275"	6	"V156"	0.177737921	0.001826116	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	15
"276"	16	"V2"	0.177526974	7.85e-05	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	37
"277"	5	"V306"	0.177472645	8.02e-05	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	69
"278"	7	"V462"	-0.176861229	0.000103854	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	118
"279"	3	"V350"	-0.176707252	8.47e-05	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	82
"280"	17	"V17"	0.176540922	8.75e-05	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	21
"281"	15	"V95"	-0.176428978	0.000280671	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	136
"282"	20	"V95"	-0.176254988	8.99e-05	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	136
"283"	13	"V10"	0.175813719	9.84e-05	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	1
"284"	22	"V91"	-0.175782601	9.24e-05	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	134
"285"	10	"V21"	-0.175032379	0.000396081	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	41
"286"	7	"V320"	-0.17448578	0.000128848	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	73
"287"	16	"V32"	0.174474176	0.000104313	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	72
"288"	21	"V72"	-0.174446564	0.00010458	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	125
"289"	7	"V72"	-0.174404826	0.000129793	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	125
"290"	13	"V92"	-0.174344015	0.000112689	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	135
"291"	20	"V90"	0.174209718	0.000108649	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	133
"292"	6	"V291"	-0.174038114	0.002277145	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	64
"293"	15	"V55"	-0.173816355	0.000346122	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	122
"294"	17	"V160"	-0.173786913	0.000112964	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	16
"295"	13	"V63"	-0.173671293	0.00011985	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	123
"296"	14	"V460"	0.173626902	0.0001128	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	116
"297"	3	"V418"	-0.173562184	0.000113474	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	105
"298"	16	"V216"	-0.173451513	0.000114636	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	43
"299"	6	"V186"	0.173361729	0.002369842	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	33
"300"	6	"V405"	-0.17257729	0.00248165	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	99
"301"	13	"V350"	-0.171828916	0.000141715	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	82
"302"	7	"V265"	-0.171022254	0.000175588	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	53
"303"	7	"V95"	-0.170888957	0.000177671	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	136
"304"	12	"V142"	0.170825131	0.000148027	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	11
"305"	11	"V10"	0.17076206	0.000146561	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	1
"306"	11	"V396"	-0.170598685	0.000148747	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	97
"307"	6	"V171"	-0.170582477	0.002787966	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	23
"308"	5	"V161"	0.170444226	0.000153215	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	17
"309"	15	"V416"	0.170046717	0.00046596	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	104
"310"	17	"V21"	-0.169993589	0.000159573	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	41
"311"	16	"V156"	0.169782969	0.00016013	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	15
"312"	22	"V126"	-0.169706418	0.000161239	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	9
"313"	16	"V383"	0.169603843	0.000162736	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	93
"314"	11	"V414"	0.169549079	0.000163541	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	103
"315"	13	"V332"	-0.168940313	0.000183678	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	77
"316"	10	"V10"	0.168902555	0.000632675	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	1
"317"	23	"V95"	-0.168785141	0.000175165	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	136
"318"	17	"V216"	-0.168712311	0.000179032	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	43
"319"	15	"V350"	-0.16833222	0.000532362	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	82
"320"	22	"V381"	0.167987677	0.000188124	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	91
"321"	19	"V186"	0.167684065	0.000376662	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	33
"322"	23	"V208"	-0.167347024	0.00019918	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	40
"323"	6	"V55"	-0.16729604	0.003368364	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	122
"324"	4	"V11"	0.167120374	0.000206312	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	4
"325"	22	"V341"	-0.166687949	0.000211187	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	78
"326"	14	"V208"	0.166589287	0.000213041	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	40
"327"	18	"V332"	-0.166507666	0.000241808	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	77
"328"	7	"V346"	-0.166501455	0.000260701	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	80
"329"	12	"V383"	0.166184863	0.000224112	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	93
"330"	4	"V175"	-0.166181085	0.000224187	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	26
"331"	20	"V72"	-0.166106635	0.000225664	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	125
"332"	17	"V186"	0.165954709	0.000228707	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	33
"333"	13	"V166"	-0.165740959	0.000243629	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	20
"334"	14	"V418"	-0.165266289	0.000239433	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	105
"335"	7	"V118"	0.165214327	0.000291226	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	6
"336"	13	"V200"	-0.165205482	0.000255298	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	38
"337"	6	"V118"	0.165078837	0.003819687	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	6
"338"	12	"V405"	-0.165004329	0.000248629	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	99
"339"	6	"V459"	0.164589243	0.003926444	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	115
"340"	17	"V418"	0.164498748	0.000259878	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	105
"341"	23	"V9"	0.164201642	0.000262861	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	131
"342"	23	"V9"	0.164201642	0.000262861	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	132
"343"	2	"V258"	0.163960707	0.000272371	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	50
"344"	23	"V55"	-0.163260557	0.000285339	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	122
"345"	14	"V9"	0.163256144	0.000285449	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	131
"346"	14	"V9"	0.163256144	0.000285449	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	132
"347"	4	"V447"	-0.163228696	0.000290271	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	112
"348"	4	"V320"	0.16296996	0.000296857	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	73
"349"	1	"V11"	0.162926358	0.00029798	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	4
"350"	16	"V294"	-0.162673674	0.000300253	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	65
"351"	6	"V463"	-0.162565113	0.004397051	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	119
"352"	14	"V439"	0.162407565	0.000307253	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	110
"353"	7	"V418"	0.161865241	0.000387016	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	105
"354"	13	"V186"	0.161691637	0.00034583	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	33
"355"	23	"V358"	-0.16127887	0.000338671	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	85
"356"	1	"V12"	0.16126262	0.000343939	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	8
"357"	13	"V367"	-0.161209251	0.000360374	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	88
"358"	23	"V258"	0.161190404	0.000341256	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	50
"359"	20	"V299"	-0.160855165	0.000356162	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	66
"360"	7	"V405"	-0.160849584	0.000421425	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	99
"361"	12	"V186"	0.160815112	0.000357385	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	33
"362"	23	"V171"	-0.160728708	0.000355049	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	23
"363"	13	"V344"	-0.160694553	0.000376521	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	79
"364"	3	"V150"	0.160667649	0.000356912	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	12
"365"	16	"V291"	-0.160384562	0.000365667	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	64
"366"	21	"V414"	0.160361627	0.000366385	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	103
"367"	6	"V258"	0.160353773	0.004968895	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	50
"368"	12	"V102"	0.160289795	0.000373794	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	3
"369"	22	"V177"	-0.160131734	0.000373656	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	28
"370"	23	"V24"	0.159980372	0.000378516	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	47
"371"	7	"V2"	0.159963728	0.000453741	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	37
"372"	17	"V63"	-0.15980266	0.000389636	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	123
"373"	4	"V208"	0.159758376	0.000391107	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	40
"374"	18	"V155"	0.159737182	0.000431532	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	14
"375"	20	"V448"	-0.159731852	0.00039199	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	113
"376"	23	"V291"	-0.159583568	0.000391538	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	64
"377"	14	"V182"	-0.159395734	0.000397847	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	31
"378"	20	"V10"	0.159382319	0.000403807	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	1
"379"	21	"V299"	-0.159381237	0.000398337	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	66
"380"	6	"V252"	-0.159254385	0.005277417	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	49
"381"	16	"V95"	-0.159114114	0.000407483	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	136
"382"	6	"V84"	0.159013566	0.005347257	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	129
"383"	23	"V186"	0.158803598	0.00041836	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	33
"384"	8	"V2"	0.157521156	0.000466212	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	37
"385"	15	"V150"	0.157444765	0.001205212	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	12
"386"	6	"V294"	-0.15738019	0.005843313	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	65
"387"	17	"V2"	0.15704386	0.000491809	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	37
"388"	8	"V418"	-0.157005199	0.000486864	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	105
"389"	23	"V84"	0.156906929	0.000490893	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	129
"390"	21	"V381"	0.156829534	0.000494087	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	91
"391"	6	"V266"	-0.156113696	0.006255981	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	54
"392"	10	"V280"	0.155921764	0.001621606	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	61
"393"	11	"V84"	0.155645088	0.000545454	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	129
"394"	17	"V460"	-0.155504849	0.000559132	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	116
"395"	15	"V216"	-0.155188996	0.001418698	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	43
"396"	17	"V381"	0.155037297	0.000581222	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	91
"397"	2	"V164"	0.154934022	0.000586209	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	19
"398"	15	"V367"	-0.154764953	0.001462518	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	88
"399"	12	"V320"	-0.154763603	0.000594526	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	73
"400"	14	"V218"	-0.154753028	0.000587371	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	44
"401"	22	"V207"	-0.154542734	0.000597678	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	39
"402"	11	"V207"	-0.153814992	0.000634661	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	39
"403"	8	"V160"	-0.153808081	0.000635022	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	16
"404"	23	"V327"	0.153585173	0.000646774	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	74
"405"	12	"V462"	-0.1534915	0.000660157	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	118
"406"	16	"V358"	-0.153383336	0.000657588	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	85
"407"	8	"V9"	0.153357519	0.000658984	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	131
"408"	8	"V9"	0.153357519	0.000658984	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	132
"409"	15	"V175"	-0.153299009	0.001623768	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	26
"410"	5	"V170"	-0.153178368	0.000677312	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	22
"411"	1	"V80"	-0.15315192	0.00067878	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	127
"412"	22	"V11"	0.153067369	0.000674856	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	4
"413"	13	"V357"	0.152868738	0.000721634	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	84
"414"	14	"V447"	-0.152854244	0.000686739	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	112
"415"	16	"V320"	-0.15285167	0.000686884	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	73
"416"	17	"V462"	-0.15281772	0.000697583	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	118
"417"	16	"V126"	-0.152763706	0.000691846	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	9
"418"	18	"V175"	-0.152669709	0.000771492	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	26
"419"	22	"V102"	0.15252406	0.000705534	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	3
"420"	22	"V208"	-0.152350089	0.000715627	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	40
"421"	14	"V33"	-0.152268077	0.000720431	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	76
"422"	1	"V32"	-0.152171631	0.000735309	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	72
"423"	4	"V218"	-0.152121162	0.000738334	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	44
"424"	23	"V81"	0.151996284	0.000736568	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	128
"425"	4	"V460"	0.151919741	0.000750523	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	116
"426"	7	"V275"	-0.151875286	0.00087556	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	59
"427"	4	"V182"	-0.151829928	0.000756017	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	31
"428"	1	"V393"	-0.151799202	0.000757906	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	96
"429"	18	"V350"	0.151771603	0.000829181	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	82
"430"	24	"V200"	-0.151755482	0.000830252	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	38
"431"	23	"V175"	-0.151705132	0.000754225	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	26
"432"	13	"V260"	0.151677162	0.000794703	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	52
"433"	10	"V9"	0.151475844	0.002203747	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	131
"434"	10	"V9"	0.151475844	0.002203747	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	132
"435"	12	"V126"	-0.151080104	0.000803367	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	9
"436"	22	"V90"	0.150854725	0.000808069	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	133
"437"	24	"V273"	0.150846034	0.000892791	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	58
"438"	20	"V346"	-0.150765965	0.000824009	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	80
"439"	23	"V266"	-0.150756341	0.000814523	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	54
"440"	15	"V268"	-0.150564224	0.00196892	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	55
"441"	17	"V150"	0.150117214	0.0008682	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	12
"442"	6	"V299"	-0.150101615	0.008593284	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	66
"443"	3	"V118"	-0.150094328	0.000859205	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	6
"444"	16	"V186"	0.15008504	0.000859848	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	33
"445"	11	"V294"	-0.150009496	0.000865092	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	65
"446"	17	"V393"	0.149674417	0.00089961	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	96
"447"	17	"V396"	-0.149609734	0.000904285	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	97
"448"	21	"V161"	-0.149524358	0.000899481	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	17
"449"	10	"V414"	0.149504662	0.002518417	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	103
"450"	20	"V91"	-0.149498611	0.000912369	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	134
"451"	18	"V344"	0.149307566	0.001008588	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	79
"452"	16	"V170"	0.149123494	0.000928844	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	22
"453"	16	"V459"	0.149060549	0.000933535	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	115
"454"	12	"V258"	0.148303405	0.001003649	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	50
"455"	22	"V2"	0.148230809	0.000997446	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	37
"456"	2	"V161"	-0.148191876	0.001012583	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	17
"457"	15	"V81"	0.148132025	0.002331002	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	128
"458"	16	"V241"	0.147788959	0.001033107	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	48
"459"	16	"V463"	-0.147633366	0.001045942	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	119
"460"	2	"V414"	0.147608228	0.001060547	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	103
"461"	4	"V414"	0.147356964	0.001081835	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	103
"462"	10	"V344"	-0.147236808	0.002930802	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	79
"463"	14	"V80"	-0.147052804	0.001095143	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	127
"464"	6	"V372"	0.146978935	0.010091052	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	89
"465"	20	"V142"	0.146905932	0.001121039	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	11
"466"	24	"V350"	-0.146835497	0.001224032	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	82
"467"	3	"V170"	-0.146781161	0.00111889	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	22
"468"	1	"V266"	0.146764532	0.001133597	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	54
"469"	23	"V405"	-0.146720774	0.001124233	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	99
"470"	6	"V17"	0.146602002	0.010286673	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	21
"471"	17	"V346"	-0.146569445	0.001151136	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	80
"472"	7	"V102"	0.146520244	0.001330107	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	3
"473"	1	"V102"	-0.146044258	0.001199603	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	3
"474"	22	"V118"	0.14580226	0.00120846	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	6
"475"	3	"V383"	0.145711197	0.00121712	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	93
"476"	1	"V154"	0.145700902	0.001232299	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	13
"477"	17	"V341"	-0.145310926	0.001270429	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	78
"478"	6	"V175"	-0.145045687	0.011130433	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	26
"479"	14	"V85"	-0.145044491	0.001282284	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	130
"480"	13	"V216"	-0.144928638	0.0013547	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	43
"481"	6	"V9"	0.144858477	0.011235948	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	131
"482"	6	"V9"	0.144858477	0.011235948	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	132
"483"	21	"V177"	-0.144821352	0.001304802	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	28
"484"	23	"V463"	-0.144793433	0.001307645	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	119
"485"	17	"V266"	-0.144588834	0.001343914	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	54
"486"	6	"V71"	-0.144572008	0.01139912	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	124
"487"	14	"V466"	-0.14452061	0.001335726	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	121
"488"	13	"V197"	0.144165215	0.001436979	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	36
"489"	4	"V100"	0.144093776	0.001396534	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	2
"490"	21	"V462"	-0.143946877	0.001396601	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	118
"491"	15	"V275"	-0.143888304	0.003111224	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	59
"492"	23	"V387"	0.143860764	0.001405955	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	94
"493"	13	"V154"	-0.1437674	0.001481652	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	13
"494"	23	"V412"	0.14348064	0.001447938	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	101
"495"	17	"V299"	-0.1433942	0.001474128	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	66
"496"	22	"V329"	-0.143370432	0.001460324	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	75
"497"	6	"V150"	0.14304878	0.012302429	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	12
"498"	2	"V291"	-0.143039368	0.001514981	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	64
"499"	17	"V200"	-0.142949805	0.001525456	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	38
"500"	22	"V266"	-0.14293357	0.001510386	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	54
"501"	23	"V33"	-0.142913139	0.001512765	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	76
"502"	12	"V329"	-0.142754653	0.001548511	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	75
"503"	17	"V294"	-0.142408187	0.001590233	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	65
"504"	5	"V241"	-0.142100477	0.001628151	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	48
"505"	15	"V155"	0.142030032	0.003522313	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	14
"506"	22	"V460"	-0.141921249	0.001632513	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	116
"507"	20	"V21"	-0.141869539	0.001657152	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	41
"508"	4	"V33"	-0.141294423	0.001731446	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	76
"509"	11	"V341"	-0.140742529	0.001786103	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	78
"510"	14	"V126"	0.140721099	0.001789014	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	9
"511"	6	"V176"	0.140584895	0.013897635	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	27
"512"	11	"V299"	-0.140584038	0.001807737	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	66
"513"	12	"V10"	0.140581109	0.001827836	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	1
"514"	20	"V405"	-0.140346928	0.001860537	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	99
"515"	20	"V460"	-0.14009712	0.001896012	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	116
"516"	15	"V265"	-0.140039026	0.004016936	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	53
"517"	16	"V329"	-0.139970928	0.001893705	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	75
"518"	16	"V418"	0.139850178	0.001911072	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	105
"519"	12	"V177"	-0.139802474	0.001938649	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	28
"520"	13	"V80"	0.139767324	0.002007327	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	127
"521"	9	"V291"	0.139469199	0.001987934	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	64
"522"	11	"V306"	-0.139352985	0.001984128	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	69
"523"	24	"V462"	-0.139345694	0.002161994	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	118
"524"	14	"V102"	-0.139226953	0.002003048	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	3
"525"	4	"V396"	0.139126712	0.002039775	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	97
"526"	16	"V21"	-0.138944609	0.002046036	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	41
"527"	10	"V332"	-0.138793254	0.005063082	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	77
"528"	23	"V12"	-0.138759094	0.00207474	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	8
"529"	6	"V85"	-0.138579612	0.015327433	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	130
"530"	12	"V281"	0.138430534	0.002148984	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	62
"531"	20	"V372"	0.138181317	0.002189362	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	89
"532"	12	"V90"	0.138172214	0.00219085	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	133
"533"	21	"V396"	-0.138086872	0.002181862	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	97
"534"	15	"V173"	-0.137947706	0.004603437	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	25
"535"	21	"V291"	-0.137867548	0.002217892	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	64
"536"	3	"V2"	0.137809582	0.002227505	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	37
"537"	20	"V357"	0.137734159	0.002263552	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	84
"538"	20	"V156"	0.137674021	0.002273703	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	15
"539"	19	"V11"	0.137601703	0.003582139	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	4
"540"	8	"V346"	-0.13760009	0.002262565	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	80
"541"	21	"V164"	0.137568235	0.00226794	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	19
"542"	20	"V344"	-0.137356855	0.002327932	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	79
"543"	4	"V393"	-0.137348582	0.002329362	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	96
"544"	7	"V291"	-0.13729642	0.002648481	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	64
"545"	5	"V2"	0.136919276	0.002404689	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	37
"546"	15	"V436"	-0.136878318	0.004932297	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	109
"547"	20	"V81"	0.136836231	0.002419515	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	128
"548"	24	"V411"	-0.136794072	0.002608565	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	100
"549"	4	"V207"	-0.136719698	0.002440459	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	39
"550"	15	"V349"	0.136701888	0.004988545	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	81
"551"	2	"V207"	-0.136629359	0.00245681	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	39
"552"	18	"V459"	0.136414447	0.002681765	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	115
"553"	21	"V142"	0.136361282	0.002480403	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	11
"554"	16	"V344"	-0.136312438	0.002489372	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	79
"555"	22	"V186"	0.136229673	0.002504637	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	33
"556"	8	"V118"	-0.136108853	0.002527074	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	6
"557"	7	"V461"	-0.136049931	0.002898004	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	117
"558"	13	"V466"	0.135913845	0.002670168	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	121
"559"	7	"V154"	-0.135886724	0.002932214	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	13
"560"	14	"V175"	-0.135845402	0.002576636	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	26
"561"	13	"V349"	0.135783041	0.002695824	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	81
"562"	12	"V118"	0.135705081	0.002629936	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	6
"563"	19	"V329"	-0.135655342	0.004087936	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	75
"564"	19	"V270"	-0.135424452	0.00415204	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	57
"565"	5	"V350"	-0.135247397	0.00271972	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	82
"566"	7	"V208"	-0.13483319	0.003162035	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	40
"567"	22	"V294"	-0.134786188	0.002784979	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	65
"568"	23	"V200"	-0.13470928	0.002800689	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	38
"569"	17	"V170"	0.134682789	0.002834325	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	22
"570"	7	"V281"	0.134415093	0.003257693	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	62
"571"	22	"V36"	-0.134264276	0.002893183	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	86
"572"	18	"V12"	-0.134183364	0.003151128	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	8
"573"	14	"V100"	0.134158513	0.002915571	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	2
"574"	22	"V13"	-0.134076489	0.002933043	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	10
"575"	16	"V405"	-0.133800788	0.002992469	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	99
"576"	23	"V259"	-0.133746852	0.003004222	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	51
"577"	22	"V156"	0.133734031	0.003007022	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	15
"578"	8	"V432"	0.133675001	0.003019944	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	108
"579"	12	"V463"	-0.133673586	0.00305019	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	119
"580"	23	"V459"	0.133504369	0.003057582	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	115
"581"	8	"V414"	0.133348844	0.003092258	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	103
"582"	16	"V9"	0.13314563	0.003138107	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	131
"583"	16	"V9"	0.13314563	0.003138107	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	132
"584"	21	"V344"	-0.133080088	0.003153026	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	79
"585"	11	"V381"	0.132976222	0.0031768	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	91
"586"	14	"V92"	-0.132937549	0.003185693	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	135
"587"	20	"V118"	0.132859008	0.003235219	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	6
"588"	23	"V150"	0.132778239	0.003222569	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	12
"589"	1	"V258"	0.132709359	0.003270301	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	50
"590"	4	"V466"	-0.132685423	0.003275944	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	121
"591"	7	"V350"	-0.132585836	0.003707903	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	82
"592"	12	"V392"	-0.132584823	0.003299758	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	95
"593"	20	"V358"	-0.132383422	0.003347908	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	85
"594"	14	"V11"	0.131898114	0.003433375	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	4
"595"	16	"V306"	-0.131817492	0.003453299	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	69
"596"	5	"V462"	-0.131652511	0.00352806	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	118
"597"	14	"V71"	0.131617882	0.003503079	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	124
"598"	9	"V91"	0.13140072	0.00359213	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	134
"599"	20	"V32"	0.131314141	0.003614403	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	72
"600"	5	"V44"	0.130834767	0.00374001	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	111
"601"	21	"V90"	0.130772199	0.003721289	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	133
"602"	23	"V416"	0.130762077	0.003723974	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	104
"603"	14	"V90"	-0.130386314	0.003824895	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	133
"604"	21	"V463"	-0.130380371	0.00382651	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	119
"605"	23	"V11"	0.130318176	0.003843458	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	4
"606"	18	"V455"	0.129943451	0.00425403	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	114
"607"	2	"V142"	0.129925849	0.003989088	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	11
"608"	12	"V291"	-0.129566903	0.004091524	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	64
"609"	4	"V92"	-0.129455456	0.00412381	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	135
"610"	13	"V320"	-0.12931971	0.004280959	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	73
"611"	22	"V95"	-0.129111439	0.004186041	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	136
"612"	6	"V12"	-0.1291098	0.023960422	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	8
"613"	16	"V171"	-0.129105697	0.004187735	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	23
"614"	2	"V459"	0.12908674	0.004232276	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	115
"615"	11	"V448"	-0.128701602	0.004308531	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	113
"616"	16	"V275"	-0.128484468	0.004374734	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	59
"617"	13	"V126"	-0.128449482	0.004549188	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	9
"618"	17	"V10"	0.128427926	0.004432526	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	1
"619"	22	"V258"	0.128399105	0.004401011	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	50
"620"	10	"V396"	-0.128256396	0.009631386	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	97
"621"	17	"V177"	-0.128227888	0.004495002	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	28
"622"	17	"V405"	-0.128161409	0.004515941	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	99
"623"	7	"V299"	-0.128145341	0.005044474	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	66
"624"	4	"V126"	0.128017011	0.004561724	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	9
"625"	6	"V182"	-0.127865083	0.025361011	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	31
"626"	13	"V175"	-0.127699981	0.004792279	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	26
"627"	20	"V55"	-0.127608522	0.004693524	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	122
"628"	10	"V455"	0.127481075	0.010080896	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	114
"629"	2	"V155"	0.1273806	0.004768548	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	14
"630"	20	"V170"	0.127344534	0.004780519	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	22
"631"	16	"V118"	0.127194828	0.004787242	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	6
"632"	18	"V306"	-0.12690987	0.005245997	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	69
"633"	4	"V448"	-0.126837041	0.00495186	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	113
"634"	10	"V266"	-0.12674879	0.010522462	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	54
"635"	22	"V10"	0.126701277	0.004954184	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	1
"636"	20	"V381"	0.126641331	0.005019403	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	91
"637"	2	"V72"	-0.126621955	0.005026135	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	125
"638"	9	"V95"	0.126563767	0.005046401	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	136
"639"	11	"V91"	-0.12648346	0.005029517	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	134
"640"	23	"V260"	0.126482151	0.005029972	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	52
"641"	10	"V171"	-0.126439885	0.010713819	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	23
"642"	21	"V155"	0.126292009	0.005096582	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	14
"643"	12	"V448"	-0.125893358	0.005285266	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	113
"644"	21	"V294"	-0.125855362	0.005252566	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	65
"645"	7	"V416"	0.12582508	0.005903504	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	104
"646"	7	"V216"	-0.125800616	0.005913223	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	43
"647"	13	"V387"	0.125740826	0.005484049	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	94
"648"	11	"V460"	-0.125568412	0.005357403	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	116
"649"	7	"V372"	0.125410722	0.006070069	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	89
"650"	17	"V176"	0.125393426	0.005469971	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	27
"651"	17	"V349"	0.125261465	0.005519685	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	81
"652"	13	"V155"	0.125220622	0.005682243	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	14
"653"	15	"V241"	0.125204797	0.010165853	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	48
"654"	23	"V36"	-0.124875367	0.005618423	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	86
"655"	19	"V13"	-0.124806781	0.008284874	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	10
"656"	8	"V33"	-0.124733835	0.005673115	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	76
"657"	21	"V346"	-0.124710376	0.005682226	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	80
"658"	11	"V155"	0.124707578	0.005683313	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	14
"659"	7	"V71"	-0.124685066	0.00637197	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	124
"660"	16	"V260"	0.124662045	0.005701039	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	52
"661"	7	"V81"	0.124628253	0.006396166	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	128
"662"	1	"V2"	0.124503282	0.005813284	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	37
"663"	2	"V405"	-0.124290015	0.005898364	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	99
"664"	13	"V358"	-0.124263018	0.006064009	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	85
"665"	10	"V72"	-0.12400032	0.012336646	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	125
"666"	23	"V265"	-0.123981278	0.005972049	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	53
"667"	16	"V102"	0.123831074	0.006033382	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	3
"668"	17	"V459"	0.123740622	0.006122715	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	115
"669"	5	"V160"	-0.123732814	0.006125958	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	16
"670"	21	"V81"	0.123136547	0.006324404	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	128
"671"	1	"V396"	0.122989801	0.006441717	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	97
"672"	7	"V459"	0.122979922	0.007135066	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	115
"673"	18	"V11"	0.122913078	0.00686975	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	4
"674"	22	"V200"	-0.122787472	0.006475382	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	38
"675"	15	"V459"	0.122770014	0.011740039	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	115
"676"	16	"V299"	-0.122761001	0.006486961	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	66
"677"	3	"V462"	-0.122751457	0.006491141	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	118
"678"	2	"V91"	-0.122632414	0.006598737	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	134
"679"	23	"V17"	0.122553199	0.006578512	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	21
"680"	15	"V118"	0.122384264	0.012008307	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	6
"681"	19	"V207"	-0.122335869	0.009663062	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	39
"682"	1	"V439"	0.122324815	0.006736623	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	110
"683"	16	"V12"	-0.12223676	0.006720153	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	8
"684"	17	"V55"	-0.1222076	0.006789842	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	122
"685"	22	"V116"	0.122170832	0.006750004	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	5
"686"	15	"V327"	0.121877527	0.012368943	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	74
"687"	15	"V85"	-0.121320045	0.012776715	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	130
"688"	24	"V412"	0.121253517	0.007667109	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	101
"689"	11	"V266"	-0.12125301	0.007178118	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	54
"690"	11	"V405"	-0.12122981	0.007189247	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	99
"691"	5	"V411"	-0.121201236	0.007262504	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	100
"692"	13	"V352"	0.121174624	0.007457257	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	83
"693"	22	"V372"	0.121162813	0.007221475	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	89
"694"	6	"V216"	-0.120971817	0.034461946	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	43
"695"	20	"V341"	-0.120433961	0.007642439	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	78
"696"	13	"V463"	-0.120391461	0.007853281	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	119
"697"	15	"V102"	0.120372819	0.013496819	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	3
"698"	18	"V22"	0.120296176	0.00816382	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	45
"699"	20	"V387"	0.120287556	0.007716922	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	94
"700"	1	"V381"	-0.120206839	0.007758264	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	91
"701"	12	"V9"	0.11999829	0.007865997	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	131
"702"	12	"V9"	0.11999829	0.007865997	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	132
"703"	17	"V260"	0.119680181	0.008032902	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	52
"704"	7	"V160"	-0.119675458	0.008850467	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	16
"705"	14	"V405"	-0.119636899	0.007991371	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	99
"706"	1	"V455"	0.119620909	0.008064348	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	114
"707"	6	"V81"	0.119542403	0.036662736	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	128
"708"	23	"V372"	0.119224396	0.008211715	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	89
"709"	23	"V28"	-0.11914536	0.008254547	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	60
"710"	8	"V21"	-0.119100237	0.00827909	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	41
"711"	6	"V116"	0.119079195	0.03740103	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	5
"712"	17	"V350"	-0.119061103	0.008366813	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	82
"713"	3	"V291"	0.119046389	0.008308464	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	64
"714"	7	"V463"	-0.119037503	0.009221109	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	119
"715"	21	"V280"	0.119034528	0.008314946	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	61
"716"	17	"V207"	-0.1188972	0.008457266	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	39
"717"	14	"V172"	0.118867982	0.00840645	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	24
"718"	21	"V412"	0.118023437	0.008884428	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	101
"719"	18	"V466"	-0.117979653	0.009486526	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	121
"720"	17	"V280"	0.11788224	0.009037076	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	61
"721"	21	"V55"	-0.117796411	0.009016978	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	122
"722"	19	"V22"	0.117588191	0.012893746	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	45
"723"	5	"V166"	0.117209508	0.009440643	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	20
"724"	20	"V208"	-0.116993381	0.009573657	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	40
"725"	12	"V81"	0.116772325	0.009711427	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	128
"726"	19	"V455"	0.116754386	0.013550445	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	114
"727"	10	"V393"	0.116632691	0.018628545	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	96
"728"	18	"V9"	0.116491313	0.010433872	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	131
"729"	18	"V9"	0.116491313	0.010433872	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	132
"730"	21	"V91"	-0.116326905	0.00991838	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	134
"731"	13	"V119"	0.116160114	0.010335758	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	7
"732"	14	"V155"	0.115845104	0.010230886	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	14
"733"	13	"V173"	-0.115841987	0.010547916	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	25
"734"	6	"V33"	-0.11575674	0.043074836	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	76
"735"	19	"V21"	-0.115667997	0.014450194	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	41
"736"	11	"V2"	0.11561522	0.010383052	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	37
"737"	16	"V266"	-0.115348974	0.010561795	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	54
"738"	20	"V266"	-0.115289964	0.010681712	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	54
"739"	23	"V376"	-0.115209513	0.010656506	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	90
"740"	5	"V100"	-0.115174471	0.010760801	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	2
"741"	16	"V164"	0.115144372	0.010701003	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	19
"742"	20	"V182"	-0.115136337	0.010787029	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	31
"743"	8	"V455"	0.115114196	0.010721671	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	114
"744"	8	"V405"	-0.114947989	0.010836148	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	99
"745"	17	"V90"	0.114929591	0.010930215	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	133
"746"	7	"V412"	0.114832309	0.012029101	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	101
"747"	6	"V154"	-0.114703841	0.045017641	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	13
"748"	8	"V332"	0.114686099	0.011018726	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	77
"749"	24	"V383"	0.114116733	0.012119743	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	93
"750"	14	"V12"	0.114096595	0.011439714	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	8
"751"	1	"V36"	-0.113966442	0.01161971	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	86
"752"	4	"V90"	-0.11381331	0.011732811	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	133
"753"	10	"V448"	-0.11370967	0.021812455	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	113
"754"	2	"V462"	-0.113689386	0.011825051	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	118
"755"	1	"V71"	0.113659706	0.011847237	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	124
"756"	10	"V161"	-0.11365287	0.021878737	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	17
"757"	19	"V372"	0.113594871	0.016313913	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	89
"758"	3	"V349"	0.11355891	0.011836052	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	81
"759"	22	"V346"	-0.113394877	0.01195936	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	80
"760"	6	"V270"	-0.113209092	0.047901754	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	57
"761"	10	"V341"	-0.113154121	0.022468283	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	78
"762"	21	"V241"	0.113056082	0.012217641	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	48
"763"	8	"V269"	-0.11300475	0.012257201	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	56
"764"	17	"V463"	-0.112938001	0.012398188	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	119
"765"	7	"V436"	-0.112875526	0.01357622	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	109
"766"	8	"V459"	0.112872272	0.012359822	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	115
"767"	7	"V352"	0.112841389	0.013604699	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	83
"768"	12	"V155"	0.112831017	0.012481758	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	14
"769"	22	"V275"	-0.11266507	0.012521848	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	59
"770"	21	"V448"	-0.112643256	0.012539014	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	113
"771"	19	"V10"	0.112617488	0.017263398	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	1
"772"	6	"V211"	-0.112603486	0.049113521	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	42
"773"	17	"V413"	-0.112518761	0.012728528	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	102
"774"	15	"V311"	-0.11197559	0.021608057	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	71
"775"	4	"V172"	0.111846167	0.013274748	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	24
"776"	20	"V383"	0.11170114	0.013395199	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	93
"777"	4	"V155"	0.111689454	0.013404947	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	14
"778"	8	"V200"	-0.11162947	0.013360106	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	38
"779"	3	"V269"	-0.111573401	0.013406871	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	56
"780"	20	"V275"	-0.111497027	0.013566357	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	59
"781"	20	"V349"	0.111423037	0.013628875	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	81
"782"	4	"V183"	0.111186163	0.013830734	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	32
"783"	19	"V259"	-0.111174665	0.01875333	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	51
"784"	9	"V10"	-0.110958174	0.014027504	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	1
"785"	21	"V208"	-0.110830234	0.014040486	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	40
"786"	22	"V155"	0.110743488	0.014116136	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	14
"787"	8	"V411"	-0.110553188	0.014283354	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	100
"788"	15	"V92"	-0.110492496	0.023413542	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	135
"789"	10	"V2"	0.110485826	0.025861774	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	37
"790"	20	"V320"	-0.110461754	0.014464494	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	73
"791"	1	"V346"	-0.110456678	0.014469024	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	80
"792"	9	"V357"	-0.110396676	0.014522661	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	84
"793"	7	"V349"	0.110249007	0.015927232	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	81
"794"	11	"V260"	0.110132259	0.014659431	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	52
"795"	23	"V448"	-0.109971063	0.014805741	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	113
"796"	20	"V2"	0.10996621	0.014912615	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	37
"797"	8	"V320"	-0.109939171	0.014834839	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	73
"798"	2	"V306"	-0.109829279	0.015038574	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	69
"799"	19	"V218"	-0.109787158	0.020290743	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	44
"800"	11	"V100"	-0.109752271	0.015006381	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	2
"801"	7	"V119"	0.109693387	0.016468044	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	7
"802"	15	"V463"	-0.109661794	0.024480786	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	119
"803"	21	"V33"	-0.109615169	0.015133323	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	76
"804"	17	"V91"	-0.109541358	0.015306478	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	134
"805"	2	"V346"	-0.109439837	0.015401935	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	80
"806"	21	"V383"	0.109410887	0.015324216	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	93
"807"	12	"V160"	-0.109187892	0.015641095	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	16
"808"	3	"V33"	-0.109069916	0.015647553	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	76
"809"	12	"V84"	0.109010523	0.015811411	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	129
"810"	19	"V102"	0.108914712	0.02131264	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	3
"811"	2	"V95"	-0.108878862	0.015938888	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	136
"812"	11	"V170"	0.108736609	0.015969394	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	22
"813"	1	"V416"	-0.108734388	0.016079808	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	104
"814"	24	"V10"	-0.108635068	0.016959953	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	1
"815"	19	"V175"	-0.108627828	0.021658295	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	26
"816"	4	"V71"	0.108554223	0.016257069	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	124
"817"	18	"V273"	-0.108251397	0.017354757	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	58
"818"	16	"V13"	-0.108162682	0.0165372	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	10
"819"	7	"V241"	0.107999215	0.01821763	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	48
"820"	2	"V156"	0.107939052	0.016875304	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	15
"821"	7	"V466"	0.107929722	0.018292739	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	121
"822"	9	"V176"	0.107909634	0.016905377	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	27
"823"	11	"V186"	0.107858437	0.016845316	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	33
"824"	5	"V420"	-0.107840639	0.016976093	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	106
"825"	24	"V269"	-0.107747542	0.017885429	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	56
"826"	2	"V211"	-0.107603343	0.017221291	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	42
"827"	4	"V329"	-0.107587689	0.017237575	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	75
"828"	8	"V258"	0.107530726	0.017182808	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	50
"829"	13	"V455"	0.107445579	0.017734427	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	114
"830"	12	"V200"	-0.107388941	0.017445492	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	38
"831"	11	"V216"	-0.107347309	0.01737427	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	43
"832"	1	"V372"	-0.107323831	0.017514081	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	89
"833"	4	"V439"	0.107311095	0.017527525	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	110
"834"	13	"V28"	0.107292437	0.017897965	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	60
"835"	13	"V11"	0.107214411	0.017981793	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	4
"836"	7	"V164"	0.107205123	0.019092143	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	19
"837"	1	"V269"	-0.10713777	0.017711387	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	56
"838"	15	"V320"	-0.107137269	0.027986024	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	73
"839"	13	"V280"	0.107113425	0.018090798	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	61
"840"	3	"V411"	-0.106928263	0.017818715	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	100
"841"	23	"V182"	-0.106874248	0.017876721	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	31
"842"	4	"V80"	-0.106859735	0.018009846	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	127
"843"	23	"V176"	0.106786796	0.017970984	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	27
"844"	18	"V18"	-0.106752176	0.018975591	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	29
"845"	12	"V344"	-0.106717288	0.018164452	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	79
"846"	15	"V252"	-0.106633116	0.028735489	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	49
"847"	15	"V79"	-0.106504141	0.028929966	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	126
"848"	6	"V24"	0.106433513	0.06298316	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	47
"849"	19	"V281"	0.106410854	0.024497431	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	62
"850"	4	"V418"	-0.106384214	0.01853049	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	105
"851"	17	"V281"	0.106358726	0.018558765	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	62
"852"	11	"V72"	-0.106309669	0.018492961	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	125
"853"	22	"V463"	-0.106241752	0.018568328	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	119
"854"	7	"V258"	0.106044464	0.020436147	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	50
"855"	11	"V329"	-0.106027852	0.018807446	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	75
"856"	20	"V216"	-0.106006844	0.018952975	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	43
"857"	18	"V462"	0.105829455	0.020037512	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	118
"858"	6	"V273"	-0.105785188	0.064611616	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	58
"859"	11	"V161"	-0.105740419	0.019132996	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	17
"860"	23	"V357"	0.105729311	0.019145675	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	84
"861"	15	"V404"	-0.105642664	0.030258165	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	98
"862"	1	"V13"	0.105562982	0.019460635	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	10
"863"	13	"V44"	-0.105547306	0.019856686	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	111
"864"	19	"V118"	0.105437673	0.025841972	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	6
"865"	13	"V372"	0.10542658	0.019998844	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	89
"866"	2	"V265"	-0.105412147	0.019635828	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	53
"867"	24	"V150"	0.105285565	0.020687391	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	12
"868"	23	"V252"	-0.105218794	0.01973636	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	49
"869"	13	"V118"	0.105007362	0.020499385	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	6
"870"	10	"V91"	-0.104920508	0.03438283	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	134
"871"	12	"V266"	-0.104878882	0.020266272	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	54
"872"	16	"V265"	-0.104603122	0.02046978	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	53
"873"	24	"V460"	-0.104582946	0.021554016	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	116
"874"	7	"V357"	0.104409057	0.022469267	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	84
"875"	9	"V211"	0.104370856	0.020883192	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	42
"876"	22	"V55"	-0.104360921	0.020764737	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	122
"877"	22	"V462"	-0.104323127	0.020811095	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	118
"878"	18	"V396"	0.104155251	0.02209684	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	97
"879"	16	"V412"	0.104097502	0.021089724	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	101
"880"	15	"V383"	0.104087917	0.032787678	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	93
"881"	20	"V200"	-0.104047645	0.021284126	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	38
"882"	3	"V10"	-0.103866504	0.021378341	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	1
"883"	20	"V155"	0.103682093	0.021745629	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	14
"884"	8	"V172"	0.103635361	0.021670568	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	24
"885"	24	"V162"	-0.103549046	0.022886531	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	18
"886"	14	"V346"	-0.103543254	0.021787979	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	80
"887"	9	"V387"	-0.103487041	0.021995413	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	94
"888"	5	"V300"	0.103418235	0.02208412	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	68
"889"	4	"V21"	-0.103384031	0.022128332	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	41
"890"	19	"V28"	-0.102902361	0.029647308	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	60
"891"	2	"V332"	-0.102881888	0.022786292	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	77
"892"	20	"V9"	0.102769918	0.022935297	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	131
"893"	20	"V9"	0.102769918	0.022935297	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	132
"894"	9	"V376"	-0.10266239	0.023079186	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	90
"895"	5	"V28"	-0.102609212	0.023150634	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	60
"896"	4	"V346"	-0.102484461	0.023318999	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	80
"897"	24	"V142"	0.102395336	0.024457191	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	11
"898"	22	"V299"	-0.102330904	0.023385627	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	66
"899"	8	"V162"	-0.102309643	0.023414526	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	18
"900"	12	"V418"	0.102013831	0.023963748	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	105
"901"	22	"V170"	0.101948394	0.02391032	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	22
"902"	18	"V460"	0.101920779	0.025129812	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	116
"903"	6	"V259"	-0.10184917	0.075256148	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	51
"904"	7	"V166"	-0.101791723	0.026088214	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	20
"905"	20	"V13"	-0.101666432	0.024449515	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	10
"906"	21	"V306"	-0.101574444	0.024433087	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	69
"907"	19	"V9"	0.101475672	0.031992948	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	131
"908"	19	"V9"	0.101475672	0.031992948	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	132
"909"	5	"V273"	0.101473574	0.024722846	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	58
"910"	5	"V258"	0.101260942	0.025027257	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	50
"911"	6	"V21"	-0.101236026	0.077036046	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	41
"912"	5	"V80"	-0.101232521	0.02506819	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	127
"913"	14	"V216"	-0.101169884	0.025009745	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	43
"914"	22	"V161"	-0.101080636	0.02513853	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	17
"915"	1	"V33"	-0.100862589	0.025606276	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	76
"916"	19	"V90"	0.100690809	0.033349734	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	133
"917"	12	"V161"	-0.100677926	0.025878588	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	17
"918"	21	"V332"	-0.100566023	0.025892346	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	77
"919"	21	"V2"	0.100561351	0.025899278	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	37
"920"	20	"V329"	-0.100556644	0.026058792	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	75
"921"	4	"V43"	-0.100502875	0.026139029	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	107
"922"	16	"V81"	0.100264912	0.026342399	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	128
"923"	18	"V393"	-0.100203053	0.027699723	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	96
"924"	18	"V381"	-0.100195739	0.027711131	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	91
"925"	2	"V177"	-0.100077282	0.026781671	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	28
"926"	2	"V85"	-0.100073819	0.026786955	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	130
"927"	14	"V227"	-0.100018534	0.026715648	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	46
"928"	19	"V382"	0.100007495	0.034570668	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	92
"929"	1	"V382"	0.099855879	0.027121337	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	92
"930"	1	"V85"	-0.099802836	0.027203263	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	130
"931"	17	"V320"	-0.099762482	0.027265732	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	73
"932"	12	"V32"	0.099676343	0.027399492	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	72
"933"	21	"V405"	-0.099663208	0.027261966	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	99
"934"	19	"V36"	-0.099543682	0.035420928	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	86
"935"	6	"V461"	-0.099535221	0.082152775	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	117
"936"	24	"V306"	0.099522876	0.028778143	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	69
"937"	15	"V11"	0.099481939	0.04136566	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	4
"938"	15	"V84"	0.099466669	0.041396984	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	129
"939"	5	"V118"	-0.099461995	0.02773479	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	6
"940"	20	"V17"	0.099454274	0.027746934	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	21
"941"	2	"V197"	0.099451589	0.027751158	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	36
"942"	20	"V260"	0.099356058	0.027901805	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	52
"943"	22	"V311"	0.099331789	0.027780169	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	71
"944"	12	"V275"	-0.099276893	0.028027176	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	59
"945"	12	"V460"	-0.099269288	0.028039246	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	116
"946"	9	"V270"	0.099139337	0.028246172	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	57
"947"	7	"V175"	-0.098949653	0.030576604	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	26
"948"	5	"V173"	0.098942146	0.028562675	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	25
"949"	11	"V13"	-0.098775115	0.028669653	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	10
"950"	1	"V180"	-0.0987694	0.028842441	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	30
"951"	22	"V180"	0.098522846	0.029080731	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	30
"952"	18	"V43"	-0.098519573	0.030434626	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	107
"953"	12	"V447"	-0.098471308	0.029330744	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	112
"954"	16	"V11"	0.098459257	0.029185145	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	4
"955"	3	"V341"	0.0983598	0.029349103	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	78
"956"	15	"V172"	0.098331971	0.043781311	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	24
"957"	24	"V63"	-0.098304009	0.030801001	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	123
"958"	1	"V161"	0.098178982	0.029816477	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	17
"959"	22	"V291"	-0.098117111	0.0297525	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	64
"960"	17	"V154"	-0.098036011	0.030056541	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	13
"961"	19	"V24"	0.098002972	0.038374224	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	47
"962"	12	"V352"	0.097545878	0.030892149	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	83
"963"	4	"V161"	-0.097535057	0.030910819	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	17
"964"	7	"V63"	-0.097533048	0.033050753	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	123
"965"	22	"V332"	-0.097367198	0.031029199	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	77
"966"	15	"V332"	-0.097113405	0.046469618	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	77
"967"	24	"V252"	0.097051068	0.033006151	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	49
"968"	13	"V275"	-0.09701625	0.032347751	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	59
"969"	23	"V461"	-0.096963579	0.031735563	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	117
"970"	20	"V404"	-0.096926591	0.031976331	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	98
"971"	24	"V180"	-0.096820851	0.033425659	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	30
"972"	17	"V447"	-0.096743753	0.032302581	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	112
"973"	6	"V412"	0.096730002	0.091188797	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	101
"974"	5	"V33"	-0.096264252	0.033171733	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	76
"975"	4	"V30"	0.09624072	0.033214897	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	67
"976"	19	"V84"	0.096236523	0.042014576	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	129
"977"	24	"V95"	0.096214654	0.034552114	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	136
"978"	16	"V17"	0.096023348	0.033434564	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	21
"979"	18	"V72"	-0.096010764	0.034938187	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	125
"980"	18	"V166"	0.095896784	0.03515561	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	20
"981"	20	"V350"	-0.095860724	0.033918573	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	82
"982"	3	"V44"	0.095813674	0.033823857	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	111
"983"	7	"V171"	-0.09573801	0.03642967	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	23
"984"	13	"V268"	-0.095733765	0.034712489	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	55
"985"	20	"V84"	0.09557402	0.034457872	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	129
"986"	18	"V372"	0.095489738	0.035941501	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	89
"987"	6	"V448"	-0.095461413	0.095528477	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	113
"988"	22	"V81"	0.095387501	0.034627042	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	128
"989"	20	"V154"	-0.095309966	0.034961014	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	13
"990"	12	"V382"	0.095308635	0.034963566	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	92
"991"	20	"V150"	0.095297426	0.034985063	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	12
"992"	11	"V156"	0.095244597	0.034899979	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	15
"993"	11	"V18"	0.095199419	0.034986647	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	29
"994"	10	"V102"	0.095183221	0.055047588	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	3
"995"	3	"V320"	-0.095117249	0.035144748	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	73
"996"	11	"V12"	-0.094896112	0.035573255	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	8
"997"	23	"V71"	-0.094865695	0.035632544	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	124
"998"	18	"V412"	-0.094664766	0.037580204	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	101
"999"	15	"V387"	0.094649491	0.052329909	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	94
"1000"	4	"V310"	-0.094627837	0.036289823	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	70
"1001"	9	"V413"	0.094576975	0.036390603	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	102
"1002"	1	"V17"	-0.094528244	0.036487382	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	21
"1003"	16	"V175"	-0.09448901	0.036373751	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	26
"1004"	6	"V349"	0.094468823	0.0990376	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	81
"1005"	1	"V218"	-0.094401755	0.03673961	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	44
"1006"	1	"V91"	0.094364726	0.036813728	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	134
"1007"	5	"V91"	0.094334178	0.036874971	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	134
"1008"	16	"V404"	-0.094307942	0.036734682	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	98
"1009"	11	"V241"	0.094290232	0.036770146	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	48
"1010"	8	"V156"	0.094263282	0.03682417	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	15
"1011"	11	"V372"	0.094130276	0.037091785	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	89
"1012"	18	"V341"	0.094114308	0.038708543	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	78
"1013"	16	"V208"	-0.09410414	0.037144564	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	40
"1014"	6	"V376"	-0.093991375	0.100761656	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	90
"1015"	12	"V91"	-0.093863961	0.037828616	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	134
"1016"	17	"V265"	-0.093793301	0.037973716	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	53
"1017"	2	"V81"	0.093776471	0.038008346	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	128
"1018"	13	"V100"	-0.093754143	0.038651165	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	2
"1019"	14	"V341"	0.093718694	0.037930393	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	78
"1020"	17	"V291"	-0.093715641	0.038133732	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	64
"1021"	4	"V459"	0.093572672	0.038429816	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	115
"1022"	12	"V265"	-0.093526732	0.038525369	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	53
"1023"	19	"V43"	-0.093471406	0.048296125	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	107
"1024"	20	"V461"	-0.093425217	0.038737229	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	117
"1025"	11	"V208"	-0.093371032	0.038651244	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	40
"1026"	2	"V465"	0.093355103	0.03888413	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	120
"1027"	15	"V439"	0.09333484	0.055701003	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	110
"1028"	6	"V387"	0.093255936	0.103463829	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	94
"1029"	22	"V405"	-0.093214533	0.038979507	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	99
"1030"	2	"V2"	0.093169771	0.039274712	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	37
"1031"	13	"V172"	0.093165991	0.039891971	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	24
"1032"	13	"V294"	-0.092903448	0.040456642	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	65
"1033"	3	"V32"	-0.092877127	0.039695269	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	72
"1034"	15	"V227"	0.092791219	0.057146766	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	46
"1035"	11	"V418"	0.092677237	0.040124535	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	105
"1036"	12	"V412"	0.092579966	0.040539898	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	101
"1037"	14	"V30"	0.092553187	0.040392903	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	67
"1038"	13	"V281"	0.092552801	0.041221335	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	62
"1039"	7	"V173"	-0.092540427	0.043177248	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	25
"1040"	12	"V299"	-0.092439194	0.040846911	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	66
"1041"	7	"V155"	0.092357144	0.043594018	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	14
"1042"	10	"V176"	0.092351736	0.062710247	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	27
"1043"	3	"V95"	0.092276088	0.040997867	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	136
"1044"	1	"V118"	-0.092265417	0.041228615	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	6
"1045"	1	"V208"	0.092180445	0.041416352	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	40
"1046"	5	"V455"	0.092059291	0.041685277	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	114
"1047"	3	"V412"	0.091962691	0.04169129	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	101
"1048"	6	"V327"	0.091924525	0.108501425	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	74
"1049"	23	"V197"	0.09192021	0.04178604	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	36
"1050"	16	"V33"	-0.091910645	0.041807399	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	76
"1051"	23	"V155"	0.091901655	0.041827483	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	14
"1052"	18	"V172"	0.091895355	0.043552536	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	24
"1053"	2	"V162"	-0.091829697	0.042198955	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	18
"1054"	11	"V175"	-0.091800774	0.04205341	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	26
"1055"	17	"V376"	0.091799914	0.042265979	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	90
"1056"	16	"V166"	-0.091717582	0.042240496	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	20
"1057"	14	"V306"	0.091715211	0.042245839	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	69
"1058"	2	"V241"	0.091604322	0.042708379	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	48
"1059"	13	"V436"	-0.091475094	0.043648478	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	109
"1060"	10	"V177"	-0.09144927	0.065329927	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	28
"1061"	19	"V126"	-0.09132927	0.053687311	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	9
"1062"	7	"V28"	0.091245984	0.046193898	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	60
"1063"	8	"V412"	0.091234625	0.043340523	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	101
"1064"	19	"V275"	-0.091162645	0.054126887	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	59
"1065"	23	"V21"	-0.091131266	0.043579053	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	41
"1066"	8	"V349"	0.091102647	0.043645294	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	81
"1067"	18	"V102"	-0.091054329	0.045517437	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	3
"1068"	10	"V463"	-0.090845441	0.067132473	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	119
"1069"	4	"V265"	-0.090818028	0.044526472	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	53
"1070"	1	"V116"	-0.090753873	0.044677645	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	5
"1071"	23	"V294"	-0.090687872	0.044614902	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	65
"1072"	23	"V13"	-0.090674336	0.044646847	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	10
"1073"	12	"V22"	0.090644735	0.04493581	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	45
"1074"	20	"V160"	-0.09064313	0.044939614	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	16
"1075"	20	"V280"	0.09051281	0.045249548	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	61
"1076"	13	"V162"	-0.090417439	0.046146442	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	18
"1077"	20	"V116"	-0.090369163	0.045593259	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	5
"1078"	16	"V150"	0.090294855	0.04555031	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	12
"1079"	2	"V160"	-0.090263274	0.045848026	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	16
"1080"	22	"V216"	-0.090229665	0.045707051	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	43
"1081"	7	"V85"	-0.089943413	0.04940626	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	130
"1082"	15	"V466"	0.089853457	0.065508133	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	121
"1083"	5	"V439"	0.089752224	0.047094484	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	110
"1084"	6	"V350"	-0.089734964	0.117204146	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	82
"1085"	22	"V211"	-0.089725332	0.046935034	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	42
"1086"	23	"V241"	0.089654823	0.0471089	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	48
"1087"	11	"V344"	-0.089651254	0.047117716	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	79
"1088"	15	"V432"	0.089577888	0.06634158	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	108
"1089"	14	"V207"	-0.089575554	0.047305014	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	39
"1090"	6	"V43"	-0.08948912	0.118214449	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	107
"1091"	10	"V44"	0.089396164	0.071625802	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	111
"1092"	3	"V208"	-0.08936764	0.047822653	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	40
"1093"	8	"V13"	0.089310284	0.047966283	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	10
"1094"	16	"V332"	-0.089235635	0.048153761	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	77
"1095"	13	"V160"	-0.089157812	0.049277048	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	16
"1096"	11	"V291"	-0.089090552	0.048519887	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	64
"1097"	19	"V211"	0.089042337	0.059986798	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	42
"1098"	21	"V275"	-0.089005783	0.048734885	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	59
"1099"	8	"V265"	-0.088767544	0.049343403	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	53
"1100"	2	"V33"	-0.088701612	0.049746409	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	76
"1101"	23	"V183"	0.088669277	0.049596244	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	32
"1102"	8	"V275"	-0.088457782	0.050144104	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	59
"1103"	3	"V175"	0.088450739	0.050162436	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	26
"1104"	7	"V80"	0.088313776	0.053686465	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	127
"1105"	6	"V28"	-0.088286285	0.123255944	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	60
"1106"	2	"V79"	-0.088224239	0.050992037	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	126
"1107"	7	"V383"	0.088198605	0.054000302	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	93
"1108"	8	"V92"	-0.087957219	0.051460957	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	135
"1109"	11	"V81"	0.08789149	0.051636	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	128
"1110"	13	"V18"	0.087769146	0.052932435	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	29
"1111"	21	"V118"	0.08775555	0.051999597	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	6
"1112"	7	"V176"	0.087753604	0.055227294	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	27
"1113"	19	"V411"	-0.087701469	0.063956523	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	100
"1114"	1	"V79"	0.087595014	0.05267361	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	126
"1115"	18	"V432"	0.087588017	0.054419533	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	108
"1116"	19	"V459"	0.087566704	0.064367201	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	115
"1117"	21	"V166"	-0.087522877	0.052626884	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	20
"1118"	20	"V294"	-0.087455377	0.053052986	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	65
"1119"	16	"V281"	0.087381886	0.053010059	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	62
"1120"	8	"V420"	-0.08731135	0.053202625	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	106
"1121"	22	"V84"	0.087279795	0.053288961	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	129
"1122"	11	"V21"	-0.087195497	0.053520177	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	41
"1123"	23	"V92"	0.087179044	0.053565401	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	135
"1124"	5	"V358"	0.087159443	0.053864535	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	85
"1125"	16	"V36"	-0.087018036	0.054009656	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	86
"1126"	18	"V118"	0.086999566	0.056066053	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	6
"1127"	14	"V154"	0.086882093	0.054387133	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	13
"1128"	8	"V100"	-0.086867984	0.054426437	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	2
"1129"	12	"V162"	-0.086689849	0.055173521	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	18
"1130"	6	"V166"	-0.086681388	0.130241174	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	20
"1131"	12	"V270"	-0.086609612	0.055399805	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	57
"1132"	2	"V10"	0.086433091	0.055900348	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	1
"1133"	20	"V412"	0.086257746	0.056401267	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	101
"1134"	19	"V252"	-0.086246579	0.068506034	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	49
"1135"	15	"V18"	0.086220781	0.077211877	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	29
"1136"	10	"V170"	0.086152222	0.082576349	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	22
"1137"	15	"V289"	0.086107547	0.077602376	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	63
"1138"	10	"V155"	0.086063964	0.082892214	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	14
"1139"	12	"V211"	-0.086034172	0.057045368	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	42
"1140"	18	"V55"	0.086003177	0.058948285	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	122
"1141"	20	"V281"	0.085969466	0.057232916	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	62
"1142"	14	"V197"	0.08595585	0.057017933	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	36
"1143"	15	"V300"	0.085930881	0.078214821	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	68
"1144"	16	"V55"	-0.085737878	0.057652155	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	122
"1145"	17	"V466"	0.085616721	0.058264359	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	121
"1146"	14	"V350"	0.085504803	0.058336784	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	82
"1147"	2	"V173"	-0.085489979	0.058638699	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	25
"1148"	7	"V259"	-0.085436919	0.061995229	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	51
"1149"	13	"V461"	-0.085392955	0.059710631	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	117
"1150"	8	"V207"	-0.085272492	0.059025861	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	39
"1151"	14	"V414"	0.085270925	0.059030532	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	103
"1152"	10	"V17"	0.085254562	0.085834693	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	21
"1153"	4	"V79"	-0.084953561	0.060245175	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	126
"1154"	14	"V329"	-0.084903758	0.060133421	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	75
"1155"	21	"V150"	0.084859663	0.060267011	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	12
"1156"	16	"V119"	0.084780673	0.060506935	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	7
"1157"	10	"V273"	0.084752318	0.087702469	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	58
"1158"	7	"V156"	0.08472118	0.064219661	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	15
"1159"	16	"V300"	-0.084675231	0.060828434	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	68
"1160"	6	"V364"	0.084604069	0.13973234	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	87
"1161"	16	"V465"	0.084534718	0.06125906	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	120
"1162"	19	"V300"	0.084456134	0.074465519	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	68
"1163"	5	"V162"	-0.084421249	0.06187517	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	18
"1164"	16	"V416"	0.084325432	0.061905115	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	104
"1165"	21	"V182"	-0.084142802	0.062473475	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	31
"1166"	1	"V197"	0.084091269	0.062903763	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	36
"1167"	6	"V241"	0.084076362	0.142225874	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	48
"1168"	1	"V432"	0.084038021	0.063071058	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	108
"1169"	21	"V102"	0.084037247	0.06280393	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	3
"1170"	1	"V28"	-0.084032513	0.063088385	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	60
"1171"	17	"V404"	-0.083881466	0.063565052	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	98
"1172"	19	"V176"	0.083800206	0.076751837	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	27
"1173"	5	"V150"	0.08370155	0.064136693	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	12
"1174"	2	"V186"	0.083689577	0.064174883	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	33
"1175"	1	"V294"	-0.083510031	0.064749843	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	65
"1176"	17	"V102"	0.08349277	0.064805341	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	3
"1177"	10	"V11"	0.083480651	0.092578021	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	4
"1178"	9	"V268"	-0.083438732	0.06497934	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	55
"1179"	23	"V392"	-0.083419623	0.064766505	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	95
"1180"	8	"V85"	-0.08332531	0.065070592	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	130
"1181"	22	"V171"	-0.083312874	0.065110776	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	23
"1182"	6	"V44"	0.083301137	0.145950542	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	111
"1183"	3	"V81"	-0.083154774	0.065623424	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	128
"1184"	11	"V459"	0.082973382	0.066215679	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	115
"1185"	7	"V260"	0.082957434	0.069982778	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	52
"1186"	20	"V291"	-0.082870476	0.066832449	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	64
"1187"	23	"V116"	0.082862465	0.066579992	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	5
"1188"	3	"V461"	0.082727749	0.067024683	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	117
"1189"	23	"V216"	-0.082700691	0.067114294	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	43
"1190"	8	"V170"	-0.082694772	0.067133909	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	22
"1191"	17	"V258"	0.082660479	0.067528152	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	50
"1192"	10	"V294"	-0.082624499	0.095981036	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	65
"1193"	20	"V211"	-0.08260025	0.067728777	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	42
"1194"	22	"V349"	-0.082559305	0.06758414	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	81
"1195"	4	"V227"	-0.082529805	0.067964055	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	46
"1196"	1	"V162"	-0.082529232	0.067965974	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	18
"1197"	15	"V455"	0.082498364	0.090912503	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	114
"1198"	20	"V268"	0.082425352	0.068314149	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	55
"1199"	1	"V420"	-0.082407231	0.068375037	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	106
"1200"	24	"V208"	-0.082245375	0.070943082	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	40
"1201"	2	"V372"	0.081998859	0.069759004	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	89
"1202"	2	"V299"	-0.081914121	0.070049038	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	66
"1203"	4	"V357"	0.081675011	0.070872763	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	84
"1204"	2	"V71"	0.08157852	0.071207406	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	124
"1205"	16	"V154"	-0.081477807	0.071268101	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	13
"1206"	21	"V270"	-0.081387074	0.071584499	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	57
"1207"	17	"V166"	-0.081358239	0.071976216	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	20
"1208"	5	"V275"	-0.081339746	0.072041066	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	59
"1209"	16	"V200"	-0.081317873	0.071826577	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	38
"1210"	22	"V383"	0.081249417	0.072066713	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	93
"1211"	16	"V455"	0.081189127	0.072278744	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	114
"1212"	5	"V177"	0.080997491	0.073249914	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	28
"1213"	17	"V364"	0.08098232	0.073303876	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	87
"1214"	10	"V208"	-0.080954575	0.102905427	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	40
"1215"	17	"V197"	0.080859942	0.073740376	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	36
"1216"	17	"V241"	0.080852356	0.073767505	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	48
"1217"	16	"V182"	-0.080565041	0.074503639	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	31
"1218"	2	"V396"	-0.080507164	0.075010547	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	97
"1219"	6	"V119"	0.080423044	0.160431251	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	7
"1220"	21	"V156"	0.080313142	0.075417342	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	15
"1221"	1	"V72"	-0.08028344	0.07582526	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	125
"1222"	22	"V175"	-0.080265804	0.075590064	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	26
"1223"	1	"V275"	-0.08020571	0.076109999	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	59
"1224"	17	"V175"	-0.080156617	0.076290285	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	26
"1225"	9	"V462"	0.080140014	0.076351334	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	118
"1226"	12	"V166"	-0.080073108	0.076597756	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	20
"1227"	4	"V197"	0.080005339	0.076848015	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	36
"1228"	21	"V18"	0.080000995	0.076562222	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	29
"1229"	5	"V119"	-0.079995686	0.076883714	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	7
"1230"	10	"V71"	0.079973026	0.107156768	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	124
"1231"	3	"V211"	0.079873526	0.077033795	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	42
"1232"	4	"V156"	0.079819871	0.077536315	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	15
"1233"	20	"V258"	0.079809826	0.077573735	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	50
"1234"	23	"V154"	-0.079773914	0.077403952	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	13
"1235"	21	"V372"	0.079589094	0.078094569	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	89
"1236"	17	"V357"	0.079586051	0.078411186	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	84
"1237"	24	"V36"	-0.079481734	0.080982757	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	86
"1238"	16	"V387"	0.079456699	0.07859236	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	94
"1239"	20	"V300"	-0.079449132	0.078927201	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	68
"1240"	7	"V367"	-0.079427341	0.082789497	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	88
"1241"	10	"V81"	0.079318077	0.110069872	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	128
"1242"	6	"V218"	0.079271724	0.166517704	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	44
"1243"	14	"V459"	0.079251539	0.079368825	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	115
"1244"	11	"V383"	0.079244568	0.079395316	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	93
"1245"	3	"V455"	0.079236994	0.079424106	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	114
"1246"	19	"V332"	-0.079198004	0.094442674	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	77
"1247"	3	"V273"	0.079163667	0.07970329	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	58
"1248"	10	"V291"	-0.079160129	0.110781654	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	64
"1249"	23	"V166"	-0.079153131	0.079743468	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	20
"1250"	17	"V81"	0.079098934	0.080259553	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	128
"1251"	24	"V170"	-0.079080534	0.082531527	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	22
"1252"	14	"V266"	0.078966699	0.080457159	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	54
"1253"	3	"V357"	-0.078911766	0.080668436	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	84
"1254"	10	"V462"	-0.078873507	0.112082546	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	118
"1255"	20	"V166"	-0.07880088	0.08140783	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	20
"1256"	1	"V252"	-0.07874364	0.081629866	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	49
"1257"	8	"V186"	0.078729445	0.081372876	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	33
"1258"	5	"V291"	0.078678995	0.081881216	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	64
"1259"	21	"V352"	0.078441438	0.082495804	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	83
"1260"	18	"V79"	-0.078378646	0.085298601	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	126
"1261"	12	"V294"	-0.078301872	0.083360042	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	65
"1262"	14	"V382"	0.078250741	0.083246197	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	92
"1263"	2	"V170"	0.078238589	0.083610299	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	22
"1264"	4	"V216"	-0.078187883	0.083811254	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	43
"1265"	11	"V367"	-0.078140503	0.083682495	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	88
"1266"	6	"V80"	0.078139668	0.172669346	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	127
"1267"	8	"V142"	0.07813877	0.083689366	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	11
"1268"	6	"V200"	-0.078128779	0.17272933	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	38
"1269"	20	"V102"	0.077918774	0.084884322	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	3
"1270"	16	"V85"	-0.077831883	0.08491377	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	130
"1271"	8	"V173"	0.077808107	0.085009232	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	25
"1272"	7	"V126"	-0.077805995	0.089275547	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	9
"1273"	24	"V156"	0.077693248	0.088072403	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	15
"1274"	21	"V341"	-0.077594584	0.085870414	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	78
"1275"	3	"V436"	0.077561062	0.08600625	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	109
"1276"	8	"V311"	-0.077537832	0.086100484	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	71
"1277"	1	"V90"	-0.077526999	0.086466304	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	133
"1278"	19	"V414"	0.077499888	0.101740803	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	103
"1279"	19	"V241"	-0.077469518	0.101875289	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	48
"1280"	19	"V418"	0.077395899	0.102201885	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	105
"1281"	10	"V154"	-0.077381848	0.119047704	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	13
"1282"	10	"V346"	-0.077314562	0.11936969	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	80
"1283"	1	"V95"	0.077267697	0.087526368	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	136
"1284"	24	"V189"	0.077256386	0.089877933	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	34
"1285"	7	"V100"	-0.077240783	0.091630356	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	2
"1286"	5	"V186"	0.077234936	0.087661043	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	33
"1287"	9	"V252"	0.077218928	0.087726906	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	49
"1288"	2	"V436"	-0.07718352	0.087872735	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	109
"1289"	7	"V200"	-0.077053842	0.092420066	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	38
"1290"	24	"V299"	0.076951791	0.091154305	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	66
"1291"	11	"V358"	-0.076923125	0.088624458	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	85
"1292"	24	"V414"	0.076898359	0.091379699	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	103
"1293"	3	"V197"	0.076822119	0.089044822	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	36
"1294"	13	"V300"	-0.076766938	0.09059496	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	68
"1295"	19	"V12"	-0.076763291	0.105042686	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	8
"1296"	11	"V346"	-0.076726049	0.089446128	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	80
"1297"	16	"V84"	0.076602562	0.089964094	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	129
"1298"	7	"V306"	-0.076592342	0.094392975	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	69
"1299"	18	"V71"	0.076544799	0.092882413	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	124
"1300"	10	"V405"	-0.076526788	0.123190249	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	99
"1301"	7	"V43"	-0.07646888	0.094926446	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	107
"1302"	1	"V92"	-0.076439194	0.090983669	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	135
"1303"	5	"V197"	0.076411778	0.091099921	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	36
"1304"	19	"V170"	0.076377978	0.106803388	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	22
"1305"	7	"V24"	0.076356553	0.095413894	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	47
"1306"	1	"V22"	0.076305972	0.091549685	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	45
"1307"	14	"V260"	-0.076254586	0.091436645	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	52
"1308"	12	"V33"	-0.076242049	0.091822277	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	76
"1309"	2	"V9"	0.076207834	0.091968449	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	131
"1310"	2	"V9"	0.076207834	0.091968449	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	132
"1311"	9	"V265"	-0.07617313	0.092116898	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	53
"1312"	5	"V176"	0.076122004	0.092335948	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	27
"1313"	17	"V173"	-0.075964815	0.093012034	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	25
"1314"	6	"V306"	-0.075906131	0.185300363	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	69
"1315"	10	"V92"	-0.07590439	0.126275562	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	135
"1316"	16	"V436"	-0.075757996	0.093571499	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	109
"1317"	21	"V364"	-0.075711225	0.093774607	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	87
"1318"	10	"V207"	-0.075653596	0.127535614	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	39
"1319"	12	"V268"	0.075635882	0.094439633	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	55
"1320"	14	"V448"	-0.075580097	0.09434593	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	113
"1321"	21	"V126"	-0.075573685	0.094373935	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	9
"1322"	12	"V466"	0.075570753	0.094724366	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	121
"1323"	17	"V411"	-0.075544576	0.094839001	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	100
"1324"	9	"V281"	0.075485829	0.095096674	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	62
"1325"	17	"V171"	-0.075482289	0.095112216	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	23
"1326"	11	"V142"	0.075448108	0.094923809	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	11
"1327"	19	"V269"	-0.075385681	0.111445191	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	56
"1328"	13	"V327"	-0.075316663	0.096868684	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	74
"1329"	4	"V164"	0.075277315	0.096015754	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	19
"1330"	3	"V173"	0.075272261	0.095698101	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	25
"1331"	23	"V306"	-0.075227018	0.095898128	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	69
"1332"	24	"V291"	0.074825003	0.100476299	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	64
"1333"	15	"V208"	-0.074809439	0.125353705	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	40
"1334"	10	"V175"	-0.07478521	0.131974052	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	26
"1335"	5	"V432"	0.074706215	0.098569382	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	108
"1336"	21	"V455"	0.074704447	0.0982328	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	114
"1337"	1	"V175"	-0.074526252	0.099385188	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	26
"1338"	5	"V180"	-0.074514034	0.099440767	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	30
"1339"	22	"V28"	-0.074494178	0.099184897	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	60
"1340"	13	"V392"	-0.074468253	0.100696568	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	95
"1341"	17	"V155"	0.074451358	0.099726277	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	14
"1342"	21	"V459"	0.074364062	0.099777729	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	115
"1343"	4	"V266"	0.07435956	0.10014562	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	54
"1344"	19	"V44"	0.0743561	0.116427765	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	111
"1345"	12	"V71"	-0.074332287	0.100270476	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	124
"1346"	4	"V12"	0.074313275	0.100357586	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	8
"1347"	24	"V265"	-0.074220515	0.103259835	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	53
"1348"	3	"V161"	0.074161011	0.1007085	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	17
"1349"	24	"V2"	0.074136123	0.103653264	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	37
"1350"	19	"V258"	0.073909506	0.118642582	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	50
"1351"	14	"V381"	-0.073832476	0.102229089	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	91
"1352"	14	"V180"	-0.073770023	0.102520196	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	30
"1353"	15	"V258"	0.073714679	0.130990353	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	50
"1354"	10	"V404"	-0.073706226	0.137654048	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	98
"1355"	20	"V63"	-0.073701592	0.103192494	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	123
"1356"	15	"V294"	-0.073686958	0.131135588	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	65
"1357"	18	"V280"	-0.073671218	0.105841951	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	61
"1358"	20	"V265"	-0.073625566	0.103549237	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	53
"1359"	14	"V465"	0.073600429	0.103314032	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	120
"1360"	6	"V344"	-0.073553651	0.199326703	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	79
"1361"	19	"V294"	-0.073549546	0.120451618	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	65
"1362"	14	"V269"	-0.073533091	0.103630576	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	56
"1363"	12	"V252"	-0.073523588	0.104029293	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	49
"1364"	9	"V72"	0.073466042	0.104300968	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	125
"1365"	21	"V260"	0.073333514	0.104573278	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	52
"1366"	18	"V90"	-0.073292177	0.107653336	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	133
"1367"	3	"V17"	-0.073278371	0.104834937	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	21
"1368"	19	"V2"	0.073211414	0.122170504	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	37
"1369"	9	"V207"	0.073065758	0.106206286	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	39
"1370"	17	"V455"	0.073049299	0.106285213	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	114
"1371"	5	"V32"	-0.072987268	0.106583099	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	72
"1372"	4	"V306"	0.072969042	0.106670749	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	69
"1373"	21	"V252"	-0.072924025	0.106528751	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	49
"1374"	19	"V466"	-0.072890771	0.123818089	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	121
"1375"	1	"V142"	-0.072887301	0.107064549	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	11
"1376"	1	"V207"	0.072870776	0.107144301	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	39
"1377"	7	"V404"	-0.072587582	0.112960057	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	98
"1378"	10	"V55"	-0.072351106	0.145051704	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	122
"1379"	22	"V439"	0.072342015	0.109357715	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	110
"1380"	11	"V154"	-0.072322976	0.109451248	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	13
"1381"	14	"V43"	-0.072322508	0.109453549	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	107
"1382"	21	"V85"	-0.072284174	0.109642068	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	130
"1383"	10	"V329"	-0.072267654	0.145517013	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	75
"1384"	4	"V102"	-0.072230912	0.110268614	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	3
"1385"	22	"V21"	-0.072230031	0.109908772	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	41
"1386"	12	"V182"	-0.072140879	0.11071393	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	31
"1387"	19	"V208"	-0.072042458	0.128260487	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	40
"1388"	7	"V289"	0.071975472	0.116035214	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	63
"1389"	2	"V268"	-0.071947247	0.111676461	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	55
"1390"	23	"V270"	-0.071933601	0.111378024	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	57
"1391"	1	"V55"	0.071908541	0.111869651	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	122
"1392"	15	"V156"	0.071903627	0.140742801	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	15
"1393"	21	"V173"	-0.07187982	0.11164624	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	25
"1394"	18	"V275"	0.071677906	0.115643377	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	59
"1395"	23	"V344"	-0.071581563	0.113142941	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	79
"1396"	5	"V460"	0.071537043	0.113737306	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	116
"1397"	22	"V310"	0.071496891	0.113570697	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	70
"1398"	12	"V55"	-0.071468614	0.114083979	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	122
"1399"	12	"V150"	0.071399606	0.114434425	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	12
"1400"	12	"V436"	-0.071397513	0.114445066	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	109
"1401"	20	"V455"	0.07120575	0.115423419	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	114
"1402"	18	"V461"	0.071196122	0.118116056	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	117
"1403"	19	"V432"	0.071175842	0.132925346	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	108
"1404"	21	"V268"	-0.071120655	0.115486813	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	55
"1405"	19	"V92"	0.071099648	0.133341677	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	135
"1406"	12	"V420"	-0.071098003	0.115976001	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	106
"1407"	10	"V439"	0.071064584	0.152352289	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	110
"1408"	10	"V216"	-0.071053879	0.152414183	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	43
"1409"	10	"V95"	-0.071049728	0.152438188	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	136
"1410"	12	"V11"	0.071048799	0.116229033	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	4
"1411"	10	"V281"	0.070946178	0.153037975	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	62
"1412"	23	"V43"	-0.070846003	0.116901519	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	107
"1413"	18	"V28"	-0.070755007	0.120416114	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	60
"1414"	2	"V382"	0.070619456	0.118455344	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	92
"1415"	15	"V413"	-0.070581458	0.148207378	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	102
"1416"	24	"V418"	-0.070456378	0.121992974	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	105
"1417"	21	"V171"	-0.070349989	0.119490799	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	23
"1418"	12	"V36"	-0.070297471	0.120146746	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	86
"1419"	11	"V90"	0.070259173	0.119969694	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	133
"1420"	19	"V156"	0.07025364	0.138032178	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	15
"1421"	23	"V22"	0.07020626	0.12024941	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	45
"1422"	5	"V95"	0.07015193	0.120917441	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	136
"1423"	8	"V280"	0.070111057	0.120753959	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	61
"1424"	21	"V420"	-0.070039228	0.121135731	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	106
"1425"	22	"V411"	-0.07003115	0.121178726	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	100
"1426"	5	"V22"	0.06999554	0.12174989	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	45
"1427"	21	"V382"	0.069954619	0.12158663	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	92
"1428"	18	"V367"	0.069929142	0.124816215	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	88
"1429"	17	"V156"	0.06991518	0.122179371	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	15
"1430"	21	"V447"	-0.069862515	0.122078963	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	112
"1431"	3	"V346"	0.069850591	0.122142815	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	80
"1432"	21	"V21"	-0.069830223	0.122251949	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	41
"1433"	6	"V183"	0.069782227	0.223399842	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	32
"1434"	19	"V33"	-0.069772879	0.140753596	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	76
"1435"	24	"V329"	-0.069736172	0.125862147	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	75
"1436"	11	"V462"	-0.069691389	0.122997827	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	118
"1437"	12	"V404"	-0.069662108	0.123539623	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	98
"1438"	8	"V11"	-0.069618004	0.123393517	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	4
"1439"	14	"V170"	-0.06957248	0.123639481	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	22
"1440"	2	"V448"	-0.069550589	0.124142769	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	113
"1441"	15	"V183"	0.069544491	0.154269904	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	32
"1442"	1	"V300"	0.069530038	0.124254167	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	68
"1443"	13	"V43"	-0.069493223	0.125617856	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	107
"1444"	1	"V311"	-0.0694468	0.124706161	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	71
"1445"	9	"V28"	0.069407994	0.12491732	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	60
"1446"	24	"V182"	-0.069405868	0.127668237	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	31
"1447"	14	"V118"	-0.069347761	0.12485921	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	6
"1448"	21	"V162"	-0.06933551	0.124925975	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	18
"1449"	24	"V349"	0.069270486	0.128414289	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	81
"1450"	15	"V420"	0.069238381	0.156094992	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	106
"1451"	19	"V344"	0.069194638	0.144081108	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	79
"1452"	5	"V175"	0.069154638	0.126302776	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	26
"1453"	2	"V260"	0.069123107	0.12647603	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	52
"1454"	1	"V160"	-0.069120275	0.126491602	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	16
"1455"	13	"V36"	-0.069065071	0.127969036	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	86
"1456"	15	"V12"	-0.068953649	0.15780724	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	8
"1457"	5	"V349"	0.068937044	0.127502172	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	81
"1458"	6	"V280"	0.068921563	0.229172426	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	61
"1459"	24	"V320"	-0.068907879	0.130429164	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	73
"1460"	21	"V376"	0.068790586	0.127923819	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	90
"1461"	24	"V85"	0.068732866	0.131410366	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	130
"1462"	15	"V160"	-0.068714024	0.159259204	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	16
"1463"	16	"V160"	-0.068512529	0.129474881	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	16
"1464"	20	"V71"	-0.068455505	0.130187868	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	124
"1465"	8	"V71"	0.068423575	0.129974148	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	124
"1466"	13	"V190"	0.068420815	0.131571084	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	35
"1467"	18	"V418"	0.068405841	0.133259095	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	105
"1468"	11	"V416"	0.068387318	0.130178075	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	104
"1469"	17	"V275"	-0.068381759	0.130603011	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	59
"1470"	21	"V170"	0.068355582	0.130356772	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	22
"1471"	11	"V273"	-0.068345314	0.130414632	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	58
"1472"	10	"V166"	-0.068284218	0.169077937	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	20
"1473"	8	"V259"	0.068282023	0.130771701	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	51
"1474"	3	"V91"	0.068255628	0.13092084	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	134
"1475"	2	"V327"	-0.068212138	0.13156176	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	74
"1476"	17	"V383"	0.068124825	0.132057398	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	93
"1477"	16	"V173"	-0.068040952	0.132138691	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	25
"1478"	24	"V393"	0.068026582	0.135428193	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	96
"1479"	17	"V387"	0.068022809	0.132638319	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	94
"1480"	6	"V18"	0.067938606	0.235893689	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	29
"1481"	19	"V63"	-0.067932948	0.151549991	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	123
"1482"	19	"V268"	0.067798047	0.15236566	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	55
"1483"	9	"V418"	0.067764299	0.134119238	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	105
"1484"	22	"V404"	-0.067549593	0.134959107	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	98
"1485"	11	"V176"	0.06754016	0.135013703	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	27
"1486"	21	"V460"	-0.067481672	0.135352598	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	116
"1487"	20	"V176"	0.067435857	0.13601913	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	27
"1488"	12	"V154"	-0.067413075	0.136151679	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	13
"1489"	14	"V24"	-0.067371369	0.13599351	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	47
"1490"	10	"V63"	-0.067368426	0.174877382	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	123
"1491"	17	"V436"	-0.06725001	0.137103319	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	109
"1492"	19	"V95"	-0.06724882	0.155720973	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	136
"1493"	9	"V63"	-0.067184766	0.137485511	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	123
"1494"	1	"V462"	-0.067078089	0.138112176	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	118
"1495"	8	"V30"	-0.067047732	0.137887485	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	67
"1496"	11	"V258"	0.067039044	0.137938602	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	50
"1497"	14	"V150"	-0.067025408	0.138018868	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	12
"1498"	16	"V447"	-0.066940606	0.138518849	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	112
"1499"	23	"V436"	-0.066865036	0.138965572	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	109
"1500"	3	"V119"	-0.066737688	0.13972087	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	7
"1501"	22	"V320"	-0.066674954	0.140094105	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	73
"1502"	19	"V180"	0.066646717	0.159463253	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	30
"1503"	24	"V18"	-0.066624763	0.143682329	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	29
"1504"	8	"V387"	0.066612939	0.140463813	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	94
"1505"	20	"V411"	-0.066589926	0.141007915	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	100
"1506"	13	"V22"	-0.066516205	0.14267892	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	45
"1507"	20	"V241"	0.066469191	0.141731234	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	48
"1508"	6	"V466"	0.066420404	0.24654579	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	121
"1509"	5	"V270"	-0.066385315	0.142235402	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	57
"1510"	22	"V289"	0.066350398	0.142037262	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	63
"1511"	5	"V71"	0.066339751	0.142509857	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	124
"1512"	3	"V252"	0.066278992	0.142467543	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	49
"1513"	2	"V447"	-0.066253892	0.143028134	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	112
"1514"	16	"V357"	0.066230728	0.142758935	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	84
"1515"	12	"V172"	0.066133316	0.143758411	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	24
"1516"	12	"V17"	0.066061297	0.144195959	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	21
"1517"	24	"V30"	-0.0660182	0.147370977	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	67
"1518"	15	"V24"	0.065966788	0.17663247	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	47
"1519"	19	"V299"	-0.065828909	0.164654368	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	66
"1520"	14	"V258"	0.065819266	0.14526168	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	50
"1521"	3	"V100"	-0.065807108	0.145336141	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	2
"1522"	18	"V439"	0.06562002	0.149831379	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	110
"1523"	18	"V216"	-0.065553844	0.150243302	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	43
"1524"	12	"V116"	0.06550857	0.147587977	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	5
"1525"	17	"V162"	-0.065483412	0.147743805	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	18
"1526"	23	"V404"	-0.065460278	0.14747252	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	98
"1527"	5	"V9"	0.065455541	0.147916582	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	131
"1528"	5	"V9"	0.065455541	0.147916582	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	132
"1529"	10	"V299"	-0.065376271	0.188002221	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	66
"1530"	7	"V162"	-0.065372235	0.153521688	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	18
"1531"	22	"V166"	-0.065332486	0.148265689	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	20
"1532"	9	"V171"	0.065312777	0.148804023	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	23
"1533"	16	"V197"	0.065301168	0.148460568	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	36
"1534"	13	"V176"	0.065190812	0.150822957	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	27
"1535"	20	"V306"	-0.065138285	0.149894184	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	69
"1536"	9	"V33"	0.065101308	0.150125984	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	76
"1537"	13	"V420"	0.065052216	0.151694589	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	106
"1538"	7	"V329"	-0.064982585	0.155991913	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	75
"1539"	19	"V327"	0.064942499	0.170423189	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	74
"1540"	16	"V372"	0.064920525	0.150844767	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	89
"1541"	7	"V211"	-0.064913498	0.156433018	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	42
"1542"	17	"V306"	-0.064811031	0.151955127	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	69
"1543"	18	"V84"	0.064533197	0.15670606	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	129
"1544"	2	"V43"	-0.064503111	0.153913896	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	107
"1545"	10	"V381"	0.064469654	0.194209682	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	91
"1546"	5	"V367"	0.064441707	0.154306783	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	88
"1547"	1	"V182"	-0.064386322	0.154661813	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	31
"1548"	17	"V72"	-0.064356255	0.154854805	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	125
"1549"	23	"V364"	0.064291412	0.154848952	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	87
"1550"	4	"V465"	0.064283491	0.155322619	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	120
"1551"	2	"V381"	0.064282552	0.155328663	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	91
"1552"	9	"V392"	-0.064207706	0.155810991	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	95
"1553"	2	"V166"	-0.064198192	0.155872384	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	20
"1554"	24	"V241"	-0.064144344	0.159222854	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	48
"1555"	12	"V350"	-0.064084364	0.156608312	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	82
"1556"	5	"V269"	-0.064032233	0.15694623	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	56
"1557"	11	"V357"	0.064026737	0.15655743	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	84
"1558"	5	"V211"	0.063848624	0.158140794	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	42
"1559"	19	"V177"	-0.063703992	0.178734628	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	28
"1560"	24	"V275"	-0.063538391	0.163205445	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	59
"1561"	21	"V63"	0.063527975	0.159815642	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	123
"1562"	19	"V260"	0.063520419	0.179991724	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	52
"1563"	21	"V32"	0.063511186	0.159926195	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	72
"1564"	21	"V465"	0.063482847	0.160112949	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	120
"1565"	1	"V155"	0.063478763	0.160567958	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	14
"1566"	11	"V197"	0.063456755	0.160285033	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	36
"1567"	21	"V9"	0.063429658	0.160463895	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	131
"1568"	21	"V9"	0.063429658	0.160463895	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	132
"1569"	12	"V216"	-0.063286384	0.161841469	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	43
"1570"	6	"V36"	-0.063284322	0.269600922	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	86
"1571"	2	"V21"	-0.063242472	0.162133223	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	41
"1572"	21	"V393"	0.063200476	0.161982713	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	96
"1573"	24	"V172"	0.063195936	0.165489107	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	24
"1574"	1	"V63"	0.063112047	0.163002107	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	123
"1575"	5	"V461"	0.063093888	0.16312336	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	117
"1576"	13	"V439"	0.063041009	0.164777461	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	110
"1577"	24	"V364"	0.062993443	0.166850671	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	87
"1578"	12	"V43"	-0.062944101	0.164126104	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	107
"1579"	15	"V126"	-0.062937639	0.197379073	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	9
"1580"	12	"V376"	-0.062933127	0.16419975	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	90
"1581"	20	"V79"	-0.062838219	0.164837725	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	126
"1582"	5	"V81"	0.06283073	0.164888142	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	128
"1583"	12	"V289"	0.062802002	0.165081661	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	63
"1584"	2	"V460"	-0.062751139	0.16542471	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	116
"1585"	12	"V170"	0.062459668	0.167400863	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	22
"1586"	24	"V396"	-0.062406237	0.170846529	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	97
"1587"	9	"V177"	0.062373985	0.167985139	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	28
"1588"	15	"V310"	-0.062252827	0.202306439	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	70
"1589"	4	"V463"	-0.062220036	0.169038768	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	119
"1590"	21	"V320"	-0.062213823	0.168645187	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	73
"1591"	1	"V349"	-0.062188677	0.169253989	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	81
"1592"	24	"V161"	0.062159411	0.172547336	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	17
"1593"	8	"V43"	-0.062125647	0.169250446	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	107
"1594"	24	"V300"	0.062110803	0.172883764	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	68
"1595"	22	"V164"	0.062048008	0.169784725	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	19
"1596"	13	"V376"	0.062016393	0.171760163	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	90
"1597"	9	"V411"	-0.061957756	0.170845185	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	100
"1598"	9	"V116"	-0.061901012	0.17123789	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	5
"1599"	11	"V227"	-0.061876728	0.170967853	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	46
"1600"	6	"V447"	0.061812189	0.280916333	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	112
"1601"	24	"V173"	0.061804315	0.175016309	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	25
"1602"	19	"V463"	-0.061765766	0.192339661	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	119
"1603"	3	"V241"	-0.061741318	0.171907562	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	48
"1604"	21	"V190"	-0.061678192	0.172346953	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	35
"1605"	3	"V300"	0.061648273	0.172555505	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	68
"1606"	14	"V119"	-0.061616172	0.172779469	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	7
"1607"	2	"V341"	-0.061498238	0.174044762	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	78
"1608"	10	"V364"	-0.06144767	0.215982185	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	87
"1609"	6	"V310"	0.06139128	0.284209822	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	70
"1610"	8	"V344"	-0.061274522	0.17517656	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	79
"1611"	11	"V280"	0.061230065	0.17549029	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	61
"1612"	15	"V100"	-0.061162061	0.21033832	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	2
"1613"	4	"V241"	0.061148917	0.176506774	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	48
"1614"	11	"V413"	-0.061059608	0.176697079	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	102
"1615"	4	"V387"	0.061046958	0.177230232	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	94
"1616"	3	"V376"	0.061037375	0.176854935	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	90
"1617"	20	"V392"	0.061033565	0.177325428	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	95
"1618"	6	"V155"	0.060983774	0.287423156	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	14
"1619"	4	"V294"	-0.060950843	0.177914246	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	65
"1620"	12	"V189"	0.060947263	0.177939764	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	34
"1621"	1	"V466"	-0.060927153	0.178083138	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	121
"1622"	2	"V411"	-0.060904688	0.178243412	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	100
"1623"	14	"V265"	-0.06084953	0.178192845	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	53
"1624"	18	"V447"	-0.060828401	0.181937179	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	112
"1625"	3	"V186"	0.060691689	0.179322855	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	33
"1626"	11	"V387"	0.060682795	0.179386685	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	94
"1627"	11	"V281"	0.060600985	0.179974615	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	62
"1628"	3	"V299"	0.060590016	0.180053552	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	66
"1629"	4	"V461"	0.060581089	0.180563927	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	117
"1630"	1	"V270"	-0.060494031	0.181192023	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	57
"1631"	11	"V211"	-0.060424911	0.181244825	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	42
"1632"	22	"V142"	0.060334105	0.181902492	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	11
"1633"	14	"V352"	-0.060275909	0.182324913	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	83
"1634"	11	"V9"	0.060269839	0.182369014	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	131
"1635"	11	"V9"	0.060269839	0.182369014	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	132
"1636"	14	"V310"	-0.060223893	0.182703087	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	70
"1637"	21	"V197"	0.060145076	0.183277216	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	36
"1638"	9	"V381"	-0.060112929	0.183960597	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	91
"1639"	10	"V142"	0.060045363	0.226660102	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	11
"1640"	16	"V289"	0.059961886	0.184616784	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	63
"1641"	10	"V164"	0.059881735	0.227930099	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	19
"1642"	20	"V413"	-0.059863902	0.185786494	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	102
"1643"	19	"V150"	-0.059818592	0.206757042	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	12
"1644"	2	"V216"	-0.059801893	0.186243225	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	43
"1645"	12	"V24"	0.059772649	0.186458909	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	47
"1646"	17	"V164"	0.059756193	0.186580363	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	19
"1647"	22	"V241"	0.059726605	0.18634785	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	48
"1648"	7	"V13"	-0.05971508	0.192397411	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	10
"1649"	5	"V396"	0.059712235	0.186905069	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	97
"1650"	10	"V190"	-0.059636839	0.229840287	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	35
"1651"	2	"V17"	0.059634201	0.187482514	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	21
"1652"	13	"V182"	-0.059474697	0.190031832	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	31
"1653"	2	"V266"	-0.059470297	0.188699669	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	54
"1654"	10	"V227"	-0.059447432	0.231325425	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	46
"1655"	4	"V24"	-0.059359101	0.189528719	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	47
"1656"	3	"V332"	0.059327922	0.189308416	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	77
"1657"	8	"V352"	0.059284787	0.18963079	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	83
"1658"	18	"V13"	-0.059194152	0.193976945	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	10
"1659"	9	"V126"	0.05910496	0.191433574	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	9
"1660"	24	"V171"	-0.059104488	0.19465401	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	23
"1661"	22	"V172"	-0.05900411	0.191738333	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	24
"1662"	2	"V55"	-0.059001582	0.192212425	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	122
"1663"	24	"V72"	0.058981319	0.195586892	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	125
"1664"	9	"V170"	-0.058842136	0.193418254	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	22
"1665"	19	"V436"	0.058831448	0.214358105	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	109
"1666"	5	"V392"	-0.0587381	0.194208016	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	95
"1667"	22	"V182"	-0.058704016	0.194010636	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	31
"1668"	5	"V332"	0.058679904	0.194650821	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	77
"1669"	17	"V382"	-0.05854379	0.195689391	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	92
"1670"	20	"V171"	-0.058539299	0.195723727	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	23
"1671"	11	"V190"	-0.058522041	0.195398117	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	35
"1672"	17	"V100"	-0.058462537	0.196311288	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	2
"1673"	7	"V413"	-0.058450791	0.2019961	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	102
"1674"	15	"V412"	0.058450299	0.231297498	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	101
"1675"	15	"V357"	0.058434559	0.231423324	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	84
"1676"	8	"V180"	-0.058394112	0.196377853	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	30
"1677"	23	"V352"	0.058373827	0.196533535	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	83
"1678"	16	"V280"	0.058171996	0.19808744	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	61
"1679"	24	"V341"	0.058152721	0.201947786	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	78
"1680"	19	"V439"	0.05814976	0.219723149	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	110
"1681"	1	"V404"	-0.058084109	0.19922676	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	98
"1682"	6	"V22"	0.057900881	0.312522377	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	45
"1683"	2	"V376"	0.057867944	0.200906233	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	90
"1684"	17	"V412"	0.057737052	0.201928175	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	101
"1685"	20	"V175"	-0.057725997	0.202014664	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	26
"1686"	5	"V299"	0.057677348	0.202395571	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	66
"1687"	5	"V311"	-0.057600957	0.202994748	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	71
"1688"	16	"V44"	0.057586866	0.202643012	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	111
"1689"	4	"V180"	-0.057461221	0.204094115	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	30
"1690"	15	"V43"	-0.057460317	0.239305946	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	107
"1691"	10	"V186"	0.057457244	0.247342378	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	33
"1692"	14	"V275"	-0.057435615	0.203832875	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	59
"1693"	19	"V80"	-0.057413977	0.225621063	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	127
"1694"	4	"V44"	-0.057349809	0.204973733	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	111
"1695"	8	"V270"	-0.05732897	0.204674882	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	57
"1696"	8	"V190"	0.057323525	0.204717935	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	35
"1697"	19	"V32"	-0.057300905	0.226537332	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	72
"1698"	21	"V266"	-0.057126948	0.206276829	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	54
"1699"	4	"V350"	0.05710394	0.206924628	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	82
"1700"	11	"V32"	0.057078282	0.206664083	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	72
"1701"	17	"V367"	-0.057019553	0.207597309	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	88
"1702"	21	"V11"	0.056996493	0.2073161	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	4
"1703"	22	"V358"	-0.056928772	0.207857092	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	85
"1704"	19	"V164"	-0.05691505	0.229683998	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	19
"1705"	13	"V183"	0.056854975	0.21031911	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	32
"1706"	5	"V416"	0.056812386	0.209255409	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	104
"1707"	1	"V383"	-0.056812078	0.209257881	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	93
"1708"	6	"V30"	-0.056756262	0.322196834	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	67
"1709"	12	"V28"	-0.056670256	0.210398503	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	60
"1710"	15	"V372"	0.05664606	0.246037508	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	89
"1711"	8	"V448"	-0.056623213	0.210310764	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	113
"1712"	14	"V259"	0.056612405	0.210397933	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	51
"1713"	11	"V463"	-0.056591087	0.210569949	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	119
"1714"	4	"V341"	0.056528103	0.211546276	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	78
"1715"	3	"V259"	0.056495019	0.211346384	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	51
"1716"	16	"V176"	0.056451906	0.211695497	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	27
"1717"	21	"V367"	-0.05636768	0.212378724	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	88
"1718"	2	"V358"	-0.056337342	0.213093609	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	85
"1719"	18	"V405"	-0.056289178	0.216800454	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	99
"1720"	6	"V13"	-0.056274206	0.326328869	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	10
"1721"	23	"V350"	-0.056155031	0.214110779	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	82
"1722"	16	"V439"	0.056150316	0.214149296	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	110
"1723"	16	"V270"	-0.056148259	0.214166097	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	57
"1724"	15	"V291"	-0.05613251	0.250350559	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	64
"1725"	2	"V270"	-0.056103039	0.215005265	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	57
"1726"	15	"V182"	-0.05606767	0.250898837	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	31
"1727"	8	"V358"	0.056038671	0.215062835	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	85
"1728"	9	"V260"	0.056035196	0.215561082	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	52
"1729"	2	"V80"	0.055905423	0.216627151	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	127
"1730"	15	"V329"	-0.055877379	0.252512737	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	75
"1731"	7	"V465"	0.055829962	0.222993276	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	120
"1732"	21	"V411"	-0.055824708	0.216821415	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	100
"1733"	9	"V227"	0.0558157	0.217366429	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	46
"1734"	21	"V17"	0.05578189	0.217174573	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	21
"1735"	11	"V17"	0.055752232	0.217419432	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	21
"1736"	18	"V416"	-0.05568075	0.221815444	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	104
"1737"	2	"V208"	-0.055671877	0.218555227	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	40
"1738"	13	"V116"	0.055646672	0.220185835	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	5
"1739"	2	"V273"	0.055638382	0.218832756	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	58
"1740"	24	"V33"	-0.055629862	0.222238615	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	76
"1741"	4	"V462"	-0.055584481	0.219279896	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	118
"1742"	19	"V280"	-0.055571199	0.240884851	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	61
"1743"	16	"V432"	-0.055544737	0.219138077	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	108
"1744"	18	"V420"	-0.055489891	0.223405552	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	106
"1745"	11	"V182"	-0.055396665	0.220370466	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	31
"1746"	12	"V259"	-0.055361352	0.221137826	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	51
"1747"	14	"V116"	-0.05532971	0.220929353	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	5
"1748"	17	"V372"	0.055325823	0.221434707	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	89
"1749"	24	"V55"	-0.055324412	0.224790782	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	122
"1750"	17	"V310"	-0.055300469	0.221646736	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	70
"1751"	16	"V259"	-0.055280846	0.22133787	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	51
"1752"	7	"V387"	0.055278161	0.227605877	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	94
"1753"	5	"V155"	0.055275394	0.221856568	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	14
"1754"	15	"V13"	-0.05523133	0.258045799	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	10
"1755"	17	"V420"	0.05518927	0.222578373	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	106
"1756"	21	"V357"	0.055116728	0.22271389	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	84
"1757"	15	"V166"	-0.055108463	0.259107504	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	20
"1758"	19	"V461"	0.055099793	0.244903409	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	117
"1759"	12	"V44"	0.055080625	0.223491317	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	111
"1760"	20	"V416"	0.055080008	0.22349651	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	104
"1761"	21	"V259"	-0.055066672	0.223134795	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	51
"1762"	5	"V13"	0.054977049	0.224364153	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	10
"1763"	9	"V463"	0.054927046	0.22478639	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	119
"1764"	17	"V172"	0.054926746	0.224788928	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	24
"1765"	10	"V252"	-0.054880922	0.269204318	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	49
"1766"	7	"V392"	-0.05487128	0.231050244	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	95
"1767"	19	"V465"	0.054817384	0.247333201	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	120
"1768"	17	"V84"	0.054781809	0.226016039	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	129
"1769"	3	"V275"	-0.054714949	0.226108306	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	59
"1770"	3	"V327"	-0.054678101	0.226421453	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	74
"1771"	17	"V183"	0.054674403	0.226928458	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	32
"1772"	12	"V85"	-0.054662239	0.227031957	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	130
"1773"	5	"V84"	0.054595395	0.227601316	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	129
"1774"	23	"V349"	0.05450632	0.227885362	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	81
"1775"	14	"V36"	-0.054461812	0.228265752	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	86
"1776"	17	"V11"	0.054446616	0.228872197	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	4
"1777"	1	"V44"	0.054378899	0.229452309	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	111
"1778"	9	"V299"	0.0543595	0.229618687	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	66
"1779"	10	"V22"	-0.054302434	0.274289682	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	45
"1780"	1	"V9"	0.054198448	0.231003274	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	131
"1781"	1	"V9"	0.054198448	0.231003274	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	132
"1782"	10	"V459"	0.054175727	0.275412225	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	115
"1783"	9	"V273"	0.054165736	0.231285227	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	58
"1784"	23	"V280"	0.054145663	0.230980726	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	61
"1785"	17	"V218"	-0.054126796	0.23162118	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	44
"1786"	21	"V265"	-0.054069751	0.231636023	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	53
"1787"	12	"V100"	-0.054007379	0.232653588	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	2
"1788"	18	"V91"	0.053946612	0.236562463	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	134
"1789"	7	"V268"	-0.053937226	0.239096623	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	55
"1790"	11	"V404"	-0.053870364	0.233363467	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	98
"1791"	24	"V413"	0.05372584	0.2384884	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	102
"1792"	20	"V44"	-0.053673668	0.235555922	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	111
"1793"	17	"V416"	0.053662637	0.235652291	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	104
"1794"	18	"V85"	-0.053643736	0.239207454	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	130
"1795"	23	"V63"	-0.053606857	0.235660393	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	123
"1796"	3	"V358"	0.053605918	0.235668604	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	85
"1797"	9	"V80"	0.053573887	0.23642867	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	127
"1798"	12	"V358"	-0.053559441	0.236555218	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	85
"1799"	2	"V412"	0.053491991	0.237146694	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	101
"1800"	15	"V36"	0.053491226	0.273363797	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	86
"1801"	19	"V289"	0.053323719	0.260464218	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	63
"1802"	11	"V102"	0.053224922	0.239017879	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	3
"1803"	12	"V164"	0.05317561	0.239934989	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	19
"1804"	1	"V268"	0.053073716	0.240837876	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	55
"1805"	11	"V275"	-0.053041522	0.24064201	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	59
"1806"	19	"V216"	-0.052998873	0.26338253	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	43
"1807"	14	"V177"	0.052996477	0.241042095	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	28
"1808"	12	"V21"	-0.05295455	0.241896843	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	41
"1809"	2	"V172"	0.052926795	0.242143956	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	24
"1810"	8	"V310"	0.052842429	0.24241387	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	70
"1811"	18	"V311"	-0.052783981	0.246828763	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	71
"1812"	4	"V63"	-0.05277725	0.243478458	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	123
"1813"	19	"V266"	-0.052757815	0.265562617	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	54
"1814"	14	"V164"	0.052730734	0.243411921	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	19
"1815"	13	"V269"	0.052722641	0.245422203	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	56
"1816"	21	"V218"	-0.052707289	0.243621781	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	44
"1817"	13	"V289"	0.052684719	0.245762272	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	63
"1818"	22	"V432"	-0.052661326	0.244033558	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	108
"1819"	14	"V183"	0.052640413	0.244221082	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	32
"1820"	19	"V364"	0.052603121	0.266968161	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	87
"1821"	24	"V9"	0.052600892	0.248473435	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	131
"1822"	24	"V9"	0.052600892	0.248473435	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	132
"1823"	10	"V118"	0.052575711	0.28985629	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	6
"1824"	5	"V383"	0.05250141	0.245953482	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	93
"1825"	4	"V36"	-0.052427191	0.246622425	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	86
"1826"	10	"V306"	-0.052327101	0.29214544	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	69
"1827"	9	"V160"	-0.052280221	0.247950824	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	16
"1828"	4	"V259"	0.05223135	0.248393651	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	51
"1829"	10	"V460"	-0.052181387	0.293492762	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	116
"1830"	8	"V182"	-0.052133043	0.248801515	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	31
"1831"	5	"V381"	-0.052080057	0.249768038	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	91
"1832"	4	"V173"	-0.052073128	0.249831115	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	25
"1833"	21	"V310"	0.052038738	0.249659443	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	70
"1834"	19	"V265"	0.052027998	0.272238388	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	53
"1835"	14	"V294"	-0.051923845	0.250707457	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	65
"1836"	24	"V310"	0.051806246	0.255700219	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	70
"1837"	15	"V197"	-0.051804216	0.288795411	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	36
"1838"	24	"V455"	0.051723442	0.256461574	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	114
"1839"	15	"V28"	0.051691451	0.289847382	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	60
"1840"	10	"V376"	0.051663851	0.298311637	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	90
"1841"	6	"V11"	0.051642538	0.367767098	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	4
"1842"	22	"V447"	0.051596427	0.253710826	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	112
"1843"	20	"V80"	0.051526046	0.254846039	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	127
"1844"	20	"V126"	-0.051521319	0.254889671	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	9
"1845"	14	"V367"	-0.051426444	0.255279884	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	88
"1846"	23	"V273"	-0.051360228	0.255892918	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	58
"1847"	9	"V327"	0.051296885	0.256967305	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	74
"1848"	10	"V358"	-0.051250302	0.302199929	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	85
"1849"	10	"V372"	0.051204644	0.302631274	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	89
"1850"	18	"V80"	-0.051203422	0.261278827	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	127
"1851"	18	"V329"	-0.051193968	0.261366977	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	75
"1852"	9	"V12"	0.051193844	0.257925087	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	8
"1853"	8	"V197"	0.051159014	0.257762031	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	36
"1854"	3	"V463"	-0.051054494	0.258736663	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	119
"1855"	22	"V260"	0.05102113	0.259048307	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	52
"1856"	17	"V269"	-0.050923003	0.260454389	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	56
"1857"	23	"V172"	0.050856301	0.260591753	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	24
"1858"	16	"V43"	-0.050826798	0.260868688	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	107
"1859"	21	"V216"	-0.050814689	0.260982413	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	43
"1860"	23	"V119"	0.050746948	0.261619224	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	7
"1861"	10	"V28"	0.050674874	0.307665969	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	60
"1862"	7	"V376"	-0.050584402	0.269595511	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	90
"1863"	14	"V32"	-0.050503754	0.263914264	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	72
"1864"	6	"V92"	0.050490798	0.37855747	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	135
"1865"	3	"V404"	0.050480691	0.264132622	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	98
"1866"	22	"V459"	0.05047309	0.264204619	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	115
"1867"	20	"V183"	0.050274842	0.266576693	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	32
"1868"	9	"V118"	-0.050211278	0.267182374	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	6
"1869"	8	"V166"	0.050191619	0.266880143	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	20
"1870"	7	"V182"	-0.050088196	0.274325953	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	31
"1871"	12	"V176"	0.050051473	0.268709272	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	27
"1872"	2	"V227"	-0.05004573	0.268764258	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	46
"1873"	16	"V180"	0.050029984	0.268424936	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	30
"1874"	1	"V387"	-0.049976266	0.269429923	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	94
"1875"	6	"V164"	0.049857132	0.384576081	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	19
"1876"	17	"V352"	0.049794847	0.271173749	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	83
"1877"	12	"V180"	-0.049735272	0.271748078	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	30
"1878"	2	"V413"	-0.049703095	0.272058623	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	102
"1879"	18	"V36"	-0.049678338	0.275765005	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	86
"1880"	13	"V465"	0.049674454	0.273814506	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	120
"1881"	8	"V341"	-0.049605762	0.272508465	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	78
"1882"	11	"V265"	-0.049562044	0.272931689	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	53
"1883"	4	"V162"	-0.04949069	0.274114644	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	18
"1884"	21	"V273"	0.049479385	0.273733113	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	58
"1885"	1	"V126"	0.049467351	0.274341199	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	9
"1886"	1	"V461"	0.049403087	0.274965696	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	117
"1887"	14	"V463"	-0.049186695	0.276583807	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	119
"1888"	24	"V28"	-0.049076925	0.28162511	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	60
"1889"	4	"V252"	-0.049045238	0.278460819	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	49
"1890"	9	"V459"	0.049035278	0.278558533	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	115
"1891"	3	"V460"	-0.048972858	0.27867923	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	116
"1892"	12	"V311"	0.048947296	0.279422661	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	71
"1893"	4	"V154"	0.048933958	0.279553826	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	13
"1894"	19	"V18"	-0.048879872	0.302340819	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	29
"1895"	22	"V281"	0.048838431	0.280001995	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	62
"1896"	24	"V11"	0.04881648	0.28418882	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	4
"1897"	9	"V173"	-0.048791918	0.280953167	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	25
"1898"	4	"V269"	-0.048737657	0.281488988	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	56
"1899"	8	"V216"	-0.048630356	0.282057842	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	43
"1900"	8	"V116"	-0.048560081	0.282754486	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	5
"1901"	14	"V461"	0.048551898	0.282835678	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	117
"1902"	11	"V92"	-0.048494854	0.283402125	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	135
"1903"	24	"V21"	-0.04848691	0.287455503	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	41
"1904"	1	"V84"	-0.048472169	0.284120608	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	129
"1905"	12	"V208"	-0.048347918	0.285357916	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	40
"1906"	2	"V416"	0.048253012	0.286305453	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	104
"1907"	3	"V164"	-0.048231573	0.286026439	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	19
"1908"	19	"V462"	-0.048204964	0.309071381	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	118
"1909"	10	"V367"	-0.04820385	0.331875716	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	88
"1910"	7	"V327"	0.048173596	0.293106344	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	74
"1911"	3	"V447"	0.048151467	0.286828149	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	112
"1912"	11	"V63"	-0.048087027	0.287474177	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	123
"1913"	10	"V382"	-0.048033232	0.333591482	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	92
"1914"	9	"V32"	0.047973205	0.289111355	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	72
"1915"	1	"V166"	0.04795285	0.289316194	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	20
"1916"	4	"V364"	-0.047930854	0.289537648	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	87
"1917"	20	"V310"	-0.047851678	0.290335765	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	70
"1918"	21	"V436"	-0.04777238	0.290642632	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	109
"1919"	1	"V170"	-0.047720579	0.291660509	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	22
"1920"	10	"V162"	-0.047693523	0.337024593	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	18
"1921"	9	"V432"	-0.047655616	0.292318452	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	108
"1922"	7	"V294"	-0.047585464	0.299044255	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	65
"1923"	8	"V154"	-0.047485301	0.293553853	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	13
"1924"	19	"V142"	0.047479756	0.31641283	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	11
"1925"	16	"V100"	-0.047441681	0.293997906	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	2
"1926"	1	"V176"	-0.047261852	0.296327777	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	27
"1927"	23	"V164"	0.047168869	0.296785286	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	19
"1928"	14	"V411"	-0.047121704	0.297268967	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	100
"1929"	1	"V171"	0.047095785	0.298029642	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	23
"1930"	19	"V200"	-0.04708441	0.320462696	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	38
"1931"	18	"V465"	0.047026474	0.302234576	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	120
"1932"	2	"V344"	-0.046937991	0.299652737	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	79
"1933"	4	"V118"	-0.046909106	0.299950489	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	6
"1934"	9	"V358"	0.04687979	0.300252881	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	85
"1935"	10	"V270"	0.046866863	0.345473119	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	57
"1936"	12	"V416"	0.046841944	0.30064357	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	104
"1937"	2	"V439"	0.046823924	0.300829711	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	110
"1938"	4	"V150"	-0.046788699	0.301193783	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	12
"1939"	10	"V418"	0.046777294	0.34639654	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	105
"1940"	12	"V63"	0.046773804	0.301347831	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	123
"1941"	16	"V327"	0.046751908	0.301079437	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	74
"1942"	4	"V275"	-0.046617018	0.302972442	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	59
"1943"	11	"V33"	-0.046586612	0.302793145	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	76
"1944"	17	"V259"	-0.046447914	0.304731207	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	51
"1945"	3	"V466"	-0.046402454	0.304710005	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	121
"1946"	21	"V183"	0.046398366	0.304752647	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	32
"1947"	13	"V71"	-0.046382218	0.306908043	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	124
"1948"	24	"V207"	-0.046310719	0.309658754	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	39
"1949"	16	"V269"	-0.046209846	0.306723402	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	56
"1950"	18	"V21"	-0.046172605	0.311105064	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	41
"1951"	9	"V460"	0.04611859	0.308175685	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	116
"1952"	7	"V183"	0.046100098	0.314395143	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	32
"1953"	16	"V18"	0.046049227	0.30840912	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	29
"1954"	8	"V266"	0.046041936	0.308485777	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	54
"1955"	20	"V43"	-0.046031071	0.30909538	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	107
"1956"	18	"V63"	-0.045918068	0.313782166	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	123
"1957"	22	"V376"	-0.045889583	0.310090644	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	90
"1958"	16	"V268"	-0.045879011	0.310202209	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	55
"1959"	2	"V63"	0.045859113	0.31090765	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	123
"1960"	9	"V155"	-0.045834212	0.311170662	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	14
"1961"	11	"V55"	-0.045724069	0.311840368	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	122
"1962"	8	"V463"	-0.045717531	0.311909611	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	119
"1963"	5	"V266"	0.045715999	0.312421264	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	54
"1964"	10	"V311"	-0.045701806	0.357606523	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	71
"1965"	19	"V171"	-0.045694191	0.334971012	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	23
"1966"	9	"V186"	-0.045661452	0.312999438	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	33
"1967"	9	"V180"	0.045658593	0.313029763	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	30
"1968"	4	"V116"	-0.045592906	0.313726992	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	5
"1969"	13	"V432"	-0.045560509	0.31556376	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	108
"1970"	17	"V190"	0.045467091	0.315065295	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	35
"1971"	18	"V346"	-0.045360119	0.319703151	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	80
"1972"	7	"V310"	-0.045358755	0.322246767	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	70
"1973"	14	"V156"	0.045324787	0.316088026	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	15
"1974"	13	"V364"	0.045257654	0.318793931	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	87
"1975"	18	"V227"	-0.045238825	0.320999907	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	46
"1976"	17	"V28"	0.045234912	0.317544812	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	60
"1977"	10	"V416"	0.045221408	0.36268654	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	104
"1978"	8	"V32"	-0.045201011	0.317412438	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	72
"1979"	9	"V344"	0.045167585	0.318266203	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	79
"1980"	23	"V44"	0.04512812	0.318194081	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	111
"1981"	7	"V36"	0.045117114	0.324833361	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	86
"1982"	22	"V350"	0.045106338	0.318427897	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	82
"1983"	3	"V310"	0.045075536	0.318758736	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	70
"1984"	22	"V43"	-0.045048652	0.31904767	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	107
"1985"	15	"V162"	-0.045029627	0.356563527	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	18
"1986"	10	"V387"	-0.044995955	0.365086072	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	94
"1987"	4	"V404"	-0.044994353	0.320127243	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	98
"1988"	5	"V341"	0.044971939	0.320368558	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	78
"1989"	3	"V177"	0.044903001	0.32061605	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	28
"1990"	24	"V352"	-0.044779991	0.32593631	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	83
"1991"	1	"V299"	0.044765123	0.322600778	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	66
"1992"	17	"V327"	0.044714456	0.323149178	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	74
"1993"	12	"V95"	-0.044705558	0.32324554	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	136
"1994"	5	"V268"	-0.044649233	0.32385602	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	55
"1995"	8	"V176"	0.044633803	0.323527991	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	27
"1996"	15	"V306"	-0.044555309	0.361655825	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	69
"1997"	22	"V33"	-0.044544481	0.324497979	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	76
"1998"	24	"V211"	0.044458359	0.329425806	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	42
"1999"	14	"V357"	0.044399043	0.326081398	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	84
"2000"	24	"V259"	-0.04438221	0.330255492	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	51
"2001"	3	"V63"	-0.044366787	0.326433265	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	123
"2002"	17	"V358"	-0.044307992	0.327570511	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	85
"2003"	18	"V268"	0.044217286	0.332057062	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	55
"2004"	14	"V372"	-0.044153452	0.328766574	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	89
"2005"	22	"V173"	-0.04413837	0.328931931	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	25
"2006"	24	"V90"	0.044090134	0.33345034	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	133
"2007"	9	"V43"	0.044031503	0.330600322	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	107
"2008"	4	"V299"	-0.04402296	0.330694221	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	66
"2009"	11	"V150"	0.043877855	0.331796785	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	12
"2010"	1	"V119"	-0.043872355	0.332352468	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	7
"2011"	8	"V273"	0.043804642	0.332604784	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	58
"2012"	7	"V84"	0.043772034	0.339477023	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	129
"2013"	22	"V183"	0.043723173	0.33350539	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	32
"2014"	23	"V289"	-0.043717633	0.333566694	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	63
"2015"	22	"V382"	-0.043710916	0.333641028	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	92
"2016"	24	"V392"	-0.043693575	0.337819799	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	95
"2017"	2	"V357"	0.04369032	0.334363916	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	84
"2018"	9	"V142"	0.043687632	0.334393668	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	11
"2019"	2	"V350"	-0.043679822	0.334480151	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	82
"2020"	16	"V392"	0.043589556	0.334985873	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	95
"2021"	6	"V172"	0.043556069	0.447540714	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	24
"2022"	8	"V189"	0.043544505	0.335485989	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	34
"2023"	22	"V92"	0.043515226	0.33581128	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	135
"2024"	19	"V376"	-0.043504061	0.358669413	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	90
"2025"	2	"V455"	0.04346343	0.336881935	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	114
"2026"	16	"V211"	-0.043448586	0.336552398	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	42
"2027"	21	"V439"	0.04341859	0.336886332	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	110
"2028"	4	"V119"	-0.043389874	0.337700854	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	7
"2029"	2	"V259"	0.043353637	0.338104765	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	51
"2030"	9	"V346"	0.043242591	0.339344447	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	80
"2031"	8	"V367"	-0.043145194	0.33993974	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	88
"2032"	20	"V36"	-0.04314138	0.340476864	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	86
"2033"	2	"V367"	-0.043116195	0.34075902	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	88
"2034"	3	"V30"	-0.042953354	0.342092825	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	67
"2035"	17	"V30"	-0.042946061	0.342669044	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	67
"2036"	19	"V320"	0.04294114	0.364926403	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	73
"2037"	8	"V252"	0.042902954	0.342659927	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	49
"2038"	1	"V327"	0.042880436	0.3434076	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	74
"2039"	18	"V2"	-0.042798868	0.347812171	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	37
"2040"	1	"V310"	-0.04270478	0.345389479	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	70
"2041"	23	"V465"	0.04268722	0.345094117	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	120
"2042"	10	"V197"	-0.04267851	0.390320918	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	36
"2043"	3	"V392"	-0.042616664	0.345892606	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	95
"2044"	20	"V459"	0.042595283	0.34662857	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	115
"2045"	19	"V160"	-0.042578604	0.368991854	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	16
"2046"	14	"V268"	-0.04257498	0.346364898	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	55
"2047"	17	"V85"	-0.042441775	0.348370455	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	130
"2048"	13	"V24"	-0.042260688	0.351917964	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	47
"2049"	15	"V364"	0.042256784	0.386971745	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	87
"2050"	3	"V21"	-0.042199622	0.350636261	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	41
"2051"	2	"V352"	0.042099059	0.352279294	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	83
"2052"	15	"V260"	0.04206015	0.389186407	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	52
"2053"	10	"V259"	-0.042058515	0.397247246	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	51
"2054"	15	"V44"	0.042053102	0.389265928	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	111
"2055"	14	"V432"	0.042034501	0.35252576	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	108
"2056"	17	"V80"	0.042033315	0.35303229	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	127
"2057"	8	"V44"	0.041965846	0.353313269	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	111
"2058"	24	"V465"	-0.041857946	0.358520808	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	120
"2059"	14	"V327"	-0.041817276	0.355021246	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	74
"2060"	21	"V300"	-0.04174819	0.355817242	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	68
"2061"	7	"V270"	-0.041670169	0.363191349	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	57
"2062"	8	"V260"	0.041644132	0.357018287	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	52
"2063"	19	"V310"	-0.041595798	0.380153564	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	70
"2064"	23	"V85"	-0.04157696	0.357794936	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	130
"2065"	24	"V416"	0.041568069	0.361861154	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	104
"2066"	24	"V13"	-0.041540467	0.362180227	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	10
"2067"	23	"V439"	-0.041536149	0.358267318	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	110
"2068"	9	"V461"	0.041521478	0.358929285	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	117
"2069"	6	"V268"	-0.041476656	0.469534537	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	55
"2070"	22	"V197"	0.041345859	0.360475066	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	36
"2071"	23	"V466"	0.041304921	0.360951141	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	121
"2072"	24	"V100"	-0.041268359	0.365335179	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	2
"2073"	3	"V207"	-0.041245257	0.361645693	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	39
"2074"	10	"V85"	0.041187289	0.407104191	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	130
"2075"	9	"V329"	0.041172329	0.362987147	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	75
"2076"	14	"V79"	-0.041161218	0.362625406	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	126
"2077"	23	"V160"	-0.041142641	0.362842195	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	16
"2078"	9	"V55"	-0.041048944	0.364427961	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	122
"2079"	9	"V11"	-0.040998799	0.365014551	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	4
"2080"	3	"V372"	-0.040956137	0.365023147	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	89
"2081"	18	"V183"	-0.040955924	0.368978752	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	32
"2082"	17	"V79"	-0.040901766	0.366151287	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	126
"2083"	8	"V299"	0.040796135	0.366900688	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	66
"2084"	12	"V79"	0.040792782	0.367430652	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	126
"2085"	19	"V346"	-0.040780566	0.389567413	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	80
"2086"	9	"V294"	0.040741473	0.36803393	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	65
"2087"	5	"V387"	-0.040718106	0.368308878	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	94
"2088"	23	"V30"	-0.040689766	0.368152193	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	67
"2089"	24	"V176"	0.040677978	0.372238996	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	27
"2090"	8	"V376"	-0.040676048	0.368313791	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	90
"2091"	8	"V392"	-0.04064795	0.368644911	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	95
"2092"	21	"V392"	0.04062374	0.368930367	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	95
"2093"	11	"V320"	-0.040614746	0.36903645	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	73
"2094"	22	"V461"	-0.040534121	0.369988235	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	117
"2095"	19	"V197"	0.040519578	0.392610795	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	36
"2096"	6	"V160"	-0.040448466	0.48062574	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	16
"2097"	9	"V416"	0.040369671	0.372423856	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	104
"2098"	24	"V258"	0.040295525	0.376754103	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	50
"2099"	3	"V102"	-0.04027906	0.373009266	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	3
"2100"	19	"V55"	0.040271741	0.39551409	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	122
"2101"	19	"V172"	-0.040265369	0.395588907	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	24
"2102"	11	"V310"	-0.04023256	0.373561666	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	70
"2103"	2	"V300"	-0.040193572	0.374514324	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	68
"2104"	9	"V24"	0.040181625	0.374656414	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	47
"2105"	5	"V182"	-0.040136603	0.375192161	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	31
"2106"	9	"V161"	0.040115754	0.375440411	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	17
"2107"	3	"V448"	-0.040111331	0.375004186	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	113
"2108"	12	"V173"	-0.040075192	0.375923679	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	25
"2109"	20	"V12"	-0.040024597	0.376527023	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	8
"2110"	20	"V92"	0.040019411	0.376588906	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	135
"2111"	8	"V211"	0.039963345	0.376769744	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	42
"2112"	20	"V382"	0.039940562	0.377530457	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	92
"2113"	8	"V218"	-0.039896887	0.377564287	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	44
"2114"	24	"V81"	-0.039894203	0.381528042	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	128
"2115"	14	"V281"	-0.039874414	0.377833197	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	62
"2116"	8	"V329"	-0.039852206	0.378099051	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	75
"2117"	16	"V162"	-0.039841503	0.378227229	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	18
"2118"	16	"V367"	-0.039832478	0.378335322	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	88
"2119"	24	"V311"	-0.039813413	0.382493535	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	71
"2120"	12	"V280"	0.039809777	0.379095383	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	61
"2121"	24	"V344"	-0.039803887	0.382607479	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	79
"2122"	10	"V189"	-0.039801366	0.423080713	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	34
"2123"	8	"V439"	0.039799954	0.378725029	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	110
"2124"	23	"V189"	-0.039780722	0.378955585	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	34
"2125"	1	"V448"	0.039731064	0.380039155	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	113
"2126"	5	"V344"	-0.039699309	0.3804203	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	79
"2127"	19	"V393"	0.039694449	0.402326787	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	96
"2128"	12	"V197"	0.039640882	0.38112221	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	36
"2129"	2	"V24"	-0.039588875	0.381747649	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	47
"2130"	17	"V273"	0.039510088	0.382696342	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	58
"2131"	17	"V118"	0.039508891	0.382710776	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	6
"2132"	1	"V447"	-0.039468599	0.383196502	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	112
"2133"	5	"V412"	0.039463069	0.383263203	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	101
"2134"	8	"V36"	0.039457025	0.382849021	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	86
"2135"	19	"V227"	-0.039418819	0.405604144	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	46
"2136"	13	"V81"	0.039364086	0.385923893	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	128
"2137"	19	"V416"	0.039196606	0.408257888	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	104
"2138"	19	"V352"	-0.039186167	0.408382814	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	83
"2139"	8	"V268"	-0.039152583	0.386533103	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	55
"2140"	14	"V404"	-0.039151573	0.38654536	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	98
"2141"	21	"V100"	-0.039118039	0.386952479	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	2
"2142"	24	"V119"	-0.039082887	0.391291529	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	7
"2143"	5	"V18"	0.039053746	0.388219605	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	29
"2144"	4	"V432"	0.038928268	0.389746757	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	108
"2145"	15	"V273"	-0.038915417	0.425640806	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	58
"2146"	4	"V281"	-0.038879948	0.390335817	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	62
"2147"	20	"V367"	-0.038864191	0.390528018	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	88
"2148"	2	"V463"	-0.038813618	0.391145307	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	119
"2149"	18	"V119"	-0.038804574	0.39467534	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	7
"2150"	5	"V17"	-0.038796152	0.39135863	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	21
"2151"	22	"V364"	0.038734039	0.391633021	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	87
"2152"	17	"V332"	-0.038637071	0.393304839	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	77
"2153"	12	"V190"	0.038607652	0.393665385	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	35
"2154"	11	"V162"	0.038599052	0.393286483	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	18
"2155"	9	"V102"	-0.038594123	0.39383126	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	3
"2156"	7	"V92"	-0.038568333	0.400026111	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	135
"2157"	24	"V92"	0.038522428	0.398123716	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	135
"2158"	19	"V190"	-0.038500548	0.416636969	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	35
"2159"	8	"V95"	0.038441632	0.395220032	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	136
"2160"	18	"V182"	-0.038326892	0.400524132	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	31
"2161"	18	"V173"	-0.03831726	0.400642601	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	25
"2162"	14	"V28"	0.038303271	0.396924223	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	60
"2163"	6	"V197"	0.038261836	0.504678603	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	36
"2164"	3	"V24"	-0.038183744	0.398399976	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	47
"2165"	10	"V173"	-0.038134065	0.442777788	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	25
"2166"	22	"V80"	0.038104927	0.399374907	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	127
"2167"	2	"V466"	-0.03803046	0.400779663	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	121
"2168"	24	"V155"	-0.038012225	0.404405182	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	14
"2169"	2	"V418"	0.037997506	0.401188155	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	105
"2170"	10	"V432"	0.03794859	0.445000791	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	108
"2171"	23	"V162"	-0.037940073	0.401418709	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	18
"2172"	22	"V44"	0.03788284	0.402129712	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	111
"2173"	19	"V154"	0.037844891	0.424621478	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	13
"2174"	5	"V164"	-0.0378154	0.40345	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	19
"2175"	11	"V412"	0.037678631	0.404672765	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	101
"2176"	7	"V300"	-0.037657849	0.411249549	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	68
"2177"	2	"V150"	0.037653681	0.405465008	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	12
"2178"	24	"V405"	-0.037619819	0.409276385	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	99
"2179"	14	"V241"	0.037580318	0.405900488	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	48
"2180"	4	"V176"	-0.037568278	0.406531537	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	27
"2181"	9	"V2"	-0.037543707	0.406838697	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	37
"2182"	8	"V177"	0.037441008	0.40764398	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	28
"2183"	14	"V412"	0.037412945	0.407995727	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	101
"2184"	20	"V466"	0.037411763	0.408490462	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	121
"2185"	12	"V357"	0.037371432	0.408996149	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	84
"2186"	23	"V211"	-0.037328618	0.409053791	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	42
"2187"	14	"V392"	0.037296533	0.409456797	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	95
"2188"	16	"V252"	-0.037199964	0.410671176	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	49
"2189"	20	"V364"	0.037172	0.41150215	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	87
"2190"	2	"V289"	-0.037156612	0.411695895	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	63
"2191"	2	"V28"	0.037103853	0.412360551	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	60
"2192"	19	"V349"	-0.037067351	0.434204936	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	81
"2193"	6	"V352"	0.037038061	0.518410922	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	83
"2194"	8	"V63"	-0.037018355	0.412960726	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	123
"2195"	4	"V170"	-0.036886478	0.415105727	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	22
"2196"	2	"V102"	0.036886324	0.415107672	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	3
"2197"	9	"V9"	0.036859484	0.415447371	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	131
"2198"	9	"V9"	0.036859484	0.415447371	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	132
"2199"	20	"V189"	0.036856015	0.415491292	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	34
"2200"	9	"V352"	-0.036813188	0.416033713	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	83
"2201"	19	"V100"	-0.036795652	0.437582879	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	2
"2202"	6	"V311"	0.036758293	0.52157708	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	71
"2203"	3	"V11"	-0.036724714	0.416678587	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	4
"2204"	1	"V173"	0.036657993	0.418002786	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	25
"2205"	11	"V349"	0.036563577	0.418727121	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	81
"2206"	3	"V265"	-0.036472443	0.419888323	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	53
"2207"	18	"V266"	-0.036465754	0.423802938	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	54
"2208"	18	"V357"	-0.03637086	0.425010639	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	84
"2209"	14	"V171"	0.036357022	0.421361678	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	23
"2210"	3	"V126"	0.036322214	0.421806607	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	9
"2211"	14	"V416"	-0.036305395	0.422021689	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	104
"2212"	20	"V11"	0.03619437	0.423917653	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	4
"2213"	5	"V207"	-0.036170589	0.424222364	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	39
"2214"	18	"V383"	-0.036145218	0.427890376	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	93
"2215"	17	"V126"	0.036096276	0.425175363	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	9
"2216"	20	"V432"	0.036043238	0.425856286	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	108
"2217"	7	"V30"	0.035947422	0.432831108	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	67
"2218"	3	"V216"	0.035944732	0.426649273	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	43
"2219"	10	"V200"	-0.035910777	0.469839064	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	38
"2220"	8	"V465"	-0.03590534	0.427156481	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	120
"2221"	5	"V260"	-0.035894649	0.427767326	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	52
"2222"	24	"V294"	-0.035883483	0.431244923	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	65
"2223"	19	"V405"	-0.035838876	0.449597538	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	99
"2224"	15	"V352"	0.035789714	0.463770997	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	83
"2225"	11	"V171"	-0.035782111	0.428745442	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	23
"2226"	4	"V91"	-0.035737692	0.429791388	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	134
"2227"	9	"V162"	0.035718234	0.430042697	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	18
"2228"	14	"V358"	0.03570707	0.429714718	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	85
"2229"	5	"V172"	0.035639912	0.431055119	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	24
"2230"	8	"V81"	0.035611661	0.430948927	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	128
"2231"	24	"V102"	0.035592139	0.434996768	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	3
"2232"	23	"V420"	-0.035551847	0.431723712	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	106
"2233"	24	"V116"	0.035528326	0.435821044	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	5
"2234"	20	"V436"	-0.035470487	0.433249906	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	109
"2235"	22	"V416"	0.035467786	0.432813951	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	104
"2236"	8	"V383"	0.03525509	0.435579607	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	93
"2237"	21	"V175"	0.035238836	0.435791379	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	26
"2238"	3	"V289"	-0.035223165	0.435995602	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	63
"2239"	14	"V436"	0.035170477	0.436682652	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	109
"2240"	14	"V364"	-0.0350227	0.438612952	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	87
"2241"	18	"V208"	0.035015051	0.442483597	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	40
"2242"	3	"V396"	0.035013535	0.438732822	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	97
"2243"	12	"V300"	-0.034930738	0.44028481	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	68
"2244"	2	"V11"	0.034842636	0.441439269	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	4
"2245"	12	"V332"	0.034808086	0.441892484	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	77
"2246"	9	"V218"	0.03479582	0.442053435	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	44
"2247"	19	"V273"	-0.034683479	0.464351945	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	58
"2248"	2	"V176"	-0.034682736	0.443538966	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	27
"2249"	5	"V55"	0.03458262	0.444856527	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	122
"2250"	24	"V17"	-0.034532104	0.448805209	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	21
"2251"	18	"V17"	0.034483322	0.449446571	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	21
"2252"	12	"V432"	0.03436714	0.44769983	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	108
"2253"	20	"V28"	-0.03433726	0.448094905	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	60
"2254"	7	"V420"	-0.034305919	0.454144785	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	106
"2255"	24	"V358"	0.034275323	0.452187091	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	85
"2256"	4	"V383"	0.034269638	0.448989758	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	93
"2257"	9	"V396"	0.034268193	0.4490089	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	97
"2258"	8	"V291"	-0.034254153	0.448730449	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	64
"2259"	19	"V81"	0.034225089	0.470279213	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	128
"2260"	14	"V462"	-0.034175785	0.449769487	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	118
"2261"	18	"V327"	-0.03413175	0.454084242	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	74
"2262"	9	"V447"	-0.034116657	0.451017923	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	112
"2263"	18	"V30"	0.034098394	0.454525638	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	67
"2264"	21	"V36"	-0.034063303	0.451263217	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	86
"2265"	14	"V21"	-0.033962947	0.452598274	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	41
"2266"	2	"V294"	-0.033944925	0.453300819	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	65
"2267"	9	"V21"	-0.033790491	0.455359307	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	41
"2268"	4	"V412"	0.033753217	0.45585693	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	101
"2269"	19	"V306"	-0.033724128	0.476804342	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	69
"2270"	3	"V382"	0.033677744	0.456404505	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	92
"2271"	20	"V227"	0.033663667	0.457053697	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	46
"2272"	17	"V92"	-0.033558276	0.458464419	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	135
"2273"	19	"V387"	-0.033527675	0.479376616	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	94
"2274"	1	"V150"	-0.033484955	0.459447297	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	12
"2275"	22	"V17"	0.033470455	0.459182147	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	21
"2276"	2	"V218"	-0.033399966	0.460588063	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	44
"2277"	2	"V116"	0.033382651	0.460820678	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	5
"2278"	3	"V116"	-0.033374082	0.460476744	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	5
"2279"	4	"V55"	0.033277565	0.462233773	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	122
"2280"	22	"V327"	0.033271593	0.46185573	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	74
"2281"	20	"V259"	-0.033200752	0.463268211	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	51
"2282"	2	"V310"	0.033176431	0.463595999	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	70
"2283"	9	"V85"	-0.033175438	0.463609383	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	130
"2284"	13	"V13"	-0.033171818	0.465035901	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	10
"2285"	22	"V300"	-0.033155308	0.463423124	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	68
"2286"	14	"V162"	-0.033149452	0.463502135	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	18
"2287"	24	"V281"	0.033061525	0.468366262	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	62
"2288"	22	"V387"	-0.032924619	0.466541283	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	94
"2289"	15	"V116"	0.032908335	0.500539361	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	5
"2290"	11	"V126"	-0.03286944	0.467288838	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	9
"2291"	20	"V289"	0.032865465	0.467798528	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	63
"2292"	14	"V280"	-0.032822532	0.467924857	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	61
"2293"	24	"V387"	0.032628692	0.474212057	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	94
"2294"	22	"V367"	-0.032547001	0.471670421	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	88
"2295"	5	"V382"	0.032527883	0.472384481	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	92
"2296"	20	"V33"	-0.03249919	0.47277541	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	76
"2297"	2	"V92"	-0.032493164	0.472857535	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	135
"2298"	7	"V44"	0.03247268	0.478630553	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	111
"2299"	6	"V100"	-0.032404717	0.572090909	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	2
"2300"	1	"V280"	-0.032350329	0.474806395	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	61
"2301"	3	"V200"	-0.032328026	0.474658882	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	38
"2302"	5	"V208"	-0.032316154	0.475273326	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	40
"2303"	2	"V154"	-0.032263514	0.475993048	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	13
"2304"	10	"V447"	0.032251103	0.516302606	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	112
"2305"	24	"V160"	-0.032244407	0.479435517	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	16
"2306"	7	"V11"	0.032166666	0.482786789	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	4
"2307"	24	"V461"	0.032116964	0.481174708	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	117
"2308"	14	"V55"	0.032105242	0.477709939	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	122
"2309"	19	"V173"	0.032062481	0.498797394	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	25
"2310"	23	"V79"	0.032045402	0.478531274	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	126
"2311"	5	"V154"	-0.032031944	0.479166263	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	13
"2312"	10	"V241"	0.032028708	0.519200771	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	48
"2313"	21	"V413"	-0.031866051	0.480997573	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	102
"2314"	23	"V80"	0.031864567	0.481018013	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	127
"2315"	13	"V413"	-0.031843931	0.483101674	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	102
"2316"	12	"V269"	-0.031837022	0.481846192	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	56
"2317"	8	"V364"	0.031781815	0.482158299	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	87
"2318"	4	"V289"	0.03170519	0.483663311	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	63
"2319"	3	"V71"	0.031695069	0.483355206	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	124
"2320"	11	"V411"	-0.031659145	0.483851351	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	100
"2321"	22	"V24"	0.031551938	0.485333607	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	47
"2322"	8	"V436"	0.03154552	0.485422413	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	109
"2323"	6	"V269"	-0.031544891	0.582334507	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	56
"2324"	5	"V90"	0.031511192	0.486344032	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	133
"2325"	6	"V436"	0.031496727	0.582910823	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	109
"2326"	5	"V404"	0.031429989	0.487468495	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	98
"2327"	8	"V10"	-0.031422867	0.487121402	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	1
"2328"	6	"V63"	-0.031401657	0.584049198	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	123
"2329"	10	"V275"	0.031387304	0.527605994	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	59
"2330"	3	"V260"	-0.031383273	0.487670539	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	52
"2331"	10	"V436"	-0.031354753	0.528034391	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	109
"2332"	24	"V24"	-0.031312182	0.492236087	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	47
"2333"	4	"V17"	0.03126348	0.489778607	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	21
"2334"	9	"V280"	0.031259792	0.489829849	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	61
"2335"	3	"V266"	0.031162305	0.490741311	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	54
"2336"	20	"V273"	0.031104011	0.49199656	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	58
"2337"	10	"V79"	-0.031077962	0.531684328	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	126
"2338"	12	"V171"	-0.031026537	0.49307603	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	23
"2339"	20	"V218"	-0.031004547	0.493382644	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	44
"2340"	7	"V227"	0.030965449	0.499288958	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	46
"2341"	5	"V413"	0.030949388	0.494152224	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	102
"2342"	2	"V182"	-0.030904771	0.494775178	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	31
"2343"	21	"V349"	-0.030822565	0.495482801	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	81
"2344"	8	"V357"	0.030791391	0.495919088	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	84
"2345"	9	"V436"	0.030729525	0.497226086	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	109
"2346"	10	"V327"	0.030704829	0.536624784	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	74
"2347"	22	"V420"	0.030695524	0.497262059	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	106
"2348"	10	"V156"	0.030692595	0.536787155	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	15
"2349"	7	"V190"	-0.030688207	0.503139678	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	35
"2350"	5	"V459"	0.030682621	0.497883155	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	115
"2351"	3	"V28"	-0.030657024	0.49780194	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	60
"2352"	20	"V352"	0.030654948	0.498271033	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	83
"2353"	23	"V18"	0.030642267	0.498008954	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	29
"2354"	21	"V22"	-0.030630707	0.498171153	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	45
"2355"	13	"V404"	-0.030627108	0.499984656	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	98
"2356"	23	"V268"	0.030582039	0.498854327	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	55
"2357"	9	"V17"	0.030561493	0.499582136	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	21
"2358"	21	"V329"	-0.030541324	0.499426246	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	75
"2359"	18	"V252"	-0.030531302	0.503097646	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	49
"2360"	20	"V180"	0.030526598	0.500072166	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	30
"2361"	19	"V404"	-0.030525025	0.519615966	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	98
"2362"	14	"V176"	-0.030480362	0.50028322	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	27
"2363"	24	"V332"	0.030473936	0.503900524	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	77
"2364"	13	"V310"	-0.030428772	0.502765806	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	70
"2365"	21	"V281"	-0.030392694	0.501516964	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	62
"2366"	11	"V350"	-0.030340421	0.50225338	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	82
"2367"	11	"V118"	0.030196338	0.504286118	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	6
"2368"	4	"V200"	-0.030132289	0.505626954	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	38
"2369"	24	"V367"	0.030129038	0.508741794	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	88
"2370"	5	"V216"	-0.030116907	0.505844309	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	43
"2371"	5	"V281"	-0.030041719	0.50690742	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	62
"2372"	14	"V300"	0.030022264	0.506747731	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	68
"2373"	6	"V190"	-0.030014543	0.600774442	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	35
"2374"	5	"V294"	0.029981117	0.507765139	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	65
"2375"	3	"V85"	0.029980809	0.507334882	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	130
"2376"	8	"V22"	0.029966361	0.507539611	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	45
"2377"	15	"V465"	0.029960471	0.539693748	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	120
"2378"	8	"V155"	0.029942143	0.507882858	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	14
"2379"	19	"V357"	0.029888078	0.528369971	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	84
"2380"	10	"V30"	0.029876858	0.547669112	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	67
"2381"	20	"V164"	0.02984703	0.509665639	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	19
"2382"	18	"V24"	0.029772684	0.513769304	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	47
"2383"	20	"V332"	0.029737915	0.511214913	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	77
"2384"	18	"V310"	-0.029731301	0.514354801	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	70
"2385"	10	"V33"	-0.029714541	0.549847333	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	76
"2386"	23	"V100"	-0.02964866	0.512052149	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	2
"2387"	3	"V9"	0.029599507	0.512752172	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	131
"2388"	3	"V9"	0.029599507	0.512752172	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	132
"2389"	5	"V329"	-0.029520967	0.514302555	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	75
"2390"	11	"V311"	0.029500345	0.514165914	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	71
"2391"	7	"V439"	0.029472929	0.520202127	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	110
"2392"	12	"V455"	0.029444511	0.515392994	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	114
"2393"	15	"V164"	0.029441048	0.546748026	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	19
"2394"	18	"V294"	-0.02943663	0.518533932	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	65
"2395"	16	"V352"	0.029435168	0.515096225	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	83
"2396"	3	"V92"	-0.029381003	0.515870022	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	135
"2397"	18	"V160"	-0.029275738	0.520823124	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	16
"2398"	13	"V259"	0.029263482	0.519269332	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	51
"2399"	2	"V36"	0.029227094	0.518500376	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	86
"2400"	17	"V268"	-0.02909237	0.520430729	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	55
"2401"	12	"V306"	-0.029020562	0.521461125	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	69
"2402"	10	"V116"	0.029001918	0.559460465	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	5
"2403"	9	"V84"	-0.028991917	0.52187245	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	129
"2404"	18	"V180"	0.028958949	0.525345577	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	30
"2405"	14	"V349"	0.028905277	0.522692001	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	81
"2406"	8	"V300"	0.028886637	0.522960232	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	68
"2407"	9	"V300"	0.028882608	0.52344358	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	68
"2408"	6	"V300"	-0.028874112	0.614684618	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	68
"2409"	14	"V413"	0.028863697	0.523290447	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	102
"2410"	21	"V176"	-0.028861323	0.523324623	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	27
"2411"	14	"V84"	-0.02877754	0.524531601	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	129
"2412"	10	"V36"	0.028760517	0.562735248	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	86
"2413"	2	"V281"	-0.028701238	0.526055817	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	62
"2414"	1	"V30"	0.028637978	0.52696849	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	67
"2415"	9	"V349"	-0.028590643	0.527651948	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	81
"2416"	1	"V211"	0.028566777	0.527996702	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	42
"2417"	24	"V164"	0.028549946	0.53121396	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	19
"2418"	3	"V79"	-0.028547289	0.527855904	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	126
"2419"	14	"V22"	0.028527674	0.528139597	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	45
"2420"	3	"V367"	0.028471497	0.52895251	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	88
"2421"	8	"V126"	0.02845466	0.529196268	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	9
"2422"	22	"V85"	0.028410517	0.529835634	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	130
"2423"	3	"V420"	-0.028395705	0.530050271	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	106
"2424"	1	"V259"	0.028327162	0.531464453	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	51
"2425"	10	"V80"	-0.028249972	0.569691423	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	127
"2426"	22	"V150"	-0.028220365	0.532594285	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	12
"2427"	17	"V329"	0.028202384	0.53327482	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	75
"2428"	24	"V372"	0.028169569	0.536701225	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	89
"2429"	10	"V268"	-0.028155815	0.570978766	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	55
"2430"	1	"V273"	-0.028140489	0.534173981	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	58
"2431"	9	"V383"	-0.028077201	0.53509417	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	93
"2432"	11	"V436"	-0.028071971	0.534752138	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	109
"2433"	11	"V180"	0.028017757	0.535541585	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	30
"2434"	12	"V227"	-0.02799749	0.536254284	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	46
"2435"	21	"V466"	0.02792945	0.536828728	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	121
"2436"	5	"V79"	0.027807284	0.539027626	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	126
"2437"	4	"V327"	-0.027791124	0.539263568	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	74
"2438"	5	"V289"	0.027723223	0.540255564	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	63
"2439"	21	"V30"	0.027710896	0.540021001	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	67
"2440"	5	"V171"	0.02766593	0.541093294	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	23
"2441"	13	"V270"	-0.027602922	0.543260092	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	57
"2442"	11	"V200"	0.027591858	0.541763678	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	38
"2443"	17	"V227"	-0.027578514	0.54237272	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	46
"2444"	5	"V142"	0.027539765	0.54294034	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	11
"2445"	21	"V24"	-0.027498296	0.543135353	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	47
"2446"	14	"V344"	0.027496344	0.543163998	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	79
"2447"	14	"V211"	0.027485241	0.54332689	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	42
"2448"	4	"V367"	-0.027474155	0.543902103	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	88
"2449"	10	"V182"	-0.027387921	0.581528849	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	31
"2450"	10	"V392"	-0.027382896	0.58159818	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	95
"2451"	13	"V84"	0.027164587	0.549683498	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	129
"2452"	11	"V166"	0.02698671	0.550665932	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	20
"2453"	12	"V461"	-0.0269368	0.551810711	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	117
"2454"	11	"V24"	0.026919309	0.551661894	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	47
"2455"	18	"V299"	0.0268447	0.556032956	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	66
"2456"	22	"V162"	-0.026830426	0.552976621	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	18
"2457"	16	"V273"	-0.026829044	0.552997083	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	58
"2458"	18	"V349"	-0.026815625	0.556460969	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	81
"2459"	4	"V382"	0.026791107	0.553964644	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	92
"2460"	11	"V28"	-0.02678768	0.553609449	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	60
"2461"	16	"V116"	0.026785519	0.553641462	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	5
"2462"	10	"V211"	0.026697799	0.591087263	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	42
"2463"	20	"V327"	0.02655699	0.557434411	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	74
"2464"	3	"V156"	0.026498065	0.557906357	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	15
"2465"	15	"V411"	-0.026485431	0.587733471	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	100
"2466"	9	"V154"	-0.026479252	0.558588871	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	13
"2467"	12	"V411"	-0.026440729	0.559161392	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	100
"2468"	21	"V387"	-0.026310801	0.560693306	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	94
"2469"	9	"V156"	0.026297915	0.56128635	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	15
"2470"	4	"V84"	0.026260176	0.561848523	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	129
"2471"	22	"V344"	-0.026226797	0.561945677	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	79
"2472"	8	"V90"	0.026185577	0.5625607	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	133
"2473"	2	"V383"	0.026143922	0.563581982	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	93
"2474"	3	"V80"	-0.026122924	0.563496116	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	127
"2475"	22	"V71"	-0.026054439	0.564519479	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	124
"2476"	6	"V455"	0.025982617	0.650568297	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	114
"2477"	24	"V436"	-0.025931641	0.569550166	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	109
"2478"	18	"V162"	0.025924298	0.569659507	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	18
"2479"	9	"V311"	-0.025923473	0.566876155	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	71
"2480"	19	"V189"	0.025898554	0.584850807	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	34
"2481"	8	"V72"	-0.025872373	0.567244382	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	125
"2482"	6	"V404"	-0.025841477	0.652341592	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	98
"2483"	21	"V84"	0.025826202	0.567936396	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	129
"2484"	1	"V281"	-0.025820946	0.56841135	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	62
"2485"	2	"V189"	-0.025810811	0.568563205	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	34
"2486"	19	"V448"	-0.025807174	0.586176632	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	113
"2487"	14	"V95"	0.025767764	0.568812858	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	136
"2488"	8	"V84"	0.025759544	0.568936185	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	129
"2489"	15	"V180"	-0.025614557	0.600074643	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	30
"2490"	2	"V252"	-0.025614061	0.57151516	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	49
"2491"	2	"V119"	-0.025598856	0.571743598	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	7
"2492"	8	"V208"	-0.025590834	0.57147039	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	40
"2493"	1	"V43"	0.025438316	0.574158101	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	107
"2494"	14	"V291"	0.025433406	0.573839936	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	64
"2495"	24	"V420"	-0.025400615	0.577482922	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	106
"2496"	6	"V413"	-0.025373242	0.658238501	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	102
"2497"	4	"V190"	0.02535949	0.575345397	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	35
"2498"	2	"V44"	-0.025348103	0.575517018	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	111
"2499"	19	"V161"	0.025316653	0.593317245	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	17
"2500"	17	"V36"	-0.025316614	0.5759917	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	86
"2501"	16	"V349"	-0.025229589	0.576914593	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	81
"2502"	16	"V24"	0.025205142	0.577283906	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	47
"2503"	22	"V268"	0.02515249	0.578079688	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	55
"2504"	20	"V439"	-0.025141656	0.578632485	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	110
"2505"	20	"V197"	0.02512045	0.578952945	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	36
"2506"	18	"V10"	0.025101822	0.58196916	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	1
"2507"	8	"V404"	-0.024988582	0.580560251	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	98
"2508"	9	"V382"	-0.024897469	0.58232765	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	92
"2509"	9	"V364"	0.024843695	0.583142869	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	87
"2510"	3	"V180"	-0.024811411	0.583247112	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	30
"2511"	16	"V376"	0.024806221	0.583325906	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	90
"2512"	3	"V13"	0.024796129	0.583479135	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	10
"2513"	20	"V172"	0.024765664	0.58432675	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	24
"2514"	5	"V190"	0.024743375	0.584665134	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	35
"2515"	11	"V218"	-0.024727785	0.584517344	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	44
"2516"	20	"V119"	0.024712486	0.585134215	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	7
"2517"	19	"V350"	0.024647574	0.603120671	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	82
"2518"	16	"V311"	0.024608931	0.586324861	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	71
"2519"	1	"V200"	-0.02458574	0.587060823	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	38
"2520"	3	"V439"	0.024557291	0.587110997	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	110
"2521"	5	"V376"	0.024470292	0.588818228	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	90
"2522"	1	"V172"	0.024470267	0.588818606	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	24
"2523"	7	"V116"	0.024393991	0.594591039	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	5
"2524"	2	"V32"	0.02429271	0.591526209	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	72
"2525"	5	"V126"	0.024243826	0.592272641	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	9
"2526"	22	"V252"	-0.024213391	0.592358743	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	49
"2527"	18	"V258"	-0.024158767	0.596234162	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	50
"2528"	1	"V291"	0.024155983	0.593615054	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	64
"2529"	11	"V327"	0.024148523	0.593351004	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	74
"2530"	4	"V300"	0.024011712	0.595822801	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	68
"2531"	8	"V164"	0.023950097	0.596390931	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	19
"2532"	10	"V352"	0.023911099	0.630396355	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	83
"2533"	7	"V332"	-0.023903637	0.60202225	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	77
"2534"	1	"V352"	0.023887908	0.597720323	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	83
"2535"	9	"V150"	0.023881143	0.597824091	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	12
"2536"	8	"V289"	-0.023877882	0.597499038	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	63
"2537"	22	"V190"	0.023871471	0.597597459	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	35
"2538"	8	"V393"	0.023839647	0.598086117	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	96
"2539"	10	"V100"	-0.023839443	0.631421675	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	2
"2540"	5	"V92"	-0.023817661	0.598798203	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	135
"2541"	21	"V418"	0.023722749	0.599882632	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	105
"2542"	13	"V252"	-0.023697391	0.601767653	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	49
"2543"	9	"V79"	0.023661646	0.601195251	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	126
"2544"	10	"V119"	0.023660523	0.633984933	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	7
"2545"	11	"V382"	0.023659862	0.600850096	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	92
"2546"	18	"V92"	0.023640417	0.604141995	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	135
"2547"	5	"V447"	-0.023630443	0.601675183	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	112
"2548"	3	"V311"	-0.023628929	0.601326235	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	71
"2549"	14	"V190"	0.023626108	0.601369672	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	35
"2550"	17	"V392"	0.023598129	0.602172385	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	95
"2551"	9	"V172"	0.023551128	0.602895888	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	24
"2552"	18	"V291"	-0.023521442	0.60596365	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	64
"2553"	14	"V91"	0.023521354	0.60298342	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	134
"2554"	6	"V189"	-0.023455072	0.682614242	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	34
"2555"	22	"V265"	-0.023417405	0.604586686	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	53
"2556"	3	"V459"	-0.023408824	0.604719124	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	115
"2557"	8	"V102"	-0.02338971	0.605014165	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	3
"2558"	10	"V12"	-0.023366691	0.638203939	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	8
"2559"	8	"V396"	-0.023345092	0.60570314	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	97
"2560"	9	"V266"	-0.02333559	0.606218751	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	54
"2561"	22	"V270"	-0.023329721	0.605940574	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	57
"2562"	23	"V173"	-0.023296401	0.606455408	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	25
"2563"	17	"V33"	-0.023255949	0.607448618	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	76
"2564"	4	"V258"	0.023245286	0.607613365	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	50
"2565"	1	"V24"	0.023222311	0.607968412	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	47
"2566"	12	"V13"	-0.023151831	0.609058135	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	10
"2567"	11	"V30"	0.023078647	0.609824739	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	67
"2568"	14	"V273"	-0.023040052	0.610422792	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	58
"2569"	8	"V241"	-0.023030449	0.610571637	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	48
"2570"	8	"V161"	0.023027382	0.610619167	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	17
"2571"	11	"V252"	-0.022990244	0.611194981	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	49
"2572"	1	"V164"	-0.022981879	0.611689409	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	19
"2573"	14	"V17"	0.02297982	0.611356641	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	21
"2574"	4	"V260"	-0.022951097	0.612166527	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	52
"2575"	15	"V80"	-0.022947901	0.63857019	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	127
"2576"	18	"V404"	-0.02291783	0.615243278	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	98
"2577"	3	"V142"	0.022913278	0.61238904	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	11
"2578"	21	"V80"	-0.02288529	0.612823513	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	127
"2579"	1	"V411"	-0.022792044	0.614634457	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	100
"2580"	3	"V183"	0.022744933	0.615004368	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	32
"2581"	9	"V275"	0.022734064	0.615535178	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	59
"2582"	4	"V142"	0.022713764	0.615850677	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	11
"2583"	3	"V258"	0.022670497	0.61616234	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	50
"2584"	23	"V218"	-0.02266411	0.616261741	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	44
"2585"	22	"V436"	-0.022662868	0.616281064	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	109
"2586"	24	"V346"	0.022658042	0.619256213	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	80
"2587"	16	"V310"	-0.022628605	0.616814444	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	70
"2588"	10	"V126"	0.022586127	0.649468344	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	9
"2589"	23	"V310"	0.022551918	0.618008981	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	70
"2590"	9	"V30"	-0.022509399	0.619030817	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	67
"2591"	20	"V22"	0.022507681	0.619057579	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	45
"2592"	9	"V197"	0.022497632	0.619214135	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	36
"2593"	21	"V461"	-0.022488637	0.618995452	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	117
"2594"	10	"V150"	0.02244937	0.65145025	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	12
"2595"	15	"V33"	0.022448446	0.645893839	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	76
"2596"	21	"V416"	0.022431957	0.619879592	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	104
"2597"	19	"V460"	0.022399688	0.636576107	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	116
"2598"	2	"V90"	0.02229058	0.622443785	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	133
"2599"	1	"V392"	-0.022245999	0.623140113	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	95
"2600"	5	"V72"	-0.022217661	0.623582909	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	125
"2601"	16	"V63"	-0.022166168	0.62403294	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	123
"2602"	3	"V352"	-0.02208511	0.625301968	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	83
"2603"	11	"V376"	0.022078859	0.625399879	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	90
"2604"	3	"V160"	-0.02202386	0.626261624	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	16
"2605"	12	"V310"	0.02201116	0.626813741	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	70
"2606"	3	"V344"	-0.021967416	0.627146534	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	79
"2607"	9	"V306"	0.021964836	0.627539481	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	69
"2608"	10	"V160"	0.021942756	0.658813499	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	16
"2609"	18	"V207"	0.021906993	0.630921169	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	39
"2610"	3	"V393"	0.021894828	0.628285339	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	96
"2611"	21	"V432"	-0.021877742	0.628553535	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	108
"2612"	9	"V44"	-0.021872463	0.628987749	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	111
"2613"	14	"V160"	-0.021839461	0.629154568	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	16
"2614"	15	"V190"	0.021817433	0.655195677	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	35
"2615"	22	"V218"	-0.021781133	0.63007083	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	44
"2616"	19	"V358"	0.021724508	0.646775195	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	85
"2617"	21	"V327"	0.021713659	0.631131487	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	74
"2618"	6	"V465"	0.021704009	0.705158949	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	120
"2619"	4	"V211"	-0.021703899	0.63163424	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	42
"2620"	3	"V270"	-0.021561466	0.633526644	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	57
"2621"	24	"V166"	0.021554772	0.636423701	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	20
"2622"	11	"V455"	0.021545508	0.633778001	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	114
"2623"	1	"V412"	0.021499408	0.634851116	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	101
"2624"	9	"V200"	-0.021429511	0.63595226	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	38
"2625"	9	"V310"	-0.021427311	0.635986922	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	70
"2626"	17	"V13"	0.021391129	0.636557265	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	10
"2627"	8	"V80"	-0.021370563	0.636536421	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	127
"2628"	2	"V420"	-0.021353745	0.637146767	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	106
"2629"	13	"V411"	-0.021332421	0.638519625	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	100
"2630"	20	"V30"	0.021262058	0.638593545	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	67
"2631"	14	"V420"	-0.021185512	0.639459677	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	106
"2632"	1	"V436"	0.021147177	0.640408251	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	109
"2633"	6	"V382"	-0.021139029	0.712489553	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	92
"2634"	17	"V24"	0.021124812	0.640761792	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	47
"2635"	3	"V182"	-0.020884635	0.644224548	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	31
"2636"	14	"V186"	-0.020861535	0.644590986	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	33
"2637"	4	"V270"	-0.020852124	0.645078834	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	57
"2638"	1	"V357"	0.020832484	0.645390226	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	84
"2639"	8	"V416"	-0.02080104	0.645551025	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	104
"2640"	2	"V275"	0.020796774	0.645956574	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	59
"2641"	21	"V269"	-0.020793953	0.645663525	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	56
"2642"	13	"V208"	-0.020783749	0.647178716	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	40
"2643"	8	"V24"	-0.020767936	0.646076621	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	47
"2644"	11	"V116"	0.020765507	0.646115184	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	5
"2645"	21	"V44"	0.020744615	0.646446992	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	111
"2646"	4	"V177"	0.020711562	0.647308817	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	28
"2647"	13	"V12"	0.020693464	0.648608205	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	8
"2648"	2	"V392"	0.020639363	0.648455471	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	95
"2649"	2	"V461"	-0.02061945	0.648771874	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	117
"2650"	18	"V32"	0.020588107	0.651627759	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	72
"2651"	19	"V183"	-0.020471359	0.665880267	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	32
"2652"	23	"V269"	0.020467265	0.650858473	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	56
"2653"	17	"V432"	-0.020435661	0.651695125	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	108
"2654"	23	"V190"	0.020421537	0.651587001	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	35
"2655"	16	"V413"	-0.020372736	0.652364835	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	102
"2656"	1	"V350"	0.020347338	0.65310184	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	82
"2657"	19	"V30"	0.020326833	0.668097943	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	67
"2658"	1	"V463"	-0.020280013	0.654174948	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	119
"2659"	10	"V357"	0.020190255	0.684536404	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	84
"2660"	2	"V432"	0.020169079	0.655944707	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	108
"2661"	5	"V352"	-0.020046234	0.657906751	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	83
"2662"	4	"V416"	-0.020042827	0.657961193	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	104
"2663"	7	"V455"	0.020000312	0.662602246	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	114
"2664"	5	"V357"	-0.019993001	0.658757701	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	84
"2665"	17	"V12"	0.019850521	0.661037453	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	8
"2666"	10	"V183"	0.019771026	0.690745644	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	32
"2667"	16	"V227"	-0.019750821	0.662310394	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	46
"2668"	24	"V118"	-0.019722502	0.665366272	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	6
"2669"	20	"V18"	0.019638933	0.664428769	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	29
"2670"	5	"V183"	0.019629542	0.664579454	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	32
"2671"	9	"V367"	0.019619654	0.664738128	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	88
"2672"	18	"V260"	-0.019595643	0.66738933	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	52
"2673"	10	"V24"	0.019580309	0.693577291	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	47
"2674"	7	"V172"	0.019554255	0.669677507	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	24
"2675"	4	"V352"	-0.019547939	0.665889335	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	83
"2676"	1	"V81"	0.019547091	0.665902957	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	128
"2677"	2	"V280"	0.019520876	0.666323973	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	61
"2678"	24	"V190"	0.019444777	0.66979836	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	35
"2679"	18	"V270"	-0.019367326	0.671036415	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	57
"2680"	11	"V465"	0.019359845	0.668593519	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	120
"2681"	19	"V383"	0.019337925	0.683348923	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	93
"2682"	4	"V189"	-0.019311525	0.669689969	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	34
"2683"	3	"V162"	-0.019307418	0.669437822	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	18
"2684"	17	"V311"	-0.019284946	0.670117781	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	71
"2685"	17	"V211"	-0.019270572	0.670349191	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	42
"2686"	4	"V28"	0.019205168	0.671402543	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	60
"2687"	9	"V404"	-0.019205073	0.671404068	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	98
"2688"	5	"V265"	0.019151798	0.672262558	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	53
"2689"	23	"V455"	0.019125067	0.672377682	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	114
"2690"	19	"V116"	0.019084123	0.687284261	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	5
"2691"	3	"V36"	-0.019011643	0.674208828	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	86
"2692"	17	"V119"	0.018980498	0.675025801	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	7
"2693"	21	"V71"	-0.018957571	0.675082472	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	124
"2694"	5	"V116"	-0.018866535	0.676866573	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	5
"2695"	1	"V260"	-0.018864764	0.676895186	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	52
"2696"	7	"V311"	-0.018800965	0.681692418	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	71
"2697"	14	"V289"	0.018771174	0.678097408	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	63
"2698"	3	"V190"	0.01874483	0.678523922	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	35
"2699"	24	"V459"	0.018710953	0.68156407	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	115
"2700"	4	"V2"	0.018663798	0.680146	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	37
"2701"	22	"V22"	0.018558373	0.681545712	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	45
"2702"	4	"V358"	0.018519429	0.682484984	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	85
"2703"	19	"V381"	0.018504255	0.696307043	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	91
"2704"	13	"V189"	-0.018477064	0.684094832	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	34
"2705"	4	"V420"	-0.018409133	0.684273984	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	106
"2706"	7	"V180"	0.018408145	0.687990187	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	30
"2707"	14	"V376"	0.018291592	0.685878105	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	90
"2708"	1	"V367"	-0.018264554	0.68662173	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	88
"2709"	5	"V414"	-0.018251197	0.686838778	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	103
"2710"	2	"V84"	0.018242543	0.68697941	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	129
"2711"	17	"V208"	-0.018169368	0.688169047	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	40
"2712"	22	"V352"	0.018108446	0.688858299	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	83
"2713"	15	"V119"	-0.018090316	0.711189372	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	7
"2714"	15	"V461"	-0.018045445	0.711873798	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	117
"2715"	18	"V164"	-0.018036132	0.692452462	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	19
"2716"	12	"V260"	0.018018504	0.690624144	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	52
"2717"	11	"V392"	0.018003757	0.69056399	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	95
"2718"	11	"V447"	0.018003025	0.690575932	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	112
"2719"	17	"V18"	-0.017983705	0.691190908	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	29
"2720"	6	"V420"	0.017951851	0.754322511	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	106
"2721"	11	"V466"	0.01793367	0.691706804	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	121
"2722"	12	"V364"	0.017858846	0.69322587	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	87
"2723"	9	"V439"	0.017814635	0.693946969	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	110
"2724"	11	"V420"	-0.017777376	0.694257761	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	106
"2725"	1	"V241"	-0.017757781	0.694874664	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	48
"2726"	1	"V18"	0.017709022	0.695670651	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	29
"2727"	16	"V461"	-0.017669052	0.696027825	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	117
"2728"	9	"V258"	-0.017668487	0.696332629	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	50
"2729"	7	"V197"	0.017641607	0.700341523	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	36
"2730"	24	"V154"	-0.01764133	0.698852392	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	13
"2731"	11	"V160"	-0.017581522	0.697459311	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	16
"2732"	17	"V22"	-0.017554483	0.698195678	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	45
"2733"	8	"V18"	-0.017538528	0.698162832	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	29
"2734"	13	"V227"	0.017493487	0.700074541	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	46
"2735"	3	"V218"	-0.01748212	0.699086249	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	44
"2736"	11	"V268"	0.017467232	0.699330037	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	55
"2737"	18	"V126"	-0.017438941	0.702141538	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	9
"2738"	7	"V269"	0.017418334	0.703954233	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	56
"2739"	8	"V79"	0.017413434	0.700211252	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	126
"2740"	10	"V180"	0.017393286	0.726345369	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	30
"2741"	18	"V116"	-0.017364203	0.703357566	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	5
"2742"	9	"V414"	-0.017361676	0.701350639	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	103
"2743"	12	"V367"	-0.017353997	0.701476398	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	88
"2744"	19	"V166"	0.017351027	0.714378224	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	20
"2745"	1	"V344"	0.017309766	0.702200942	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	79
"2746"	15	"V71"	-0.017206991	0.724704936	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	124
"2747"	22	"V448"	-0.017202304	0.703673465	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	113
"2748"	11	"V432"	0.017090419	0.705510692	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	108
"2749"	14	"V161"	-0.017063689	0.705949875	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	17
"2750"	1	"V405"	-0.01700099	0.707266437	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	99
"2751"	3	"V154"	-0.016980905	0.707310649	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	13
"2752"	4	"V18"	0.016948235	0.708133181	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	29
"2753"	3	"V176"	0.016820078	0.709956949	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	27
"2754"	22	"V413"	-0.016819095	0.709973136	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	102
"2755"	2	"V311"	-0.016793975	0.710669798	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	71
"2756"	3	"V329"	-0.016741205	0.711256031	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	75
"2757"	1	"V341"	0.016734037	0.711656278	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	78
"2758"	3	"V18"	-0.016722596	0.711562655	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	29
"2759"	9	"V182"	-0.016706595	0.71210808	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	31
"2760"	3	"V405"	0.01670374	0.711873388	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	99
"2761"	21	"V116"	0.016670936	0.712414093	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	5
"2762"	19	"V396"	-0.016653748	0.725383431	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	97
"2763"	5	"V393"	0.016643829	0.713141844	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	96
"2764"	21	"V189"	0.016584839	0.713833924	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	34
"2765"	24	"V466"	-0.016580867	0.716147909	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	121
"2766"	18	"V177"	0.016572943	0.716277703	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	28
"2767"	18	"V265"	0.016564202	0.71642088	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	53
"2768"	7	"V218"	-0.016502405	0.718843713	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	44
"2769"	5	"V189"	0.016498415	0.715538836	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	34
"2770"	2	"V118"	0.01649674	0.71556647	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	6
"2771"	7	"V252"	-0.016477209	0.719254849	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	49
"2772"	10	"V465"	0.016475746	0.740247101	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	120
"2773"	8	"V461"	0.016439781	0.716228319	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	117
"2774"	24	"V175"	-0.016427959	0.718654025	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	26
"2775"	8	"V281"	-0.016409493	0.716728615	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	62
"2776"	21	"V119"	-0.016278904	0.718887083	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	7
"2777"	3	"V268"	0.016239374	0.719540898	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	55
"2778"	4	"V392"	0.016232361	0.719931702	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	95
"2779"	4	"V22"	-0.016209055	0.720316964	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	45
"2780"	22	"V465"	-0.016183478	0.720465765	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	120
"2781"	18	"V382"	-0.016129152	0.723560076	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	92
"2782"	10	"V84"	0.016094748	0.746044882	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	129
"2783"	15	"V376"	-0.016092262	0.74188355	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	90
"2784"	2	"V329"	-0.016066011	0.722683038	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	75
"2785"	10	"V466"	-0.015982022	0.74776305	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	121
"2786"	22	"V392"	0.015967842	0.724037512	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	95
"2787"	8	"V171"	-0.015964249	0.724097074	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	23
"2788"	9	"V119"	-0.015954192	0.724534483	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	7
"2789"	20	"V162"	-0.015881777	0.72573435	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	18
"2790"	5	"V346"	-0.015868791	0.725949588	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	80
"2791"	5	"V259"	0.015827588	0.726632664	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	51
"2792"	13	"V311"	-0.015800927	0.72788181	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	71
"2793"	3	"V84"	-0.015774145	0.727250989	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	129
"2794"	3	"V413"	0.015772174	0.727283727	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	102
"2795"	24	"V382"	0.015763078	0.729586051	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	92
"2796"	5	"V102"	-0.015709543	0.728590848	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	3
"2797"	12	"V12"	-0.015667388	0.729290578	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	8
"2798"	11	"V173"	0.015505996	0.731707546	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	25
"2799"	13	"V447"	-0.015442281	0.733821709	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	112
"2800"	20	"V85"	0.015409999	0.733567733	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	130
"2801"	14	"V173"	-0.015337385	0.734514461	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	25
"2802"	3	"V172"	0.015293635	0.735243357	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	24
"2803"	10	"V350"	-0.015260879	0.758783911	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	82
"2804"	5	"V85"	0.015221724	0.73670164	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	130
"2805"	24	"V432"	-0.015181185	0.739198874	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	108
"2806"	16	"V28"	0.015153176	0.737585087	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	60
"2807"	8	"V466"	0.015131459	0.73794736	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	121
"2808"	14	"V270"	-0.015042442	0.739432953	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	57
"2809"	15	"V218"	0.015033681	0.75831665	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	44
"2810"	24	"V439"	-0.014975211	0.742611402	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	110
"2811"	11	"V183"	0.014931863	0.741279725	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	32
"2812"	2	"V183"	0.014921713	0.741704453	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	32
"2813"	21	"V289"	-0.014915312	0.741556276	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	63
"2814"	3	"V155"	0.014879058	0.74216215	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	14
"2815"	10	"V300"	0.014874857	0.764703596	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	68
"2816"	18	"V411"	-0.014853967	0.744622502	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	100
"2817"	20	"V252"	-0.014805931	0.74363809	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	49
"2818"	14	"V10"	-0.01476826	0.744014777	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	1
"2819"	9	"V420"	-0.01471606	0.745140123	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	106
"2820"	17	"V461"	0.01471463	0.745164029	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	117
"2821"	19	"V85"	0.01469166	0.756649495	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	130
"2822"	2	"V22"	-0.014683784	0.745679787	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	45
"2823"	21	"V79"	-0.014648806	0.746013821	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	126
"2824"	3	"V280"	0.014610766	0.746650765	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	61
"2825"	24	"V197"	0.014589338	0.749018007	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	36
"2826"	15	"V22"	-0.014504626	0.766571076	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	45
"2827"	4	"V13"	0.014485745	0.748993813	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	10
"2828"	19	"V341"	-0.014475006	0.760127459	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	78
"2829"	4	"V10"	0.014439263	0.749772321	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	1
"2830"	24	"V381"	-0.014428552	0.751692649	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	91
"2831"	16	"V382"	0.014426276	0.749742339	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	92
"2832"	8	"V183"	-0.01437564	0.750591561	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	32
"2833"	16	"V80"	-0.014335342	0.751267636	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	127
"2834"	8	"V175"	0.014324389	0.751451423	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	26
"2835"	9	"V289"	0.014306428	0.751998519	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	63
"2836"	24	"V268"	-0.01430349	0.753775099	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	55
"2837"	7	"V189"	0.014264073	0.755671001	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	34
"2838"	12	"V119"	0.014260587	0.752767262	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	7
"2839"	4	"V32"	0.014200813	0.753770011	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	72
"2840"	13	"V180"	-0.014192108	0.754649505	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	30
"2841"	1	"V364"	-0.014130301	0.754953436	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	87
"2842"	12	"V175"	-0.014085158	0.755711395	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	26
"2843"	7	"V33"	0.014075426	0.758801634	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	76
"2844"	2	"V13"	-0.014049758	0.756305917	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	10
"2845"	11	"V22"	0.014048318	0.756088418	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	45
"2846"	19	"V413"	0.014027463	0.767327176	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	102
"2847"	1	"V414"	0.013925369	0.758396138	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	103
"2848"	18	"V95"	0.013898604	0.760529184	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	136
"2849"	3	"V43"	0.01387934	0.75893098	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	107
"2850"	18	"V171"	0.013800499	0.762168481	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	23
"2851"	9	"V164"	-0.013717108	0.761899644	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	19
"2852"	9	"V36"	-0.0137104	0.762012573	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	86
"2853"	3	"V22"	0.013690784	0.762106731	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	45
"2854"	11	"V79"	-0.013689576	0.762127084	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	126
"2855"	17	"V44"	0.013667927	0.762727721	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	111
"2856"	15	"V211"	-0.013651136	0.779942874	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	42
"2857"	10	"V258"	0.013639236	0.783742723	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	50
"2858"	3	"V227"	-0.013606242	0.763531931	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	46
"2859"	1	"V376"	-0.013588031	0.764073536	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	90
"2860"	17	"V465"	0.013573698	0.764315038	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	120
"2861"	18	"V170"	0.013569864	0.766026504	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	22
"2862"	10	"V411"	-0.013483254	0.786155643	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	100
"2863"	16	"V92"	-0.01342269	0.766628972	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	135
"2864"	11	"V270"	0.013421192	0.766654269	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	57
"2865"	22	"V455"	-0.013403493	0.766953091	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	114
"2866"	1	"V289"	-0.013395135	0.767325688	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	63
"2867"	22	"V189"	0.013379086	0.767365248	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	34
"2868"	21	"V28"	0.013307906	0.768567594	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	60
"2869"	10	"V265"	-0.013282269	0.789267748	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	53
"2870"	10	"V461"	0.013248844	0.789785631	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	117
"2871"	6	"V439"	0.013241027	0.817457534	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	110
"2872"	9	"V92"	-0.013203887	0.770554107	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	135
"2873"	20	"V190"	0.013131598	0.771775431	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	35
"2874"	11	"V36"	-0.013085894	0.772321329	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	86
"2875"	13	"V30"	0.013062869	0.77361727	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	67
"2876"	4	"V411"	0.013028195	0.773523409	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	100
"2877"	11	"V352"	0.013013608	0.77354467	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	83
"2878"	19	"V119"	0.012869896	0.786040887	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	7
"2879"	22	"V269"	-0.012860829	0.776132105	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	56
"2880"	1	"V265"	-0.01285572	0.776441576	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	53
"2881"	15	"V189"	0.012842518	0.79267192	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	34
"2882"	10	"V13"	-0.012833548	0.796227902	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	10
"2883"	11	"V332"	-0.012794065	0.777263586	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	77
"2884"	4	"V273"	-0.012785413	0.777632043	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	58
"2885"	5	"V156"	0.012784281	0.777651206	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	15
"2886"	4	"V413"	0.01275843	0.778089067	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	102
"2887"	3	"V166"	-0.012667404	0.779411459	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	20
"2888"	9	"V466"	0.012619625	0.780441258	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	121
"2889"	16	"V172"	-0.012607598	0.780426229	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	24
"2890"	2	"V175"	-0.012589556	0.780951078	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	26
"2891"	19	"V17"	0.012566743	0.790962716	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	21
"2892"	21	"V172"	-0.012558701	0.781256163	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	24
"2893"	22	"V30"	-0.012485846	0.782493206	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	67
"2894"	16	"V420"	0.012425844	0.783512414	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	106
"2895"	11	"V189"	-0.012379888	0.784293291	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	34
"2896"	23	"V367"	0.012259249	0.786344196	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	88
"2897"	3	"V364"	-0.012241982	0.786637861	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	87
"2898"	2	"V12"	0.012191511	0.787708668	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	8
"2899"	11	"V43"	-0.012148134	0.788234491	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	107
"2900"	13	"V273"	-0.01212781	0.789426675	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	58
"2901"	21	"V92"	0.012126058	0.788610204	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	135
"2902"	3	"V416"	-0.012066243	0.789628442	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	104
"2903"	5	"V448"	-0.012020071	0.790624148	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	113
"2904"	2	"V171"	-0.011964621	0.79156775	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	23
"2905"	24	"V357"	-0.011819774	0.795484049	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	84
"2906"	15	"V447"	-0.011736716	0.810168073	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	112
"2907"	18	"V176"	0.011725314	0.797082718	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	27
"2908"	11	"V289"	0.011718572	0.795553875	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	63
"2909"	24	"V80"	0.011712482	0.797299962	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	127
"2910"	18	"V241"	0.011660208	0.798185088	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	48
"2911"	1	"V465"	-0.011626941	0.797320637	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	120
"2912"	24	"V71"	-0.011580519	0.799534921	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	124
"2913"	8	"V447"	-0.011492477	0.799413614	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	112
"2914"	18	"V448"	-0.011477198	0.801285949	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	113
"2915"	3	"V72"	0.011467176	0.799845843	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	125
"2916"	9	"V393"	-0.011422951	0.800801265	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	96
"2917"	16	"V30"	-0.011401924	0.800960861	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	67
"2918"	17	"V116"	0.011309202	0.802743848	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	5
"2919"	10	"V172"	-0.011257126	0.820804843	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	24
"2920"	22	"V63"	0.011220579	0.80406175	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	123
"2921"	14	"V13"	0.011216617	0.804129535	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	10
"2922"	24	"V448"	0.011201425	0.805964445	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	113
"2923"	18	"V211"	-0.011160409	0.806660884	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	42
"2924"	6	"V432"	0.011110518	0.846430395	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	108
"2925"	14	"V200"	-0.01102182	0.80746395	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	38
"2926"	8	"V17"	-0.011009749	0.807670681	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	21
"2927"	22	"V412"	0.01098688	0.808062408	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	101
"2928"	2	"V18"	-0.010974541	0.808466163	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	29
"2929"	17	"V71"	0.010942667	0.80901171	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	124
"2930"	10	"V420"	-0.010896009	0.826460515	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	106
"2931"	11	"V44"	0.010874589	0.809986482	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	111
"2932"	9	"V372"	0.010862773	0.810379557	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	89
"2933"	21	"V211"	-0.010851849	0.810376258	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	42
"2934"	23	"V332"	-0.010829498	0.810759435	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	77
"2935"	4	"V381"	-0.010813214	0.811228325	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	91
"2936"	2	"V349"	0.010808851	0.811303069	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	81
"2937"	2	"V404"	-0.010734393	0.812578725	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	98
"2938"	19	"V79"	0.010722066	0.821084544	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	126
"2939"	18	"V44"	-0.010704667	0.814409348	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	111
"2940"	9	"V71"	0.010678796	0.813531579	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	124
"2941"	2	"V393"	0.010677414	0.81355527	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	96
"2942"	5	"V63"	-0.010621726	0.814509961	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	123
"2943"	22	"V176"	0.010576468	0.815100249	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	27
"2944"	13	"V79"	0.01048616	0.817389272	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	126
"2945"	23	"V382"	0.010445976	0.8173411	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	92
"2946"	19	"V447"	0.010399797	0.826375368	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	112
"2947"	16	"V189"	0.010329338	0.819345323	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	34
"2948"	18	"V289"	0.010279605	0.821652574	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	63
"2949"	3	"V387"	0.01021679	0.821280377	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	94
"2950"	19	"V162"	-0.010091492	0.831444303	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	18
"2951"	13	"V33"	-0.010067046	0.824566978	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	76
"2952"	23	"V311"	-0.0100221	0.824630255	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	71
"2953"	2	"V100"	-0.010006375	0.825077245	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	2
"2954"	20	"V465"	0.009994398	0.825283259	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	120
"2955"	9	"V190"	0.009978518	0.825556398	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	35
"2956"	15	"V392"	-0.009957849	0.838509532	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	95
"2957"	2	"V126"	-0.009912979	0.826683945	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	9
"2958"	10	"V413"	-0.009912056	0.841915569	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	102
"2959"	12	"V183"	0.009799014	0.828645455	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	32
"2960"	22	"V154"	-0.009782202	0.828762391	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	13
"2961"	7	"V411"	-0.009748396	0.831595035	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	100
"2962"	3	"V281"	-0.009714466	0.829929969	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	62
"2963"	16	"V190"	-0.009685261	0.830433504	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	35
"2964"	24	"V183"	-0.009674238	0.831994372	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	32
"2965"	9	"V189"	0.009670827	0.830853033	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	34
"2966"	18	"V352"	-0.009651913	0.832376339	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	83
"2967"	17	"V43"	-0.009646815	0.831266699	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	107
"2968"	5	"V466"	0.009644583	0.831305156	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	121
"2969"	9	"V18"	-0.009640586	0.831374028	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	29
"2970"	9	"V405"	0.009639706	0.831389186	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	99
"2971"	12	"V241"	0.009622973	0.831677499	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	48
"2972"	4	"V186"	-0.009604357	0.831998278	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	33
"2973"	4	"V166"	-0.009596544	0.832132909	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	20
"2974"	9	"V259"	0.009562838	0.832713799	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	51
"2975"	5	"V21"	0.009542628	0.833062141	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	41
"2976"	18	"V358"	-0.009524911	0.83454994	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	85
"2977"	9	"V465"	0.009471564	0.834287273	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	120
"2978"	18	"V154"	-0.009470151	0.835487543	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	13
"2979"	10	"V310"	-0.009412652	0.849783457	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	70
"2980"	9	"V216"	0.009404814	0.835438415	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	43
"2981"	12	"V387"	0.009390122	0.835691824	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	94
"2982"	19	"V182"	-0.009378486	0.843193535	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	31
"2983"	16	"V466"	-0.009365507	0.835950946	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	121
"2984"	22	"V119"	-0.009352651	0.836172951	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	7
"2985"	5	"V280"	0.009304433	0.837170183	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	61
"2986"	14	"V2"	-0.009293185	0.837200016	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	37
"2987"	16	"V364"	0.009255267	0.837855055	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	87
"2988"	17	"V289"	-0.009227775	0.838493217	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	63
"2989"	5	"V30"	0.009204283	0.838898759	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	67
"2990"	12	"V465"	0.009186212	0.839210733	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	120
"2991"	22	"V79"	0.009112446	0.840323306	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	126
"2992"	15	"V269"	-0.0090858	0.852482411	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	56
"2993"	1	"V227"	0.00908543	0.840951137	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	46
"2994"	18	"V156"	-0.009079694	0.842179613	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	15
"2995"	17	"V270"	0.00907026	0.841213169	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	57
"2996"	21	"V180"	-0.009057053	0.841281058	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	30
"2997"	2	"V200"	0.00897306	0.842892566	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	38
"2998"	23	"V411"	0.008964717	0.84287805	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	100
"2999"	10	"V320"	0.008903636	0.857818159	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	73
"3000"	1	"V459"	0.008868767	0.844695306	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	115
"3001"	1	"V21"	0.008853363	0.844961622	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	41
"3002"	18	"V142"	-0.008822302	0.84659732	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	11
"3003"	9	"V455"	-0.008732358	0.84705439	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	114
"3004"	6	"V227"	0.008724532	0.879122982	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	46
"3005"	18	"V387"	-0.008714744	0.848444822	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	94
"3006"	4	"V95"	-0.008655548	0.848383365	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	136
"3007"	14	"V252"	-0.00859166	0.849336748	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	49
"3008"	17	"V252"	-0.00857396	0.849795484	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	49
"3009"	19	"V392"	0.008533021	0.857170543	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	95
"3010"	5	"V320"	-0.008486238	0.851314305	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	73
"3011"	4	"V372"	-0.008470736	0.85158275	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	89
"3012"	20	"V420"	-0.00846555	0.851672572	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	106
"3013"	11	"V364"	-0.008449358	0.851803104	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	87
"3014"	5	"V36"	0.008448944	0.851960166	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	86
"3015"	21	"V160"	-0.008437583	0.852007239	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	16
"3016"	18	"V190"	0.00837869	0.854222429	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	35
"3017"	13	"V382"	0.008341551	0.854265713	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	92
"3018"	3	"V294"	0.00831003	0.854219302	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	65
"3019"	19	"V420"	-0.008266745	0.861582021	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	106
"3020"	6	"V173"	-0.008263418	0.88546668	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	25
"3021"	20	"V376"	0.008258285	0.855263632	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	90
"3022"	24	"V447"	0.008247504	0.856479976	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	112
"3023"	21	"V43"	-0.008158807	0.856843337	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	107
"3024"	11	"V300"	-0.008140434	0.857162246	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	68
"3025"	22	"V18"	-0.008126146	0.857410282	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	29
"3026"	4	"V436"	0.008117067	0.857712094	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	109
"3027"	9	"V13"	-0.008114776	0.85775182	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	10
"3028"	2	"V30"	-0.008099319	0.858019898	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	67
"3029"	12	"V18"	-0.008077033	0.858406453	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	29
"3030"	10	"V260"	-0.00806496	0.871088164	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	52
"3031"	24	"V280"	0.008050263	0.859876464	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	61
"3032"	14	"V44"	0.008015874	0.85932497	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	111
"3033"	8	"V327"	0.007991793	0.859743209	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	74
"3034"	15	"V270"	0.00796144	0.870565845	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	57
"3035"	12	"V30"	-0.00791952	0.861139481	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	67
"3036"	1	"V189"	0.007913979	0.861235657	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	34
"3037"	16	"V71"	-0.007900054	0.861336875	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	124
"3038"	2	"V269"	-0.007876488	0.86188642	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	56
"3039"	12	"V327"	0.007874042	0.86192888	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	74
"3040"	16	"V79"	-0.007866697	0.861916499	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	126
"3041"	7	"V18"	0.007768611	0.865429355	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	29
"3042"	2	"V320"	0.00773385	0.864363185	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	73
"3043"	5	"V43"	-0.0077112	0.864756589	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	107
"3044"	9	"V22"	-0.007704265	0.86487706	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	45
"3045"	12	"V349"	0.007629503	0.8661759	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	81
"3046"	10	"V383"	-0.007626507	0.878040298	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	93
"3047"	14	"V383"	-0.007597802	0.866591509	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	93
"3048"	18	"V463"	-0.007406025	0.870987915	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	119
"3049"	1	"V413"	0.007346512	0.871095541	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	102
"3050"	4	"V349"	0.007294967	0.871992159	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	81
"3051"	7	"V79"	0.007281183	0.87379985	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	126
"3052"	20	"V311"	0.007267	0.872478728	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	71
"3053"	21	"V12"	0.007238947	0.872837788	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	8
"3054"	3	"V414"	-0.007233411	0.872934214	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	103
"3055"	1	"V216"	-0.007220737	0.87328368	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	43
"3056"	20	"V100"	-0.007141669	0.874659744	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	2
"3057"	7	"V12"	-0.007132768	0.876351391	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	8
"3058"	20	"V447"	-0.007109565	0.875218575	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	112
"3059"	5	"V405"	0.007103682	0.875320992	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	99
"3060"	18	"V200"	-0.007038934	0.877330811	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	38
"3061"	21	"V350"	0.007000267	0.876996697	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	82
"3062"	4	"V344"	0.00699533	0.877207557	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	79
"3063"	12	"V80"	0.006900582	0.878857829	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	127
"3064"	22	"V357"	-0.006896953	0.878797971	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	84
"3065"	15	"V259"	0.006884065	0.887957278	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	51
"3066"	24	"V270"	-0.006851486	0.880572756	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	57
"3067"	21	"V13"	-0.006824582	0.880060128	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	10
"3068"	9	"V341"	-0.006732695	0.881783275	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	78
"3069"	6	"V180"	0.006700821	0.907015877	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	30
"3070"	24	"V79"	0.006682701	0.88349363	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	126
"3071"	23	"V180"	-0.006662372	0.882890173	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	30
"3072"	11	"V259"	-0.00661682	0.883685181	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	51
"3073"	14	"V387"	-0.006607163	0.883853733	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	94
"3074"	5	"V10"	-0.006594058	0.884200272	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	1
"3075"	11	"V80"	0.006579456	0.88433737	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	127
"3076"	2	"V180"	0.006461361	0.886514711	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	30
"3077"	9	"V332"	-0.006428853	0.887081838	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	77
"3078"	19	"V291"	0.00642844	0.892148199	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	64
"3079"	4	"V268"	-0.006408003	0.887445616	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	55
"3080"	24	"V376"	-0.00628144	0.890443849	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	90
"3081"	17	"V189"	0.006249772	0.890207122	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	34
"3082"	22	"V100"	0.006207037	0.89084217	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	2
"3083"	9	"V183"	0.006161301	0.891751746	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	32
"3084"	10	"V218"	-0.006158443	0.901383354	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	44
"3085"	5	"V218"	-0.006149096	0.891964863	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	44
"3086"	18	"V413"	-0.006144575	0.892816431	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	102
"3087"	3	"V465"	0.006072743	0.893189629	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	120
"3088"	21	"V358"	-0.006050887	0.893571753	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	85
"3089"	7	"V364"	0.006044691	0.895095053	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	87
"3090"	10	"V269"	0.006016661	0.903642604	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	56
"3091"	24	"V177"	0.00596854	0.895869423	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	28
"3092"	9	"V166"	0.005939165	0.895631795	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	20
"3093"	12	"V92"	0.005888279	0.896520962	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	135
"3094"	24	"V91"	0.005877858	0.897442742	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	134
"3095"	2	"V364"	0.005869488	0.896849361	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	87
"3096"	9	"V412"	0.005809732	0.897893751	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	101
"3097"	4	"V72"	-0.005805183	0.897973266	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	125
"3098"	9	"V175"	-0.005804454	0.897986015	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	26
"3099"	12	"V273"	-0.005777571	0.898455927	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	58
"3100"	24	"V463"	0.005730629	0.89999799	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	119
"3101"	6	"V411"	-0.005725821	0.920497404	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	100
"3102"	3	"V171"	0.005683306	0.900002159	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	23
"3103"	11	"V71"	-0.005630463	0.900927142	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	124
"3104"	20	"V24"	-0.005564436	0.902182793	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	47
"3105"	1	"V332"	-0.005533129	0.902730401	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	77
"3106"	18	"V414"	-0.005532222	0.9034431	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	103
"3107"	21	"V154"	-0.005504886	0.903125816	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	13
"3108"	16	"V22"	-0.005465059	0.903823275	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	45
"3109"	12	"V218"	0.005453714	0.904119721	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	44
"3110"	5	"V252"	-0.005436915	0.904413635	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	49
"3111"	24	"V289"	-0.005418096	0.905425591	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	63
"3112"	8	"V119"	-0.005413385	0.904728317	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	7
"3113"	7	"V22"	0.005408442	0.906083165	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	45
"3114"	16	"V411"	-0.005338026	0.906048428	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	100
"3115"	10	"V32"	0.005304256	0.915005966	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	72
"3116"	17	"V182"	0.00528552	0.907063125	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	31
"3117"	23	"V447"	-0.005235358	0.907847326	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	112
"3118"	24	"V227"	0.005175483	0.909641982	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	46
"3119"	8	"V294"	-0.005175338	0.908899187	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	65
"3120"	20	"V270"	-0.005093183	0.910430607	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	57
"3121"	18	"V259"	-0.005075767	0.911375696	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	51
"3122"	7	"V432"	-0.005063089	0.912055113	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	108
"3123"	9	"V350"	-0.005049082	0.911202962	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	82
"3124"	14	"V142"	-0.005034077	0.911375449	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	11
"3125"	1	"V100"	-0.005005037	0.911974411	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	2
"3126"	22	"V227"	-0.004986607	0.912207761	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	46
"3127"	17	"V439"	-0.004919583	0.913471398	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	110
"3128"	8	"V372"	0.004788605	0.9156805	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	89
"3129"	19	"V367"	-0.004787673	0.91956693	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	88
"3130"	18	"V364"	-0.004768431	0.916721809	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	87
"3131"	5	"V200"	0.004687141	0.917544859	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	38
"3132"	18	"V392"	0.00466337	0.918550229	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	95
"3133"	21	"V311"	-0.004570805	0.91950233	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	71
"3134"	23	"V413"	-0.004537719	0.920083059	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	102
"3135"	3	"V432"	0.004487022	0.920973001	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	108
"3136"	24	"V216"	-0.004479214	0.921756182	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	43
"3137"	24	"V44"	-0.004469688	0.921922058	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	111
"3138"	14	"V81"	0.004430367	0.921967636	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	128
"3139"	18	"V436"	0.004401162	0.923115371	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	109
"3140"	9	"V269"	-0.004385863	0.922827843	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	56
"3141"	12	"V372"	0.004350251	0.923452535	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	89
"3142"	14	"V72"	0.004308404	0.924109241	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	125
"3143"	3	"V55"	-0.004281582	0.924580294	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	122
"3144"	15	"V382"	-0.00427708	0.930247276	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	92
"3145"	9	"V100"	-0.004204086	0.926017016	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	2
"3146"	14	"V189"	-0.004203261	0.925955926	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	34
"3147"	18	"V33"	-0.004166959	0.927195086	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	76
"3148"	20	"V173"	0.004151727	0.92693584	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	25
"3149"	5	"V465"	-0.004146239	0.927032151	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	120
"3150"	9	"V81"	-0.004130517	0.927308074	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	128
"3151"	15	"V30"	-0.004127667	0.932678152	"PD-0332991 "	""	"CDK4/6"	"CDK4/6 Inhibitor"	"Kinase inhibitor"	"Phase II"	"Pfizer "	67
"3152"	4	"V376"	-0.004063884	0.92847758	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	90
"3153"	14	"V166"	0.004025729	0.929074934	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	20
"3154"	10	"V349"	0.004020355	0.935527355	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	81
"3155"	10	"V412"	-0.003981032	0.936156627	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	101
"3156"	18	"V197"	-0.003976636	0.930511849	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	36
"3157"	11	"V439"	-0.00388755	0.931503323	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	110
"3158"	12	"V413"	0.003882356	0.931664446	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	102
"3159"	19	"V311"	0.003866555	0.935003703	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	71
"3160"	1	"V190"	0.003792783	0.933237366	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	35
"3161"	4	"V81"	-0.003782761	0.933413382	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	128
"3162"	22	"V466"	-0.003695374	0.934881695	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	121
"3163"	6	"V332"	-0.003686195	0.948768947	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	77
"3164"	23	"V227"	0.003620259	0.936202511	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	46
"3165"	4	"V291"	-0.003614625	0.936366644	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	64
"3166"	7	"V382"	0.003605195	0.93731617	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	92
"3167"	22	"V280"	-0.003583766	0.936844263	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	61
"3168"	24	"V126"	0.003522562	0.938429736	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	9
"3169"	10	"V18"	-0.003516801	0.943588424	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	29
"3170"	4	"V171"	-0.003491526	0.938529389	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	23
"3171"	22	"V9"	-0.003415494	0.93980396	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	131
"3172"	22	"V9"	-0.003415494	0.93980396	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	132
"3173"	11	"V164"	-0.00340475	0.939992964	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	19
"3174"	8	"V460"	0.003400246	0.940072191	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	116
"3175"	23	"V300"	0.003369868	0.940606618	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	68
"3176"	1	"V320"	-0.003258877	0.942618089	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	73
"3177"	20	"V269"	-0.003193596	0.943765652	"Sorafenib"	"Nexavar"	"Flt3, C-KIT, PDGFRbeta, RET, Raf kinase B, Raf kinase C, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2005"	"Bayer"	56
"3178"	14	"V299"	-0.003183312	0.943889117	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	66
"3179"	24	"V218"	0.003030924	0.947009486	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	44
"3180"	18	"V189"	0.0029394	0.948607416	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	34
"3181"	8	"V227"	0.002918457	0.948550913	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	46
"3182"	19	"V412"	-0.002887816	0.951432747	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	101
"3183"	22	"V160"	0.002887184	0.94910148	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	16
"3184"	6	"V367"	-0.002836839	0.960563018	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	88
"3185"	24	"V32"	-0.00279228	0.951176418	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	72
"3186"	10	"V43"	0.002765292	0.955629299	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	107
"3187"	5	"V327"	0.002720976	0.95207703	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	74
"3188"	19	"V91"	0.002592662	0.956391541	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	134
"3189"	1	"V329"	-0.002588893	0.954400784	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	75
"3190"	5	"V227"	0.002512405	0.955746628	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	46
"3191"	18	"V218"	0.00250863	0.956130917	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	44
"3192"	7	"V447"	0.00249948	0.956518413	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	112
"3193"	24	"V260"	0.002439871	0.957332189	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	52
"3194"	24	"V22"	-0.002435658	0.957405805	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	45
"3195"	11	"V85"	-0.002348061	0.958596414	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	130
"3196"	17	"V300"	-0.002336864	0.958835813	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	68
"3197"	18	"V376"	0.002322053	0.959390793	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	90
"3198"	8	"V413"	-0.002294803	0.959534725	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	102
"3199"	2	"V387"	0.002214789	0.960984483	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	94
"3200"	21	"V404"	0.002184673	0.961475196	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	98
"3201"	9	"V208"	0.002130965	0.962460047	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	40
"3202"	21	"V200"	0.00210104	0.962948945	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	38
"3203"	5	"V463"	-0.002096165	0.96307267	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	119
"3204"	3	"V90"	0.002072516	0.963451612	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	133
"3205"	3	"V189"	0.002047499	0.963892501	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	34
"3206"	5	"V372"	-0.001976165	0.965185335	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	89
"3207"	16	"V218"	-0.001945254	0.965694479	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	44
"3208"	6	"V289"	0.001943089	0.972982787	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	63
"3209"	24	"V84"	-0.001933761	0.966177126	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	129
"3210"	1	"V156"	-0.001933293	0.965940181	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	15
"3211"	6	"V79"	0.001825821	0.974612921	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	126
"3212"	10	"V289"	0.001782868	0.971384759	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	63
"3213"	22	"V273"	-0.001757395	0.9690058	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	58
"3214"	11	"V172"	0.001721912	0.96963132	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	24
"3215"	12	"V439"	0.001685997	0.97029488	"Paclitaxel"	"Taxol"	"beta-tubulin "	"Microtubule-Stabilizing Agents"	"Cytotoxic"	"Launched-1993"	"Bristol-Myers Squibb"	110
"3216"	7	"V273"	-0.001657515	0.971157791	"L-685458"	""	"Gamma Secretase"	"gamma-Secretase Inhibitor"	"Other targeted therapies"	"Preclinical"	"Merck Sharp & Dohme"	58
"3217"	16	"V183"	0.001655774	0.97079727	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	32
"3218"	24	"V404"	0.001618357	0.971691374	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	98
"3219"	4	"V160"	-0.001557144	0.972564244	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	16
"3220"	5	"V310"	0.001509097	0.973410501	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	70
"3221"	6	"V392"	0.001461034	0.979684449	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	95
"3222"	24	"V186"	-0.001450244	0.974631095	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	33
"3223"	18	"V81"	0.001426445	0.975047295	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	128
"3224"	9	"V90"	-0.001375263	0.975767914	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	133
"3225"	5	"V436"	-0.001364135	0.975963935	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	109
"3226"	2	"V190"	-0.001280119	0.97744395	"AEW541"	""	"IGF-1R"	"IGF-1R Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	35
"3227"	17	"V180"	0.00127978	0.977449909	"PHA-665752"	""	"c-MET"	"c-MET Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Pfizer "	30
"3228"	6	"V162"	0.001260841	0.982468036	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	18
"3229"	18	"V300"	-0.001259666	0.977964056	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	68
"3230"	3	"V381"	-0.001248661	0.977975582	"AZD0530"	"Saracatinib"	"Src, Abl/Bcr-Abl, EGFR"	"Src and Abl inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	91
"3231"	5	"V364"	-0.001227744	0.978366614	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	87
"3232"	18	"V269"	0.001149254	0.97989521	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	56
"3233"	1	"V186"	-0.001135902	0.979984626	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	33
"3234"	8	"V381"	-0.001131976	0.980033355	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	91
"3235"	18	"V186"	-0.001067559	0.981324153	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	33
"3236"	9	"V241"	-0.001046568	0.981558534	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	48
"3237"	18	"V281"	0.00101815	0.982188412	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	62
"3238"	19	"V71"	0.001014532	0.982929127	"RAF265"	""	"Raf kinase B, KDR"	"Raf kinase B and KDR Inhibitor"	"Kinase inhibitor"	"Phase I"	"Novartis"	124
"3239"	8	"V28"	-0.000989423	0.982547496	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	60
"3240"	16	"V350"	0.000987592	0.982579784	"PF-2341066"	"Crizotinib"	"c-MET, ALK"	"c-MET and ALK Inhibitor"	"Kinase inhibitor"	"Launched-2011"	"Pfizer "	82
"3241"	8	"V91"	-0.00095901	0.983083899	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	134
"3242"	11	"V461"	0.000953144	0.983187356	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	117
"3243"	18	"V161"	-0.000922721	0.983857706	"PLX4720"	""	"RAF "	"Raf kinase B Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Plexxikon"	17
"3244"	8	"V55"	-0.000894742	0.984217433	"Lapatinib"	"Tykerb"	"EGFR, HER2"	"EGFR and HER2 Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"GlaxoSmithKline"	122
"3245"	23	"V432"	0.000875382	0.984558915	"Topotecan"	"Hycamtin"	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1996"	"GlaxoSmithKline"	108
"3246"	4	"V280"	-0.000859521	0.984854183	"AZD6244"	"Selumetinib"	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Phase II"	"AstraZeneca"	61
"3247"	24	"V327"	0.000840627	0.985293779	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	74
"3248"	11	"V269"	-0.00082176	0.985504704	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	56
"3249"	13	"V218"	0.000754592	0.986744051	"Panobinostat  "	"Faridak "	"HDAC"	"Histone Deacetylase (HDAC) Inhibitor"	"Other targeted therapies"	"Pre-Registered"	"Novartis"	44
"3250"	11	"V119"	0.000557283	0.990169903	"Nutlin-3"	""	"MDM2"	"MDM2 Inhibitor"	"Other targeted therapies"	"Preclinical"	"Roche"	7
"3251"	9	"V320"	-0.000516301	0.990902157	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	73
"3252"	5	"V11"	0.000503684	0.991124494	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	4
"3253"	21	"V227"	0.000469248	0.99172286	"TAE684"	""	"ALK"	"ALK Inhibitor"	"Kinase inhibitor"	"Preclinical"	"Novartis"	46
"3254"	9	"V448"	0.000446911	0.99212497	"LBW242"	""	"IAP"	"Inhibitor of Apoptosis Proteins (IAP) Inhibitor"	"Other targeted therapies"	"Preclinical"	"Novartis"	113
"3255"	6	"V357"	-0.000430751	0.994011915	"Irinotecan"	"Camptosar "	"Topoisomerase I"	"DNA Topoisomerase I Inhibitor"	"Cytotoxic"	"Launched-1994"	"Pfizer "	84
"3256"	1	"V183"	-0.000397879	0.992989032	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	32
"3257"	24	"V266"	-0.000393017	0.993124612	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	54
"3258"	14	"V63"	0.000390371	0.993114297	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	123
"3259"	10	"V90"	0.000375536	0.993972497	"Nilotinib"	"Tasigna"	"Abl/Bcr-Abl"	"Abl Inhibitor"	"Kinase inhibitor"	"Launched-2007"	"Novartis"	133
"3260"	14	"V18"	0.000337134	0.994053449	"PD-0325901"	""	"MEK"	"MEK1 and MEK2 Inhibitor"	"Kinase inhibitor"	"Discontinued"	"Pfizer "	29
"3261"	1	"V10"	0.000314437	0.994459511	"17-AAG"	"Tanespimycin"	"HSP90"	"Heat Shock Protein 90 (hsp90) Inhibitor"	"Other targeted therapies"	"Phase III"	"Bristol-Myers Squibb"	1
"3262"	24	"V43"	-0.000310091	0.994575495	"Vandetanib"	"Zactima"	"Abl, EGFR, Flt3, C-KIT, RET, VEGFR-1, KDR, FLT4"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Launched-2011"	"AstraZeneca"	107
"3263"	5	"V24"	-0.000185038	0.996739931	"Erlotinib"	"Tarceva"	"EGFR"	"EGFR  Inhibitor"	"Kinase inhibitor"	"Launched-2004"	"Genentech"	47
"3264"	22	"V32"	1.12e-05	0.999802675	"TKI258"	"Dovitinib"	"EGFR, FGFR1, PDGFRbeta, VEGFR-1, KDR"	"Multi-kinase inhibitor"	"Kinase inhibitor"	"Phase III"	"Novartis"	72
